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The NGFIB family of nuclear receptors consists of three members: Nurrl, nur77 
and NOR-1. Genes from this family are classified as immediate early genes in that 
they  are  rapidly  and  transiently  induced  by  a  variety  of  stimuli,  including 
neurotransmitters, growth factors, cAMP and fatty acids. Although  identified as 
having no putative ligand binding domain, regulation of these nuclear receptors 
may  be  at  the  level  of phosphorylation  or RXR  heterodimerisation.  Nurrl  and 
nur77 are expressed in adipose tissue at levels greater than in liver, spleen, lung 
and kidney, in both human and mouse tissue. During adipogenesis in both 3T3-L1 
cells and primary sub-cutaneous murine preadipocytes, there is induction of Nurrl 
and  nur77  expression  between  60  and  120  minutes  after  which  expression 
subsides.  Using different protocols to induce differentiation it was demonstrated 
that  isobutylmethylxanthine  (IBMX),  a  phosphodiesterase  inhibitor  which 
elevates intracellular cAMP, was a critical requirement for inducing the transient 
Nurrl  expression as  well  as  adipogenesis.  In  order to investigate  the effect of 
Nurrl  expression  in  adipogenesis,  an  adenovirus  mediated  over-expression 
system  was  employed.  Over-expression  of  Nurrl  resulted  in  a  decrease  in 
adipogenesis,  as  well  as  decreases  in  the  expression  of  PPARy  and  C/EBPa. 
Examination of adipocyte morphology illustrated that cells over-expressing Nurrl 
had less lipid accumulation, as assessed by Oil red O and by confocal microscopy. 
Furthermore  mRNA  analysis  of  adipocyte  markers  showed  reduced  levels  of 
Hormone Sensitive Lipase (HSL), CD36 and Perilipin expression. In addition, the 
effect  on  adipocyte  function,  namely  lipolysis  and  glucose  uptake,  was  also 
investigated.  Results  suggest  that  Nurrl  does  not  significantly  alter  glucose 
uptake but does elevate lipolysis.  Subsequent to the findings above, microarray 
analysis has been performed on control and Nurrl  over-expressing 3T3-L1  cells 
at  two  time  points  (72hrs  and  192hrs),  post  differentiation.  Analysis  of  the 
microarray data confirmed the earlier findings on adipogenesis and has identified 
a number of additional  pathways,  in which Nurrl  would appear to play  a role, 
namely  -   NO  pathway,  steroidogenesis  and  cytokine/prostaglandin  regulation. 
Preliminary  work  has  been  performed  with  siRNA  to  knock-down  the  gene
2expression  of  Nurrl  in  order  to  investigate  potential  consequences  on 
adipogenesis.  In conclusion, a supposed role for Nurrl  has been demonstrated in 
adipogenesis and lipid accumulation and also adipocyte secretory and metabolic 
function, with implications for insulin resistance at the adipocyte level.
3Acknowledgements
Firstly I would like to thank GSK for giving me the opportunity both timewise 
and  financially  to  pursue  this  PhD  - To  Bill  Cairns,  Owen  Jenkins  and  Mike 
Romanos.
Very  special  thanks  to  Vidya  Mohamed-Ali  for being  a terrific  supervisor and 
allowing me the chance to pursue my PhD in her lab.  Her enthusiasm and zest for 
science is infectious.
For all those people in the labs both at GSK and UCL, thank you for your advice, 
help and encouragement.
Thanks to my family and friends who were there for me and encouraged me every 
step of the way.
Finally, most special thanks to my husband Barry, without whom I don’t think I 
would have reached the end.  You’ve been there for me in more ways than one.
4Abstract
Acknowledgements
Contents
Abbreviations
Chanter 1: Introduction and Literature Review 
What is a Nuclear Receptor?
Nuclear receptor domain structure
Fig.  1.1 Schematic representation of nuclear receptor 
structure 
Hormone response elements
Fig. 1.2 Variety of response elements arrangements 
Co-activators and Co-repressors 
The NGFIB subfamily of nuclear receptors 
Fig.  1.3 NGFIB family homology 
Fig. 1.4  NGFIB family nomenclature 
Regulation of the NGFIB family 
NGFIB and phosphorylation
Fig.  1.5 Potential MAPK consensus region 
NGFIB and heterodimerisation with RXR 
Pharmacological modulation of NGFIB 
Functions of the NGFIB family 
NGFIB and dopamine signalling 
NGFIB and their role in bone 
NGFIB and HPA axis
Fig 1.6 NurRE and POMC promoter 
Fig.  1.7 NGFIB and HPA axis 
NGFIB and inflammation 
NGFIB and other putative functional roles 
NGFIB and their putative role in adipogenesis
Fig. 1.8 Expression analysis of NGFIB familyFig. 1.9 Nurrl induction during adipogenesis  41
Aims of study  42
Chapter  2:  Expression of NGFIB  subfamily  in  murine  adipose  tissue  and 
during adipogenesis 
Introduction
Adipose tissue  45
In vitro induction of adipogenesis  47
Experimental Procedures
Cell culture  49
Isolation of RNA from adipocytes, murine tissues and adipose 
tissue fractions  50
cDNA synthesis  51
SybrGreen RT-PCR  52
Fig. 2.1 Primer sequences for SybrGreen PCR  analysis  52
Results
Expression of Nurrl and nur77 in murine C57BL/6J Tissues  53
Induction of Nurrl and nur77 in 3T3-L1 cells following addition of differentiation 
cocktail  53
Fig. 2.2 Expression of Nurrl in murine C57BL/6J tissues  55
Fig. 2.3 Expression of nur77 in murine C57BL/6J tissues  56
Fig. 2.4 Expression of Nurrl in murine C57BL/6J adipose tissue 
fractions  57
Fig 2.5 Expression of nur77 in murine C57BL/6J adipose tissue 
fractions  58
Fig. 2.6 Induction of Nurrl during adipogenesis  59
Fig. 2.7 Induction of nur77 during adipogenesis  60
Analysis of cocktail components on Nurrl  and nur77 induction  61
Fig. 2.8 Induction of NGFIB family members in response to 
insulin  62
Fig 2.9 Induction of NGFIB family members in response to
dexamethasone  63
6Fig 2.10 Induction of NGFIB family members in response to 
IBMX  64
Fig 2.11  Induction of NGFIB family members in response to 
insulin and dexamethasone  65
Fig 2.12 Induction of NGFIB family members in response to 
dexamethasone and IBMX  66
Fig 2.13 Induction of NGFIB family members in response to 
insulin and IBMX  67
Induction of Nurrl and nur77 in primary pre-adipocytes and analysis 
of differentiation cocktail components  68
Fig. 2.14 Induction of Nurrl in primary pre-adipocytes  69
Fig. 2.15 Induction of nur77 in primary pre-adipocytes  70
Fig. 2.16 Analysis of differentiation cocktail on Nurrl induction  71
Fig. 2.17 Analysis of differentiation cocktail on nur77 induction  72
Discussion  73
Chapter 3: Effect of Nurrl over-expression on adipogenesis 
and adipocyte function 
Introduction
In vitro adipogenesis  79
Regulation of adipogenesis  80
Fig. 3.1 Model of adipogenesis  83
Inhibitors of adipogenesis  84
Experimental Procedures
Generation of Nurrl adenovirus construct  87
Transduction of 3T3-L1 cells with NurrlpAdTrackCMV-GFP  88
Western blot analysis of Nurrl over-expression  88
Differentiation of 3T3-L1 cells  88
Isolation of RNA from differentiating 3T3-L1 cells  89
cDNA synthesis  89
SybrGreen PCR analysis  90
Fig. 3.2 Primer sequences for SybrGreen PCR analysis  91
7Analysis of lipid content in differentiated 3T3-L1 cells  91
Lipolysis analysis  93
Glucose uptake  93
Results
Over-expression of Nurrl in differentiating 3T3-L1 cells  95
Analysis of markers of adipogenesis  95
Fig. 3.3 Over-expression of Nurrl  adenovirus in 3T3-L1  cells  97
Fig. 3.4 Over-expression of Nurrl adenovirus in 3T3-L1  cells  98
Fig. 3.5 Comparison of Nurrl  and GFP null adenovirus  99
Fig. 3.6 Western Blot of Nurrl  100
Fig. 3.7 Expression of regulatory genes during adipogenesis in 
3T3-L1 Cells - PPARy  101
Fig. 3.8 Expression of regulatory genes during adipogenesis in
3T3-L1 cells - C/EBPa  102
Fig. 3.9 -  Expression of adipogenic genes during adipogenesis on 
3T3-L1 cells - Perilipin  103
Fig. 3.10 -  Expression of adipogenic genes during adipogenesis on
3T3-L1 cells - HSL  104
Fig. 3.11 -  Expression of adipogenic genes during adipogenesis on
3T3-L1 Cells-CD36  105
Analysis of lipid content in differentiated 3T3-L1 cells  106
Lipolysis analysis in differentiated primary murine adipocytes +/- Nurr  106 
Glucose uptake analysis in differentiated 3T3-L1 adipocytes +/- Nurrl  106 
Fig. 3.12 Oil Red O images of differentiated 3T3-L1 cells  107
Fig. 3.13 Confocal images of differentiated 3T3-L1 cells  108
Fig. 3.14 Index of Bodipy 493/503 staining of 3T3-L1 
adipocytes+/-Nurrl  109
Fig. 3.15 NEFA release in differentiated primary adipocytes  110
Fig. 3.16 Glucose uptake in differentiated in 3T3-L1 adipocytes  111 
Discussion  112
8Chanter 4: Effect of Nurrl over-expression on adipocvte gene expression bv 
Microarrav analysis
Introduction  119
Fig. 4.1 Overview of microarray procedure  121
Fig. 4.2 Image of an Affymetrix Genechip array  122
Experimental Procedures
Transduction of 3T3-L1 cells with Nurrl pAdTrackCMV-GFP  123
Differentiation of 3T3-L1 cells  123
Isolation of RNA from differentiating 3T3-L1 cells  123
RNA quantification and QC  124
Fig 4.3 In Silico gel image of RNA from Agilent 2100  125
Fig 4.4 RNA chromatograph from Agilent 2100  126
Microarray and Analysis  127
Results
Microarray Analysis  128
Fig. 4.5 Numerical representation of mRNA changes  130
Table 1  Regulators of adipogenesis  131
Table 2 Lipid metabolism related genes  132
Table 3 Secreted Factors/Adipokines  133
Table 4 Adipogenesis associated genes  134
Table 5 Genes associated with NO pathway  135
Table 6 Matrix Metalloproteinases and associated genes  136
Table 7 KLF Transcription factors  137
Table 8 Nuclear receptors  138
Table 9 G-Protein coupled receptors  139
Table 10 Genes associated with adipose tissue  140
Fig. 4.6 Mouse IL-6 release in differentiating 3T3-L1 cells  141
Fig. 4.7 Mouse MCP-1 release in differentiating 3T3-L1 cells  142
Fig. 4.8 Mouse RANTES release in differentiating 3T3-L1 cells  143 
Fig. 4.9 Mouse MCP-1 release in differentiating primary 
mouse adipocytes  144
9Fig. 4.10 Mouse RANTES release in differentiating
primary mouse adipocytes  145
Discussion  146
Fig. 4.11 Steroid synthesis and NGFIB involvement  158
Fig. 4.12 Interrealtionship between NO-citrulline
pathway and methionine/homocysteine metabolism  159
Chanter 5: Effect of Nurrl gene knockdown on adipogenesis and 
adinocvte secretory functions
Introduction  161
Experimental Procedures
Nurrl and nur77 siRNA  162
Transfection efficiency of 3T3-L1 cells with siRNA  162
Nurrl and nur77 siRNA transfections in 3T3-L1 cells  162
Functional analysis of Nurrl and nur77 in 3T3-L1 cells  163
Results
Transfection efficiency of 3T3-L1 cells with siRNA  165
Nurrl and nur77 siRNA transfections in 3T3-L1 cells  165
Fig. 5.1 Nurrl expression in 3T3-L1 cells expressing Nurrl siRNA 166 
Fig. 5.2 nur77 expression in 3T3-L1 cells expressing Nurrl siRNA 167 
Fig. 5.3 nur77 expression in 3T3-L1 cells expressing nur77 siRNA 168 
Fig. 5.4 Nurrl expression in 3T3-L1 cells expressing nur77 siRNA 169 
Fig. 5.5 Oil red O staining of differentiated 3T3-L1 cells following
transfection with siRNA’s  170
Discussion  171
Chapter  6: Conclusions and Future Plans  173
Supplementary Data  179
Bibliography  181
10ACTH  Adrenocorticotrophic hormone
ADDl/SREBPlc  Adipocyte determination and differentiation-
dependent factor/sterol regulatory element binding 
protein lc
ADH2  Alcohol dehydrogenase 2
AF-1/2  Activation function-1/2
AhR  Arylhydrocarbon receptor
AMPKy3  Adenosine monophosphate kinase y3
BAT  Brown adipose tissue
C/EBP  CAAT/Enhancer binding protein
COUP TF  COUP transcription factor
CPM  Counts per minute
CPT1  Carnitine palmitoyltransferase
CRE  cAMP response element
CREB  cAMP response element binding protein
CRH  corticotrophin releasing hormone
Cyp 11B2  Cytochrome P450 11B2
Cyp21  Cytochrome P450 21
DA  Dopamine
DBD  DNA binding domain
Dex  Dexamethasone
DHR38  Drosophila homolog receptor 38
DR5  Direct repeat 5
EGF  Epidermal growth factor
ERK1/2  Extracellular signal-regulated kinase 1/2
FBS  Foetal bovine serum
FXR  Faresnoid X receptor
GFP  Green fluorescent protein
GH  Growth hormone
GLUT 1/4  Glucose transporter 1/4
11GSK GlaxoSmithKline
HPA Hypothalamic pituitary adrenal
HRE Hormone response element
HSD3B2 3|3-hydroxysteroid dehydrogenase type 2
HSL Hormone Sensitive Lipase
IEG Immediate early gene
IL Interleukin
IMBX Isobutylmethylxanthine
IRS-1 Insulin receptor substrate-1
KLF Kriippel-Like factor
LBD Ligand binding domain
LPL Lipoprotein lipase
LXR Liver X receptor
MAPK Mitogen activated protein kinase
MCP-1 Monocyte chemoattractant protein 1
MMP Matrix metalloproteinase
MR Mineralocorticoid receptor
MSK1 Mitogen- and stress-activated protein kinase
NBRE NGFIB response element
NGFIB Nerve growth factor induced -B
nGRE Negative glucocorticoid receptor response element
NR Nuclear receptor
NurRE nur77 response element
Ocn Osteocalcin
OPN Osteopontin
PAI-1 Plasminogen activator inhibitor-1
PBS Phosphate buffer saline
PGC1 PPAR gamma co-activator 1
PGE2 Prostaglandin E2
PGFa2 Prostaglandin Fa2
PI3K Phosphatidylinositol-3 kinasePKA  Protein kinase A
PKC  Protein kinase C
PMA  Phorbol 12-myristate 13-acetate
POMC  Proopiomelanocortin
PPAR  Peroxisome proliferator-activated receptor
Pref-1  Preadipocyte factor 1
PTH  Parathyroid hormone
PTHrP  Parathyroid hormone-related protein
PVN  Paraventricular nucleus
RA  Retinoic acid
RANTES  Regulated  upon  activation  normal  T  cell  expressed  and
secreted
RAR  Retinoic acid receptor
RELMa  Resistin-like molecule a
RXR  Retinoid X receptor
SDS  Sodium dodecyl sulphate
TH  Thyroid hormone
TMRE  Tetramethylrhodamineethylester
TNFa  Tumor necrosis factor a
NEFA  Non esterified fatty acids
UCP  Uncoupling protein
VDR  Vitamin D receptor
VSMC  Vascular smooth muscle cell
WAT  White adipose tissue
13Chapter 1 - Introduction and Literature Review
14What is a Nuclear Receptor?
The  study  of  the  members  of  the  nuclear  receptor  family,  their  cellular 
distribution and role(s) is an exciting and novel area of research.  Many excellent 
reviews  of their  regulatory  role  in  both  central  and  peripheral  (metabolic  and 
inflammatory)  functions  are  available.  A  selection  of these  reviews  have  been 
summarised to best portray the broad  scope of their regulatory effects  (Aranda 
2001, Evans  1988, Mangelsdorf  1995, Truss  1993, Tenbaum  1997, Dean  1996, 
Beato 2000, Thompson 2003, Robinson-Rechavi 2003).
The nuclear receptors (NR) comprise a large family of proteins that regulate gene 
transcription  and  mediate  expression  responsible  for  the  biological  effects  in 
response  to NR activation.  This  superfamily,  consisting of over  150  members 
across  multiple  species,  includes  classic  endocrine  hormone  receptors,  such  as 
those  for  estrogens,  androgens,  glucocorticoids,  T3/T4  thyroid  hormones, 
retinoids and Vitamin D3 (Aprilletti  1998, Beato 2000, Hager 2001, Mangelsdorf 
1995, Zhang 2000).  There are also those that respond to intermediates of lipid 
metabolism,  e.g.  peroxisome  proliferator-activated  receptors  (PPARs),  liver  X 
receptor  (LXR)  and  famesoid  X  receptor  (FXR)  (Hihi  2002,  Waxman  1999, 
Kliewer  1999,  Repa  1999).  And  finally  there  are  those,  for which  to  date  no 
ligand  has  been  identified  eg.  COUP-TF’s  and  NGFIB’s  (Pereira  2000, 
Maruyama  1998).  For these receptors there may be an  undiscovered  ligand or 
there is also the possibility that at some stage  in evolution  they have  lost their 
ability  to  bind  ligand  and  now  are  regulated  by  some  other  means  - 
phosphorylation, for example (Privlasky 2004).  The last two decades has seen a 
total  of  48  human  nuclear  receptors  cloned  and  sequence  comparison  has 
illustrated  these  receptors exhibit an  extensive  homology  in  both  structure  and 
function.
Ligands  have  been  identified  for  many  of the  orphan  receptors  and  it  is  now 
known  that  compounds  such  as  fatty  acids,  leukotrienes,  prostaglandins  and 
cholesterol  derivatives  can  regulate  gene  expression  through  certain  nuclear 
receptors  and  many  of these  ligands  are  produced  intracellularly  as  metabolic 
products.
15Nuclear receptor domain structure
A typical nuclear receptor consists of:
1. A variable NH2 -terminal region, A/B, variable in sequence and length.
2. A conserved DNA-binding domain (DBD), region C
3. A linker hinge region D
4. A conserved E region that contains the ligand-binding domain (LBD)
5.  Some  receptors  contain  a COOH-terminal  extension  (region  F)  of unknown 
function.
These receptors also include regions required for transcriptional activation which 
are referred to as Activation Function-1  (AF-1) and Activation Function-2 (AF-2). 
AF-1,  located  in  the  N-terminal  A/B  region,  contributes  to constitutive  ligand- 
independent activation  by certain  receptors.  AF-2  which is  located at in the E 
region/LBD  is  ligand  dependent  and  conserved  among  most  members  of  the 
nuclear receptor superfamily, although it is not ligand dependent for orphans. (See 
Figure 1.1)
16A/B  C  D  E  F
DNA binding
Receptor Function
binding to hormone response element
Ligand binding  ligand binding domain (LBD)
Dimerisation Dimerisation  homo- and heterodimerisation
nucleus nuclear localisation signal (NLS)
AF-1
AF-2
activation function
silencing active repression/silencing domain
Fig. 1.1. - Schematic representation of nuclear receptor structure
Reproduced from S.Tenbaum & A Baniahmad; (1997) Int J Biochem Cell  Biol 
29:1325-41.
171. The A/B region
The  N-terminal  A/B  region  harbours  one  or  more  autonomous  transcriptional 
activation  function  (AF-1),  which  when linked to a heterologous DNA binding 
domain,  can  activate  transcription  in  a  constitutive  manner.  In  some  cases, 
multiple receptor isoforms are generated by alternative splicing of the A/B region 
e.g.  TR.pi  and  TRp2  (Williams  2000,  Murata  1998).  This  domain  can  also 
contribute to the cell  specific activity, possibly by interacting through cell  type- 
specific  factors  (Dowhan  1996).  This  region  is  very  weakly  conserved  in 
evolutionary terms.
2. The DNA binding domain (DBD)
The  DBD  is  the  most conserved  domain  of nuclear  receptors  and  confers  the 
ability to recognise specific target DNA sequences, known as response elements, 
and activate genes. This domain consists of 60-70 amino acids containing 2 zinc 
fingers and a COOH-terminal extension.  The region contains nine cysteines, as 
well  as  other  residues  which  are  conserved  across  the  nuclear  receptor 
superfamily,  which  are  required  for  high  affinity  DNA  binding.  In  each  zinc 
finger, four of the cysteines form one tetrahedrical zinc ion and both fingers fold 
together to form a compact interdependent structure (Berg 1989). Within the zinc 
finger motif are several sequence elements, termed P-, D-, T- and A-Boxes, which 
either define or contribute to:  1) response element specificity, 2) the dimerisation 
interface within the DBD and 3) contacts with the DNA backbone and residues 
flanking the core DNA recognition sequences respectively.  The actual core of the 
DBD contains 2 a-helices - the first one at the beginning of the third conserved 
cysteine, which binds the major groove of DNA,  making contacts with specific 
bases and the second spans the carboxy terminus of the second zinc finger.
3. The hinge region
This region is very poorly conserved between  the nuclear receptor sub-families 
and serves as a hinge between the DBD and LBD.  It is thought to allow rotation 
of the DBD in relation to other regions and may help dimerisation. This domain 
has also been shown to contain nuclear localisation signals for certain receptors.
184. The ligand binding domain (LBD)
As  the  name  suggests  this  domain  is  responsible  for  the  binding  of  ligands. 
However,  this domain  has many functions in addition to ligand binding.  It can 
mediate  homo-  and  heterodimerisation,  interactions  with  heat  shock  proteins, 
ligand-dependent recruitment of co-activators or co-repressors  which  results in 
transcriptional  activation  or  transcriptional  repression  respectively.  The  LBD 
contains 2 conserved regions - “a signature motif’ and the carboxy terminal AF-2 
motif, responsible for the  ligand dependent transcriptional  activation  (Danielian 
1992).  Many of the nuclear receptor family crystal structures have been solved 
and the findings show that the receptors share a very similar structure.  The region 
consists  of  12  a-helical  regions,  termed  HI-12,  folded  into  a  three-layered 
antiparallel  helical  sandwich.  A  central  core  layer  of three  helices  is  packed 
between two additional layers to form a cavity, the ligand binding pocket, which 
is  mainly  hydrophobic  and  the  size  of  the  pocket  varies  widely  among  the 
receptors.  Helix  12 of the LBD contains the AF-2 domain and the position of 
which changes upon ligand binding, making the structure more compact.
5. COOH-terminal
This region displays little evolutionary conservation.  Recent evidence suggests 
that the F region may play a role in co-activator recruitment to the E domain and 
in determining the specificity of the ligand binding domain coactivator interface 
(Pters 1999, Sladek 1999).
Hormone response elements
Nuclear  receptors  regulate  transcription  by  binding  to  derivatives  of the  same 
hexameric  DNA core  motif,  5'-PuGGTCA  (Pu  =  A  or G),  known  as  hormone 
response  elements  (HREs).  These  HREs  are  usually  located  in  the  5'-flanking 
region of the target gene.  In most cases they are found relatively close to the core 
promoter but can in some cases be located in enhancer regions several kilobases 
upstream of the transcription start site.  Nuclear receptors can bind their response 
element as monomers, but most tend to bind as either homo- or heterodimers with 
RXR  to  a  DNA  sequence  comprising  typically  of two  core  hexameric  motifs.
19These motifs can be configured as palindromes, inverted palindromes or as direct 
repeats.  The factors which determine the specificity of the HRE are:
■   The space between the half-sites.
■   Some receptors use the same half site sequence but different spacing.
■   The sequence of the half site.
The concept of the response element was initially suggested by studies on mouse 
mammary  tumour virus  (MMTV) and glucocorticoid  receptor with  research on 
thyroid  hormone  and  retinoic  acid  response  elements,  providing  additional 
evidence (Koenig 1987, Ringold 1979, Leid 1992).  This was later developed into 
a model in which the HRE's for the vitamin D receptor (VDR), thyroid hormone 
receptor (TR)  and  retinoic acid  receptor (RAR) are composed of direct repeats 
spaced by 3, 4 or 5 nucleotides (i.e. DR3, DR4 and DR5 respectively) (Umesono
1991).  An example of the variety of response elements is shown in Figure 1.2. 
Although  most  of  the  discussion  described  here  focuses  on  transcriptional 
activation,  NRs  do  have  the  ability  to  repress  gene  expression  in  a  ligand- 
dependent manner.  Transrepression can be brought about by negative response 
elements, such as the nGRE in the POMC promoter (Davis  1994), transcriptional 
antagonism e.g. COUP-TF’s (Tsai  1997) or by cross-talk with different signalling 
pathways such as AP-1 and NficB (Pfahl 1993, Wissink 1997).
20Fig. 1.2 - Variety of response elements arrangements 
Arrangement of Half-Sites
Palindrome:
5'-AGGTCA /tGACCT-3'
Direct Repeat
5'-AGGTCA(n)x AGGTCA-3'
Inverted Repeat 
5 '-TGA CCT(n )X A GGTCA -3'
Half-Site Structure
AGGTC An AGGTC A  -DR 1
AGGTCAnnAGGTCA  -DR2
AGGTCAnnnAGGTCA  -DR3 
AGGTCAnnnnAGGTCA  -DR4 
AGGTCAnnnnnAGGTCA  -DR5
PPRE, RXRE 
RARE
VDRE  Different spacing
TRE
RARE
AGAACAnnnTGTTCT
AGGTCAnnnTGACCT
A/I AGGTC A 
77CC4AGGTCA
GRE, PRE, ARE, MRE 
ERE  Same spacing different half­
sites 
NBRE
SF-1 RE  Single Half sites
21Co-activators and Co-repressors
Regulation of gene transcription by nuclear receptors requires the recruitment of 
proteins  characterised  as  coregulators,  with  ligand  dependent  exchange  of co­
repressors for co-activators  serving as  the basic  mechanism for switching gene 
repression to activation, involving modulation of the chromatin structure.  These 
proteins  do  not  bind  DNA  directly  but  enable  the  recruitment  of  the  basic 
transcriptional  machinery  to  nuclear  receptor  regulated  genes  (Torchia  1998). 
Co-activators and co-repressors have opposing effects on histone acetylation, with 
activators associated  with histone  acetylation,  whilst repressors  mediate  histone 
deacetylation.
Ligand  binding  is  the  crucial  molecular event  that  switches  the  function  of a 
number of NR’s from active  repression to transcriptional  activation.  However, 
ligand binding is not necessarily sufficient to induce dissociation of co-repressors; 
in fact it would appear the AF-2 domain  serves to trigger the release.  In some 
cases  helix  12  containing  the  AF-2  domain  is  fully  inhibitory  for co-repressor 
binding  for  NR’s.  NR’s  lacking  this  AF-2  act  as  constitutive  repressors  e.g. 
RevErbA Alpha (Sap 1989).
22The NGFIB subfamily of nuclear receptor
The  NGFIB  subfamily  in  higher  eukaryotes  comprises  of  3  closely  related 
members -  Fig.  1.3.  nur77 was the first to be identified, as a gene induced by 
nerve-growth  factor  (NGF)  in  the  rat  PC 12  cell  line  (Milbrandt  1988,  Hazel 
1988).  Nurrl  was  subsequently  isolated  from  a  neonatal  mouse  brain  cDNA 
library, using low hybridisation conditions with a probe consisting of the DNA- 
binding  domain  (DBD)  of COUP-TF1,  another  orphan  nuclear  receptor  (Law
1992).  And finally, NOR-1  was identified from cultured rat fetal forebrain cells 
(Ohkura 1994).  Genes from this family are classified as immediate early genes in 
that they are all rapidly and transiently induced by a variety of stimuli, including 
neurotransmitters (Arender  1989), growth factors (Milbrandt  1988, Bartel  1989), 
cAMP  (Kovalovsky  2002)  and  fatty  acids  (Arender  1989,  Bartel  1989).  This 
family have also been shown to function as constitutive activators in vitro (Davis 
1994, Wilson  1991). These 3 receptors comprise the NGFIB  subfamily and are 
known by many other names - see figure 1.4.
As described earlier,  these receptors consist of a central  DBD, a potential LBD 
and a variable N-terminus.  The DBD contains 2 highly conserved zinc fingers 
that bring about the specific interaction between the receptor and DNA response 
elements.  The LBD is essential for hormone/ligand recognition;  however as to 
date  no  ligand  has  been  discovered  for  a  member  of  this  family.  In  fact 
crystallography  studies  of Nurrl  suggest  that  the  ligand-binding  pocket  is  too 
small to accommodate the docking of a ligand.  Studies have shown a pocket of
approximately  100A ,  which  when  compared  to  other  nuclear  receptors  is 
extremely  small  (Wang 2003).  For example,  the pockets of the PPAR nuclear 
receptors  range  from  1100A-1600A3   (Nolte  1998).  The  LBD  region  of  the 
NGFIB  subfamily  has  also been  shown  to contain  bulky  hydrophobic  regions, 
involved in dimerisation, which fill the pocket.  These hydrophobic residues are 
conserved throughout the family so the absence of a ligand-binding pocket was 
also predicted for nur77 and NOR-1.  Recent data certainly supports this, as the 
LBD crystal structure for rat nur77 is indeed filled with bulky hydrophobic side
23chains (Flaig 2005).  DHR38, the drosophila orthologue for NOR-1, also revealed 
no ligand binding pocket (Baker 2003).
Within the NGFIB subfamily itself, the DBD exhibits more than 90% homology 
between  the  3  members.  In  relation to other members of the  nuclear receptor 
superfamily at least 50% identity is maintained.  The C-terminus of all the NGFIB 
subfamily exhibits 50-60% homology.
These  nuclear  receptors  can  bind  as  heterodimers  with  RXR  (Perlmann  1995) 
(except NOR-1) to direct repeat elements  (AGGTCA)  spaced by  5  nucleotides 
(DR5),  or  as  monomers  to  the  extended  half-site  DNA  sequence,  termed  the 
NGFIB  response  element  (NBRE  5'-AAAGGTCA-3')(Wilson  1991,  Perlmann
1995).  Recognition of the additional adenine residues depends on the A-Box in 
the DBD.  It has also been reported that homodimers of nur77 can bind to a novel 
response  element  termed  the  NurRE,  which  was  identified  within  the  POMC 
promoter.  The  NurRE  has  a  palindromic  structure  containing  2  half  sites 
separated by  6bp,  which are quite  similar to the NBRE (75%).  This  response 
element is  nearly  50x  more  sensitive  to Nur77  action  than  the  NBRE  (Philips 
1997).
241   265  353  598
nur77 N-terminal DBD LBD
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26 94 58
Fig. 1.3 NGFIB family homology
Box diagram  showing  homology of human  family  members.  Numbers  in  each 
box  represent  %age  homology.  Numbers  above  diagrams  represent  the  amino 
acid residue of each domain.
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Fig. 1.4 NGFIB family nomenclature
Species nomenclature for all three members of the NGFIB family.
26Regulation of the NGFIB family 
NGFIB and phosphorylation
As stated previously, based on the crystal  structure  there is  no apparent ligand 
binding  pocket  for  any  of  the  NGFIB  subfamily  (Wang  2003).  It  has  been 
suggested  that  NGFIB  activity  could  be  regulated  through  phosphorylation  as 
there are multiple phosphorylation sites in the N-terminus of the receptor. There 
are no apparent sites contained within the C-terminus.  Nurrl  has an unusually 
large  N-terminal  domain  which  has  been  shown  to  mediate  transcriptional 
activation as well as cell type specific activity through the AF2 region in the C- 
terminal domain (Castro 1999).
Phosphorylation of NRs in general has been shown to happen in all three major 
domains,  the N-terminal  activation  function  (AF-1),  the  ligand binding and the 
DNA  binding  domains.  A  recent  review  provides  an  overview  of the  role  of 
phosphorylation in nuclear receptor activity (Rochette-Egly 2003).  DNA binding, 
protein stability and regulation  of activation/repression  have all been shown to be
factors  that  are  influenced by the  phosphorylation  state  of the  nuclear receptor
(Weigel  1996).  Phosphorylation  occurs  mainly  through  serine/threonine 
(Sheridan  1989)  and  tyrosine  residues  (Migliaccio  1986)  in  nuclear  receptors. 
Potential  phosphorylation  sites  (Fig  1.5)  in  the  N-terminal  domain  of  Nurrl 
reveals  a  consensus  site  for  serine/threonine  mitogen-activated  protein  kinases 
(MAPK) in a region conserved between Nurrl, nur77 and NOR-1.
Fig. 1.5 Potential MAPK consensus region (amino acids refer to Nurrl)
124  133
Nurrl  ^SSPPl jPSTP
nur77  PCSAPSjPPTP
Norl  QSPPSTjPTTPj
Consensus  PXS/TP
It has been suggested that Nurrl  AF-1  activity is in part dependent on a MAPK 
phosphorylation  site  (Nordzell  2004).  Also  of  interest,  in  nur77  MAPK
27dependent phosphorylation within the DBD has been shown to negatively regulate 
DNA binding and activity (Davis  1997, Fahmer  1990, Hazel  1991, Hirata  1993, 
Katagiri  1997,  Li  1997).  This  region  is  highly  conserved  between  Nurrl  and 
nur77 and it is likely that a similar inhibitory effect may also be significant in 
Nurrl.  Thus,  MAPK signalling pathways may  impart both  positive  (AF-1)  and 
negative (inhibition of DNA binding) influences on the transcriptional activity of 
Nurrl  (Nordzell 2004).
More recently it has been demonstrated that downstream of ERK1/2, MSK1  and 
MSK2 are involved in the transcriptional activation of this family (Darragh 2005). 
MSKs have previously been shown to activate transcription of genes with CRE’s, 
suggesting a possible control mechanism for this family.  Nurrl  and NOR1  have 
one or more classical CRE sites in their promoters and are reported to be CREB 
dependent  genes  (Ohkubo  2000,  McEvoy  2002).  In  contrast  nur77  does  not 
appear  to  have  a  CRE  in  its  promoter,  although  it  does  have  two  AP-1  like 
elements, which have sequences similar to CRE and have been reported to bind 
members of the CREB family of transcription factors (Fass 2003).
NGFIB and heterodimerisation with RXR
As described earlier, Nurrl  and nur77 have been shown to bind to a DR5 element 
as  a  heterodimer  with  RXR,  which  has  been  classified  as  a  promiscuous 
dimerisation partner (Schulman  1997) and also described as a "master regulator" 
(Mangelsdorf  1995).  Three  types  of  RXR  heterodimers  exist  (Kastner  1995, 
Mangelsdorf  1995).  In  some  heterodimers,  such  as  RXR/VDR,  RXR  is  a 
completely silent partner.  In others such as RXR/RAR, RXR is a conditionally 
silent  partner  (formation  of the  heterodimer prevents  binding  of RXR  ligand). 
However,  in  contrast  RXR  acts  as  a  fully  active  and  competent  partner  of 
heterodimers with orphan receptors such as nur77 and Nurrl.  The nur77/Nurrl- 
RXR heterodimer is permissive to ligand binding such that they can be activated 
in response to RXR ligand.  Perhaps surprisingly, it has been shown that NOR-1 
does  not  have  the  ability  to  form  stable  heterodimers  with  RXR  (Zetterstrom
1996).  NOR-1  can however interfere with Nurrl-RXR heterodimer signalling as
28described  in  Zetterstrom  at  al.  It  is  unclear  as  to  why  NOR-1  fails  to 
heterodimerise with RXR.  One theory is that it lacks three critical amino acids in 
helix 9, which have been identified as being involved in the dimer interface in the 
crystal structure of RXR ligand binding domain homodimer (Bourguet 1995).
It  is  known  that  nur77  and  Nurrl  heterodimerise  with  RXR  through  the  C- 
terminal domain as this region has been shown to bind to RXR when linked to the 
Gal4 DBD  binding domain  in  a  mammalian  two-hybrid  experiment  (Perlmann 
1995).  The recent discovery that Nurrl  has a collapsed ligand binding pocket is 
very interesting in the RXR heterodimerisation story (Wang 2003).  It is possible 
that Nurrl/nur77 are regulated through the RXR partner and its ligands.  There is 
evidence to suggest that in primary neuronal cultures, RXR ligands increase the 
number of surviving dopamine cells and that this requires ligand binding to RXR 
in the context of Nurrl-RXR heterodimers (Wallen-Mackenzie 2003).  Another 
recent paper demonstrates  that the effects of RXR agonists and antagonists  are 
dependent on the presence of nur77, since these effects are not observed in nur77 
deficient mice (Ethier 2004).
Pharmacological modulation of NGFIB
Despite  the  evidence  accumulating  that  this  family  are  likely  to  be  ligand- 
independent  nuclear  receptors,  recent  literature  supports  the  discovery  of 
activators or modulators for this family.  These include 6-mercaptopurine,  1,1- 
Bis(3’-indoyl)-l-(p-substituted  phenyl)methanes,  methotrexate  and  PGA2. 
Although  the  authors  show  activation  predicted  to  be  through  the  LBD,  it  is 
possible  that  the  NGFIB’s  are  modulated  by  these  compounds  by  some  other 
means  in  addition  to  direct  interaction  with  the  ligand  binding  pocket.  For 
example this family has been shown to be modulated through adenosine receptors 
or through the AF-1  domain, via an indirect mechanism which in turn mediates 
transactivation, co-activator recruitment and activation by metabolites such as 6- 
mercaptopurine (Wansa 2003, Chintharlapalli 2005, Ralph 2005, Kagaya  2005).
29Functions of the NGFIB family
The expression of the NGFIB  family,  (nur77,  Nurrl  and NOR-1)  are far more 
ubiquitous than originally thought and their function(s) may, to some extent, be 
determined  by  the  cell  in  which  they  are  expressed  and  the  prevailing 
physiological and pathphysiological milieu.
NGFIB and dopamine signalling
Initial reports show that Nurrl  was expressed predominantly in the dopaminergic 
neurons in the brain.  The onset of this expression is just before El0.5, prior to the 
appearance  of the  dopaminergic  marker  enzyme  tyrosine  hydroxylase  (TH)  at 
El 1.5.  TH is the rate-limiting enzyme for the biosynthesis of dopamine.  Nurrl 
expression  continues  through  normal  adulthood  suggesting  a  requirement  for 
normal function of mature dopaminergic neurons (Ethier 2004).
Using  Nurrl  null  mice,  it  has  been  shown  that  Nurrl  is  essential  for  the 
differentiation  of  ventral  mesencephalic  dopaminergic  neurons,  which  can  be 
observed via the agenesis of cell markers such as TH, the retinoic acid converting 
enzyme  ADH2 and  the receptor tyrosine kinase, c-ret (Le  1999,  Castillo  1998, 
Saucedo-Cardenas  1998).  The Nurrl  homozygote knock-out is embryonic lethal 
(Zetterstrom 1997).
The dopaminergic neurons in Nurrl  null mice adopt a normal ventral localisation 
and neuronal phenotype characterised by the expression of the homeobox domain 
protein  Ptx-3  at  El 1.5.  However,  these  dopaminergic  precursor  cells  fail  to 
differentiate and commit to the dopaminergic phenotype (Le  1999, Castillo 1998, 
Saucedo-Cardenas 1998).
It has been established that both Nurrl  and retinoids can induce cell cycle arrest 
and morphological differentiation of MN9D cells.  MN9D cells show properties 
of immature  neuronal  cells  that  can  mature  and  extend  neurites  under certain 
culturing conditions.  They also have characteristic dopaminergic properties, but 
do not express Nurrl.  By over-expressing Nurrl  in these cells the authors show 
how it can influence basic dopaminergic functions such as dopamine content and 
production.  This mechanism is dependent on DNA binding but does not require 
dimerisation with RXR (Castro 2001, Hermanson 2003).
30Some reports indicate  that Nurrl  contributes to the  maintenance of mature DA 
neurons.  Consequently  DA  neurons  of  Nurrl  heterozygous  mice  are  more 
vulnerable  to  dopaminergic  toxins  such  as  l-methyl-4-phenyl-l,2,3,6- 
tetrahydropyridine (Le 1999).  Recent studies have demonstrated that nitric oxide 
mediates this increased susceptibility (Imam 2005).  Abnormal motor behaviours 
in aged Nurrl  heterozygous mice (>15  months) were associated with decreased 
DA levels, a decrease in DAergic neurons and reduced expression of Nurrl  and 
DA,  suggesting a motor impairment that is analogous to a Parkinsonian deficit 
(Jiang 2005).  Mutations in Nurrl  have also been identified in familial cases of 
Parkinson’s disease.  These mutations are situated in the 5’ untranslated region of 
Nurrl  and  have  been  shown  to  decrease  the  expression  of  Nurrl,  providing 
further compelling evidence for a clinically relevant role of Nurrl in human adult 
brain (Le 2003).
NGFIB and their role in bone
Nurrl and the other family members are expressed in primary osteoblasts and cell 
lines.  Their expression has been shown to be significantly induced in response to 
parathyroid  hormone  (PTH),  with  NOR-1  induction  more  sensitive  to  PTH 
treatment (Tetradis 2001a).  As expected for immediate early genes this induction 
is rapid and transient, with nur77 mRNA and protein levels peaking earlier and 
declining  faster than Nurrl  (Tetradis  2001b).  This  induction  is evident  in  both 
MC3T3-E1  cells and also in mouse calvarie organ cultures (Tetradis 2001a).  The 
PTH effect is mediated mainly through cAMP PKA signalling (Tetradis 2001a, 
Pirih 2003).  Tetradis et al have shown that Nurrl can be induced by a number of 
agents in osteoblasts as well as the cAMP PKA  signalling previously reported. 
The  strongest  inducers  were  activators  of  the  cAMP-PKA-coupled  pathway 
(forskolin,  PTH,  PTHrP  &  PGE2)  followed  by  PKC-  and  calcium-coupled 
signalling activators (PMA, ionomycin, PGF2a & fluprosentol) (Tetradis 2001a, 
Pirih  2003,  Pirih  2004).  New  data  also  support  these  findings  as  they  show 
induction of the NGFIB family by PTH in vivo. mRNA levels of all three genes
31peaked earlier and were more transient in vivo compared to those reported in in 
vitro experiments (Pirih 2005).
Genes with NGFIB response elements in their promoter/enhancer regions include 
alkaline phosphatase, bone sialoprotein, osteocalcin, type I (a)l  and type I (a)2 
collagen,  insulin  growth  factor,  collagenase,  mouse  osteopontin(OPN)  and 
osteocalcin(Ocn) (Tetradis 2001a, Pirih 2003, Lammi 2004).  Studies have shown 
binding  of Nurrl  to  the  mouse  osteopontin  promoter as  both  a  monomer and 
heterodimer  (with  RXR),  and  this  transactivation  is  independent  of  RXR 
heterodimerisation,  although  RXR  ligands  have  been  shown  to  enhance 
transactivation  induced through Nurrl  (Lammi  2004).  In addition Lammi et al 
have reported that Nurrl  is involved in mediating PTH-induced OPN expression. 
OPN  is  not required  for bone  formation  but  it  has  been  suggested  to  have  an 
important  role  in  bone  remodelling  in  response  to  mechanical  stress,  such  as 
postmenopausal  osteoporosis  (Rittling  1998,  Yoshitake  1999,  Terai  1999). 
Recently  Pirih  et  al  have  also  shown  that  Nurrl  can  mediate  transactivation 
through the rat Ocn promoter.  The Nurrl  response element on the Ocn promoter 
appears  to  behave  as  a  true  monomeric  site,  suggesting  the  possibility  that 
dimerisation  (with  RXR)  is  not  required  for  osteoblastic  gene  transactivation 
(Pirih 2004).
The above observations are interesting from a functional point view as neither of 
these  genes  is  required  for  normal  skeletal  development but  more  for  skeletal 
homeostasis.  Osteopontin  ablation  impairs  bone  remodelling  following 
ovariectomy (Yoshitake 1999) and PTH treatment (Ihara 2001), while osteocalcin 
knockout  mice  develop  osteopetrosis  due  to  inapt  skeletal  remodelling  (Ducy 
1996).  These  genes  are  also  expressed  at  different  points  of  development 
indicating that Nurrl  is likely to regulate  multiple genes along the osteoblastic 
lineage (Liu  2003).  Therefore it could be hypothesised that Nurrl  may have a 
role in bone remodelling through the regulation of the OPN and Ocn promoter.
32NGFIB and HPA axis
Another area where  the NGFIB  subfamily  is proposed  to play  a role  is  in  the 
regulation of the hypothalamic pituitary adrenal  (HPA) axis.  There are several 
lines of evidence to support this theory.  The axis is regulated at the level of the 
hypothalamus by corticotrophin releasing hormone (CRH), which is synthesized 
in  the  hypothalamic  paraventricular  nucleus  (PVN).  Upon  stimulation  of the 
PVN, CRH is released and transported to the anterior pituitary where it causes an 
increase in the synthesis of pro-opiomelanocortin (POMC), which is the precursor 
to  many  molecules  including  adrenocorticotrophic  hormone  (ACTH).  Other 
ACTH derived peptides include P-endorphin, P-lipotrophin, y-lipotrophin and the 
melanin-stimulating  hormones.  ACTH  is  a  primary  inducer  of  adrenal 
steroidogenesis and the subsequent release of glucocorticoids, androgens and the 
mineralocorticoid aldosterone.  In order to maintain homeostasis of the HPA axis, 
glucocorticoids  inhibit  CRH  and  POMC  synthesis  and  secretion  at  the 
hypothalamic and anterior pituitary level.
The NGFIB family have been implicated at multiple levels in the regulation of the 
HPA axis - Fig.  1.7. This is partly evident from their expression in HPA tissues. 
Studies  show  expression  of Nurrl  in  the  anterior  pituitary  (Saucedo-Cardenas 
1996) and adrenal cortex (Davis 1994, Bassett 2004).  Nurrl is also constitutively 
expressed in the PVN (Saucedo-Cardenas  1996) and nur77 is rapidly induced by 
stress  and  Interleukin-ip  in  the  PVN  (Honakaniemi  1994,  Chan  1993). 
Furthermore, administration of CRH to conscious rats significantly increases the 
level of nur77 expression in the PVN (Parkes  1993).  In addition, nur77 has been 
shown  to  be  expressed  in  both  the  adrenal  cortex  and  medulla  (Davis  1994). 
nur77  induction  has  also  been  implicated  in  the  transcriptional  induction  of 
steroid-21  a-hydroxylase, a rate limiting step in glucocorticoid synthesis (Wilson 
1993, Kelly 2004).
An  NBRE  has been  located in  the  POMC  promoter which  happens  to overlap 
with  a  negative  glucocorticoid  receptor  response  element  (nGRE)  which  is 
responsible for mediating the glucocorticoid negative feedback loop (Figure  1.6). 
It is thought  that repression of POMC transcription is  mediated in  part by  GR
33dependent  inhibition  of  NGFIB  subfamily  activation  of  the  POMC  promoter 
(Davis  1994).  A second nur77 specific response element (NurRE) has also been 
located in the POMC promoter which contributes to activation of this promoter by 
nur77 (Lin 1996).
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Fig.  1.6  Adapted  from  Drouin  et  al  (1998)  J  Steroid  Biochem  Molec  Biol 
65:59-63.
Diagram showing NurRE and putative NBRE present in the POMC promoter.
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Overview of the HPA axis and NGFIB family involvement
35The NGFIB subfamily has also been implicated in the transcriptional regulation 
of  other  steroidogenic  enzymes  in  the  human  adrenal  gland.  These  include 
CYP21,  HSD3B2  and  CYP11B2  (Bassett  2004a,  2004b,  2004c,  Wilson  1993, 
Chang and Chung 1995).
3|3-hydroxysteroid dehydrogenase type 2 (HSD3B2), an enzyme essential for the 
production of mineralocorticoids and glucocorticoids, shows a similar expression 
pattern to members of the NGFIB subfamily in the adrenal gland and has indeed 
been shown to be regulated by nur77 (Martin 2004).
As  mentioned  earlier,  evidence  also  indicates  a  role  for  NGFIB  regulation  of 
CYP21,  through  an  NBRE  in  its  promoter.  CYP21  regulates  cortisol  and 
aldosterone  production  by  conversion  of  17-hydroxy  progesterone  to  11- 
deoxycortisol  and  progesterone  to  11-deoxycorticosterone  in  the  aldosterone 
pathway.  Initial  studies on  the  nur77  knock-out  mice  suggested  that this  sub­
family did not have a major role in steroidogenesis (Crawford  1995).  However, 
there is evidence to suggest that the different subfamily members compensate for 
one another (Cheng 1997, Crawford 1995).
Angiotensinll  (AngH)  along  with  potassium  controls  the  enzyme  CYP11B2, 
which converts deoxycorticosterone to aldosterone. It has been demonstrated that 
both Nurrl  and nur77 are up regulated by AngH and directly activate CYP11B2 
promoter (Bassett 2004b).
The control  of the HPA axis and plasma glucocorticoid levels are both closely 
linked to adipose tissue mass.  Recently, evidence has been mounting to support a 
role  for CRH  in  the  regulation  of energy  balance  (Richard  2002),  including  a 
direct  influence  on  human  adipocytes,  regulation  of  11 P-hydroxysteroid 
dehydrogenase type 1  activity (Friedberg 2003) and cortisol formation (Masuzaki 
2001).  Expression  of  CRH  receptors  and  CRH-like  peptides  has  been 
demonstrated  in adipose tissue  (Seres  2004).  This  data,  along  with  the  recent 
publication  describing  the  influence  of CRH  on  adipocyte  cortisol  production 
(Friedberg 2003),  suggests systemic and autocrine/paracrine effects of the CRH 
system in adipose tissue homeostasis.
36NGFIB and inflammation
Previously it has been described how the NGFIB subfamily members are involved 
in mediating the CRH activation of POMC gene transcription.  It has also been 
demonstrated that Nurrl  is involved in the regulation of CRH expression in joint 
inflammatory disease. Elevated levels of CRH are produced locally in inflamed 
synovial  tissue  (Crofford  1993).  In  addition  enhanced  expression  of  Nurrl  is 
evident  in  synovial  fluid  of subjects  with  rheumatoid  arthritis  compared  with 
normal  subjects  (McEvoy  2001).  This  suggests  that  Nurrl  plays  a  role  in 
transcriptional  regulation  of  synovial  fluid  homeostasis.  McEvoy  et  al  have 
hypothesised  that  Nurrl  may  represent  a  point of convergence  of at  least  two 
signalling pathways involved in mediating inflammatory signals through cytokine 
induction of this nuclear receptor (McEvoy 2002).
The  NGFIB  family  are  also  induced  by  inflammatory  stimuli  in  activated 
macrophages.  Evidence  points  to  the  NF-kB  pathway  as  one  of the  principle 
regulators  of this  inducible family.  In  response to these  inflammatory stimuli, 
NGFIB  receptors may function as intracellular switches between transcriptional 
programs  of activation,  differentiation,  or  self-destruction  of macrophages  via 
interactions with the aforementioned NF-kB  and glucocorticoid signalling.  It is 
postulated  that  these  receptors  may  be  important  mediators  of  inflammatory 
signalling in the artery wall (Pei 2005).  TNFa, LPS and IL-1 induce nur77 which 
in turns regulates plasminogen activator inhibitor  1   (PAI-1) expression.  PAI-1 
regulates intravascular fibrinolysis and high plasma levels are associated with an 
increased risk for vascular disease (Gruber 2003).
NGFIB and other putative functional roles
Literature is accruing on the many putative functional physiological roles for this 
family  of  receptors.  It  has  become  apparent  that  they  are  involved  in  cell 
development, homeostasis and cell death as well as implications in a number of 
diseases -  Parkinson’s disease, cancer, atopic dermatitis, rheumatoid arthritis and 
other  inflammatory  diseases  (Wu  2002,  Ohkubo  2000,  Kolluri  2003,  Kagaya 
2005,  Murphy  2001,  Pei  2005).  A  role  has  also  been  proposed  for  nur77  in
37lipolysis  in  skeletal  muscle  cells  -  this  will  be  further  discussed  in  the  next 
section.  Collectively  the  functions  described  above  would  suggest  a  highly 
adaptive and multi-functional role for these receptors in human biology.
NGFIB and their putative role in adipogenesis
Obesity  is  a  prevalent  health  hazard  in  industrialised  countries  and  is  closely 
associated  with  a  number  of  pathological  disorders  including  non-insulin- 
dependent diabetes, hypertension, cancer, gall bladder disease and atherosclerosis 
(Albu  1998,  Bray  2003,  Bray  2002,  Dittrick  2005).  A greater insight  into the 
molecular basis of obesity, including that of the differentiation of the preadipocyte 
cell to an adipocyte (adipogenesis) would significantly increase our understanding 
of  the  aetiology  of  the  disease.  The  extracellular  and  intracellular  signalling 
pathways involved with the early events of adiposity differentiation and growth 
are unclear.  However, much has been reported on the several transcription factors 
playing  a  major  role  in  the  regulation  of adipogenesis,  notably  those  of  two 
families: CAAT/enhancer binding proteins (C/EBPs) and peroxisome proliferator- 
activated receptors (PPARs) (Cao 1991, Chawla 1994a,  1994b - these events will 
be  discussed  in  greater detail  in  Chapter 3).  Conversely,  we  know  very  little 
about transcription factors that inhibit adipogenesis.  There are reports on factors 
such as Pref-1 and Wnt signalling (see Chapter 3) which are considered to inhibit 
adipogenesis.  However, to date there is no reported evidence of transcriptional 
control of inhibition of adipogenesis.
Preliminary data produced in-house, prior to embarking on this project, suggested 
that  the  NGFIB  family  of  orphan  nuclear  receptors  may  play  a  role  in  the 
regulation  of adipogenesis.  Each  member of the  family  is  highly  expressed  in 
human  adipose  tissue  (Figure  1.8).  There  is  also  some  data to  suggest  that  it 
Nurrl  is induced transiently during differentiation of adipocytes (Figure  1.9). As 
cited earlier, the NGFIB family has been proposed to have a role regulating the 
HPA axis and CRH.  CRH has also been proposed to play a role in adipose tissue 
homeostasis  (Seres  2004). The role of the NGFIB  family in the HPA axis and 
CRH  regulation  must  also  be  considered  in  the  context  of adipogenesis.  As
38mentioned above - ACTH is a primary inducer of adrenal steroidogenesis and the 
subsequent  release  of  glucocorticoids,  androgens  and  the  mineralocorticoid, 
aldosterone.  Glucocorticoids play an important role in regulating adipose tissue 
function and recent work also predicts a role for MR/aldosterone in adipogenesis 
(Rondinone  1993,  Caprio  2005).  The  NGFIB  family  are  implicated  at  many 
levels with enzymatic control of the generation of these hormones.
Recently, nur77 has been implicated in the regulation of energy homeostasis by 
regulating  lipolysis  in  skeletal  muscle.  It  has  been  shown  that  nur77  can  be 
induced by P-adrenergic agonists such as isoprenaline (Lim 1995, Maxwell 2005). 
Given that P-adrenergic agonists and receptors are involved in regulation of cold- 
and diet- induced thermogenesis and induce increases in energy expenditure, this 
would suggest cross-talk between the NGFIB family and the adrenergic pathways. 
Using siRNA for nur77 it was demonstrated that there was a down regulation of 
genes  and  proteins  associated  with  energy  expenditure  and  lipid  homeostasis, 
AMPKy3, UCP3, CD36, adiponectin receptor 2, GLUT4 and caveolin 3 (Maxwell 
2005).  These  are  examples  of  mRNAs  encoding  proteins  involved  in  the 
regulation of energy expenditure, lipid and carbohydrate metabolism.
39Expression Profiles for NGFIB Family
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41Aims of study
Given  the  known  functions  of NGFIB  family  and  potential  role  in  metabolic 
homeostasis this project aimed to investigate the effect of the NGFIB family on 
adipogenesis and adipocyte function.
The aims were as follows:
1.  To confirm expression of Nurrl/nur77 in adipose tissue in mouse.  The 
original  expression  data  was  obtained  from  human  tissue  and  although  no 
difference is expected, confirmation would be required.
2.  To investigate the induction of Nurrl/nur77 during adipogenesis and try 
to elucidate the mechanism of induction.  Differentiation cocktail to be added to 
3T3-L1  cells and RNA to be collected at appropriate timed intervals.  This study 
will also be repeated in a primary cell model.
3.  To analyse the effects of adenoviral over-expression of Nurrl  in 3T3-L1 
cells on the regulation of a number of adipogenic and adipocyte marker genes. 
mRNA will be isolated at various time points during the differentiation period and 
cDNA synthesised for SybrGreen analysis.
4.  To analyse the effect of over-expression of Nurrl  on metabolic functions, 
lipolysis and glucose uptake in mature differentiated adipocytes.
5.  To  use  microarray  analysis  of  differentiating  3T3-L1  cells  over­
expressing Nurrl to investigate changes in the expression of multiple genes. Cells 
will be differentiated as above (3) and RNA extracted at 72hrs (T72) and 192 hrs 
(T192)  post-induction  of differentiation.  Microarray  to  be  performed  at  The 
Institute of Child Health, London.
6.  To analyse the outcome of down-regulating the expression of Nurrl  and 
nur77 during the differentiation period in 3T3-L1  cells using siRNA technology. 
siRNA’s for Nurrl and nur77 are commercially available.
This thesis describes the expression of Nurrl (and to a lesser extent nur77) and its 
effect(s) on the differentiation of 3T3-L1  adipocytes in vitro. It also describes the
42induction  of  Nurrl/nur77  in  3T3-L1  and  primary  adipocytes  and  possible 
mechanisms of induction.  The effects of over-expression are then analysed by 
SybrGreen  analysis,  microarray  studies,  investigation  of lipolysis  and  glucose 
uptake.  Finally, a small section describes some initial gene silencing studies of 
the NGFIB family using siRNA tools.
These results should throw some light on the putative physiological role(s) for this 
novel family of transcription factors in adipocyte and adipose tissue function, as 
well  as  the  consequences  of their  overexpression  or  down-regulation  in  these 
cells.
43Chapter 2: Expression of NGFIB subfamily in murine 
adipose tissue and during adipogenesis
44Introduction
Adipose Tissue
Traditionally,  adipose  tissue  was  thought  of  as  nothing  more  than  a  passive 
reservoir  for energy  storage,  however  recent  and  ongoing  research  has  shown 
adipose tissue to be a complex highly active metabolic,  immune and endocrine 
organ.  Siiteri first identified adipose tissue as a major site for the metabolism of 
sex steroids (Siiteri  1987).  The subsequent identification and characterisation of 
leptin  in  1994 (Zhang  1994) established adipose tissue as an endocrine  system 
expressing  and  secreting  signals  (adipokines)  that  regulate  a  myriad  of 
physiological  functions.  These  adipokines  are capable  of endocrine,  paracrine 
and/or autocrine effects.  In addition adipose tissue expresses numerous receptors 
allowing it to respond to the afferent signals from traditional hormone systems as 
well as the central nervous system (Mohamed-Ali  1998, Ailhaud 2000, Fruhbeck 
2001, Ahima 2000, Frayn 2003, Kershaw 2004).
Adipocytes are now thought to account for about 50% of the cellular make up of 
the tissue; it also contains connective tissue matrix, nerve tissue, stromal vascular 
cells and immune cells which all function together as an integrative unit (Frayn 
2003).  In  addition  to  its  endocrine  function,  adipose  tissue  provides  thermal 
insulation,  which  is  evident  in  many  large  marine  animals,  and  protection  for 
many body organs.
There  are  two  types  of  adipose  tissue,  distinguished  histologically  and 
functionally: brown adipose tissue (BAT) and white adipose tissue (WAT) (Cinti 
2000, Cinti 2001, Frayn 2004).  They both contain the triacylglycerol storage unit 
of adipocytes.  BAT is distinguished from WAT macroscopically by its brown 
appearance,  which  reflects  both  increased  vascularisation  and  its  greater 
mitochondrial  mass.  In  contrast,  WAT  typically  has  adipocytes  with  a  single 
large lipid vacuole, unilocular, as opposed to the multilocular adipocytes of BAT, 
with far less mitochondria and a small volume of cytoplasm.
45BAT’s  main function is in adaptive thermogenesis, which is the production of 
heat  through  the  actions  of  uncoupling  protein  1   (UCP1)  (Nicholls  1978, 
Desautels  1978, Enerback  1997).  In humans, BAT thermogenesis is important at 
birth  and early  infancy,  however,  with  age BAT diminishes,  leaving only  very 
small amounts of active tissue (Lean  1986). The site for adaptive thermogenesis 
in  humans  has  been  shown  to  be  localised  to  skeletal  muscle  and  possibly 
involves  another  uncoupling  protein  -  UCP3,  although  the  effect  of UCP3  on 
energy expenditure may be secondary to its primary functional  role (Lin  1998, 
Clapham 2000).  In contrast, in rodents and other small animals the contribution 
of  BAT  thermogenesis  to  energy  expenditure  can  help  these  animals  survive 
periods of cold and energy can be conserved during periods of inactivation such 
as hibernation.
On the other hand WAT does not express UCP1  and 3, only small  amounts of 
UCP2, whose role has yet to be fully elucidated, so therefore is not involved in 
heat  thermogenesis.  Despite  WAT  accounting  on  average  for  9-28%  (sex 
dependent),  in  regular  healthy  individuals,  it  is  characterised  by  low  O2 
consumption  compared  to  BAT.  Its  main  physiological  role  is  the  storage  of 
excess energy in the form of triacylglycerides.  The amount of lipid stored in the 
WAT is determined by the balance between body consumption and expenditure. 
If intake constantly exceeds output then adipocytes will expand enormously, with 
the ability to differentiate into new adipocytes from precursor cells when required 
for  additional  storage  (Gregoire  1998,  Rosen  2000)  and  also  apoptosis  of 
adipocytes  when  fat  stores  decrease  (Sorisky  2000).  Normal  health  relies  on 
having  WAT  in  relatively  normal  amounts  -  9-18%  in  male  and  14-28%  in 
female  (DiGirolamo  2000).  Conditions  in  which  there  is  too  little  WAT, 
lipodystrophy, currently on the increase with the use of highly active antiretroviral 
therapy  for HIV  (Loew  2003) have just as harmful  metabolic  consequences as 
having  an  excess  of  WAT  such  as  obesity,  which  is  associated  with  insulin 
resistance, hyperglycemia, dyslipidemia and hypertension (Grundy 2004).
As  with  most  biological  systems,  the  physiology,  anatomy  and  function  of 
adipose  tissue can be researched in number of ways:  humans,  animals (rat and
46mouse) or cell lines.  In an ideal situation studies on humans would be the gold 
standard,  however  there  are  ethical  and  heterogeneity  implications  which  also 
must  be  considered.  Animals  pose  less  of an  ethical  problem  and  are  more 
genetically  homogenous  as  well  as  having  the  ability  to  maintain  them  in  a 
controlled environment for the duration of their lives.  Numerous strains of mouse 
and  rat  animal  models  have  contributed  greatly  to  our  understanding  and 
knowledge of obesity and its associated diseases. The final  method available is 
the use of cell lines.  As well as adipose tissue obtained from human volunteers 
and animals, from which the adipocyte can be isolated and grown are a number of 
immortalised pre-adipocyte cell  lines.  Most frequently used are the cell lines - 
3T3-L1  and 3T3-F442A, for which the mechanisms of induction of adipogenesis 
are described below and also further in Chapter 3.
Undeniably all three forms of study have contributed greatly to our understanding 
of the adipocyte, adipose tissue and its function.
In vitro induction of adipogenesis
Adipogenesis is the program of events which brings about the conversion of a cell 
from a fibroblastic pre-adipocyte to a fully formed mature lipid laden adipocyte. 
The mechanisms of this event and the regulation of the process are discussed in 
more detail in Chapter 3.
Differentiation  of  primary  cultures  and  cell  lines  is  commonly  enhanced  by 
treating  postconfluent  cells  with  a  differentiation  cocktail,  containing  a 
combination  of  insulin  (Green  1975),  isobutylmethylxanthine  (Russell  1976), 
dexamethasone  (Rubin  1978)  and  serum  (Green  1974),  a  procedure  which 
involves three separate signal transduction pathways.  Insulin enhances the lipid 
forming capability of the cells and also has a role in promoting differentiation in 
primary  preadipocytes.  Insulin  binds  to  its  receptor  and  activates  a  tyrosine 
kinase signalling pathway which in turn phosphorylates insulin receptor substrate- 
1, and to a  lesser degree -2 and -3  (IRS-1, IRS-2, IRS-3). Phosphorylated  IRS 
initiates  several  signalling  cascades  including  mitogen-activated  protein  kinase 
(MAPK) and phosphoinositide 3 kinase (PI3K) (Saltiel 2001).
47Isobutylmethylxanthine  inhibits  phosphodiesterases,  blocks  Al  adenosine 
receptors, increases cAMP levels and potentiates the glucocorticoid effect in 3T3- 
L1 cells (Russell 1976, Rubin 1978, Schiwek 1987, Schmidt 1990). 
Dexamethasone,  a potent inducer of adipogenesis,  is  a synthetic  glucocorticoid 
steroid,  responsible for the expression of C/EBP5 (Cao  1991) and PPARy (Wu 
1996).  However,  glucocorticoids are conditional inducers as the glucocorticoid 
induced leucine zipper protein  (GILZ) antagonises adipocyte differentiation by 
binding to a CEBP binding site and inhibiting the transcription of PPARy2 and 
LPL genes (Shi 2003). Dexamethasone is also involved in the down regulation of 
the Pref-1 gene, an inhibitor of adipogenesis (see Chapter 3)( Smas 1999).
Serum contains  a  number of adipogenic  factors  such  as growth  hormone(GH), 
with FBS exhibiting the best adipogenic activity (Kuri-Harcuch 1978).
Thus the aims and objectives of this chapter are to:
(i)  Confirm and contrast the expression of Nurrl/nur77 in various  mouse 
tissues and adipose tissue.
(ii)  Assess  if  Nurrl/nur77  are  induced  in  3T3-L1  and  primary  pre­
adipocyte cells, following addition of adipogenic cocktail.
(iii)  Analyse  the  cocktail  components  for  their  ability  to  induce 
Nurrl/nur77.
48Experimental Procedures 
Cell culture
3T3-L1  cells were obtained from ATCC (VA, USA).  3T3-L1  preadipocytes are 
an  adherent cell  line  and  were cultured  routinely  in  either T75  or T175  flasks 
(Nunc,  VWR  International  LTD  UK)  in  either  15ml  or  35  ml  of Dulbecco’s 
Modified  Eagle’s  Medium  (Invitrogen,  Paisley  UK)  supplemented  with  10% 
Foetal Bovine Serum (Invitrogen) and maintained at 37°C and 5% CO2.  Before 
reaching  confluency  cells  were  trypsinised  (Trypsin/EDTA  Invitrogen)  and  re­
seeded at a split of 1:5.  Cells were fed every 48 hours.
Primary  Pre-adipocytes  from  murine  C57BL/6J  kindly  obtained  from  Jan 
Kopeky’s Laboratory (Academy of Sciences, Czech Republic).
Differentiation
Differentiation  experiments  were  performed  in  24  well  plates  (Nunc  VWR 
International  LTD  UK).  Preadipocytes  were  seeded  at  3  x  104 cells  per well. 
Cells were allowed to attach and grown to confluency.  Post confluent cells were 
then  treated  with  the  adipocyte  differentiation  induction  medium  - 
dexamethasone  2.5nM  (Sigma  Aldrich,  Dorset  UK),  isobutylmethylxanthine
0.5.M   (IBMX  Sigma Aldrich)  and  insulin  5mg/ml  (Sigma  Aldrich).  For the 
induction  of  Nurrl  studies,  RNA  was  isolated  at  TO,  T30mins,  T60mins, 
T90mins, T120mins, T240 mins, T480 mins and thereafter every 24 hours.  For 
the cocktail  analysis  studies the cells  were treated with each component of the 
cocktail individually and in varying combinations.
Primary pre-adipocytes were seeded at 5 x 104 cells per well.  Cells were allowed 
to attach and grown to confluency.  Post-confluent cells were treated with:
1.  Dexamethasone  (2.5nM),  IBMX  (0.5mM),  insulin  (5mg/ml)  and 
BRL49653 (lOOnM).
2.  Dexamethasone (2.5nM), IBMX (0.5mM), insulin (5mg/ml)
3.  Dexamethasone (2.5nM)
4.  IBMX (0.5mM)
5.  Insulin (5mg/ml).
49RNA  was  isolated  at  TO,  T30,  T60,  T90,  T120,  T240,  T480  mins  following 
induction.
Isolation of RNA from adipocytes
Cells were lysed in 500pl Trizol (Invitrogen) and stored at -80°C, whilst sample 
collection  was  completed.  Samples  were  then  thawed  on  ice  ready  for  RNA 
extraction.  To each  sample  lOOpl  of chloroform  was added and  sample  tubes 
mixed  thoroughly.  Tubes  were  then  placed  on  ice  for  15-20mins  to  allow 
separation of the phases.  Samples were then centrifuged at room temperature for 
lOmins  at  12000  x  g.  Following  centrifugation,  the  upper  aqueous  phase  is 
carefully removed to a new RNAse/DNAse free tube.  0.7 volume of isopropanol 
was  added  to  each.  To  facilitate  a  better  precipitation  of  RNA,  tubes  were 
incubated for 1-2 hours at -20°C.  Samples were then centrifuged at 12000 x g for 
10 mins to pellet the RNA.  Supernatants were carefully removed  so as not to 
dislodge the delicate pellet and washed with  lOOpl of 70% ethanol.  Following 
another centrifugation step (5mins  12000 x g), supernatant was removed and the 
pellet air-dried.  Finally, the pellet was resuspended in 25pi DEPC water.
Isolation of RNA from murine C57BL/6J tissue
Tissues  were  collected  from  WT  C57BL/6J  mice  and  quickly  snap  frozen  in 
liquid nitrogen.  Each tissue was then ground in a pestle and mortar into a fine 
powder and added to 1ml of Trizol (Invitrogen).  RNA extracted as before. 
Isolation  of  RNA  from  murine  C57BL/6J  epididymal  and  sub-cutaneous 
adipose tissue.
Adipose  tissue  isolated  from  the epididymus  (Epi  AT)  and  sub-cutaneous  (SC 
AT) regions was chopped very finely in a Petri-dish.  This was then transferred to 
a  universal  containing  9ml  of  DMEM  (Invitrogen)  and  1ml  of  30mg/ml 
collagenase  (Worthington  Type  2X3N6770,  VWR  International  Ltd,  UK)  and 
incubated  with  shaking  at  37°C  for  45mins.  The  digested  material  was  then 
filtered into a 15ml centrifuge tube and centrifuged at 3000rpm for 5 mins at 4°C. 
The  adipocytes  were  removed  from  the  upper  fraction  and  flash  frozen. 
Supernatant  was  removed  and  the  pellet  (containing  stromal  vascular  fraction)
50resupended in 1ml of DMEM and flash frozen.  1ml of Trizol was added to each 
sample for RNA extraction.  RNA extracted as before.
cDNA synthesis
Prior to cDNA synthesis, all RNA samples were subjected to DNAse treatment to 
remove any contaminating DNA in the sample.  To each RNA sample,  1   unit of 
DNAse  (Promega,  Southampton UK) and 3pl of lOx  Buffer was made up to a 
final  volume of 35pl  with  DEPC  water and  incubated at room temperature  for 
30mins.  Reaction  was  stopped  by  the  addition  of  lpl  of  Stop  reagent  and 
incubated at 65°C for 5 mins.  Tubes were then returned to ice.
The concentration of RNA was measured by optical density at 260nm; an OD of 1  
is  equivalent  to  40ug/ml  RNA  in  an  undiluted  sample.  All  readings  were 
performed on a NanoDrop spectrophotometer (Labtech, East Sussex UK),  lpl of 
undiluted  sample  is  placed  on  the  machine’s  aperture  and  an  OD  260/280 
performed, calculating the concentration per pi and also the quality of RNA.  Pure 
RNA would have and A260/A280 ratio of approximately 2.  Deviations from this 
indicate protein or RNA contaminants.
lpg of RNA was mixed with lpl (0.5pg) of oligo dT (Invitrogen) and made up to 
12pl with DEPC water and annealed at 72°C for 15 mins.  The samples were then 
cooled  slowly  on  ice  for  15mins.  To  this  5  x  First  Strand  Buffer,  2pl  DTT 
(lOOmM),  1   pi dNTP’s (lOmM) and  lpl of Superscript II Reverse Transcriptase 
(Invitrogen)  were  added,  giving  a  total  volume  of  20pl.  Samples  were  then 
incubated at 42°C for 45 mins, followed by a heat inactivation step at 70°C for 15 
mins and then cooled at 4°C.  To each reaction 80pl of DEPC water was added, 
giving a final concentration of lOng/pl.
SybrGreen RT-PCR
Semi-quantitative polymerase chain reaction was carried out using SybrGreen and 
specific  primers  for P-Actin,  Nurrl,  and  nur77  (Sigma  Genosys,  Suffolk  UK). 
Master  Mix  was  prepared  containing  12.5pl  of  2x  SybrGreen  Master  Mix
51(Applied  Biosystems,  Warrington  UK),  lpl  of forward  primer (lOmM),  lpl  of 
reverse primer (lOmM), 5.5pl of dfUO and 5pl of cDNA.  Semi- quantitative PCR 
was  performed  on  the  ABI  7700  (Applied  Biosystems,  Warrington  UK). 
Genomic  standards  (Promega)  were  run  in  parallel  to  allow  relative 
quantification.
Primer sequences:
Gene Name Forward  Primer Reverse  Primer
Seauence (5-3) Seauence (5-3’)
P-Actin gagctatgagctgcctgacg agtttcatggatgccacagga
Nurrl tcgacatttctgccttctcc ccactctcttgggttccttg
nur77 ggtatccgaaagtgggcaga cggaggatgaagagttccag
Fig. 2.1. Primer sequences for SybrGreen PCR analysis 
Statistical analysis
Results  are expressed as  mean±SD or SEM  for  normally distributed  values  or 
median (interquartile range) for skewed data. Comparisons between groups were 
made by two-tailed Student's /-test, Mann-Whitney U test or Wilcoxon rank test, 
as  appropriate.  P  <  0.05  was  considered  to  be  statistically  significant.  In  the 
induction of adipogenesis experiments expression levels are expressed as percent 
compared to levels of the mean TO value.
52Results
Expression of Nurrl and nur77 in murine C57BL/6J tissue
Extensive expression analysis has been  reported for members of this family  of 
NR’s  and  most papers cite basal  expression  of these family  members  in  brain 
(Law  1992,  Xiao  1996,  Watson  1989).  Expression  has  also  been  reported  in 
muscle  tissues  and  testes  for  nur77  (Watson  1989).  As  previously  indicated, 
members  of this  family  can  be  induced  rapidly  and  transiently  in  most  other 
tissues.  Additional data which has been made available (GSK in-house) indicates 
that as well as being constitutively expressed in brain; these genes are expressed 
abundantly  in  human  adipose  tissue  (whole)  as  well  as  some  evidence  of 
expression  in  mouse  adipose  tissue.  To  confirm  these  findings,  tissue  was 
isolated from  murine C57BL/6J  and analysed for the expression  of Nurrl  and 
nur77.
Expression was detected for Nurrl  in brain and at lower levels in adipose tissue 
with heart, kidney and lung expression at very low but detectable levels (Fig. 2.2). 
nur77 was expressed at similar levels in the brain and to a lesser degree in heart 
and  lung  but  much  higher  levels  were  detected  in  adipose  tissue  in  particular 
adipose isolated from the epididymal  area (Fig.  2.3).  The fact the  levels were 
higher  for  nur77,  than  Nurrl  in  adipose,  mirror  previous  in-house  data  from 
human tissues.  Adipose tissue was also separated into its constituent fractions - 
stromal  vascular and  adipocytes.  Nurrl  expression  was  10 fold  higher  in  the 
stromal  vascular fraction compared to the adipocytes (Fig.  2.4).  nur77  showed 
similar expression  levels in  both  the  stromal  vascular and  the  adipocytes  (Fig. 
2.5), although slightly higher in sub-cutaneous stromavascular fraction.  Levels do 
appear higher than adipose tissue but this could be down to a concentration of the 
samples.  Data normalised to P-actin expression and expressed as Nurrl/ P-actin 
+/- SEM.
53Induction  of  Nurrl  and  nur77  in  3T3-L1  cells  following  addition  of 
differentiation cocktail
Nurrl  is  an  immediate  early  gene  whose  expression  is  normally  induced 
approximately 2 hrs after the induction stimuli has been applied.  To assess if the 
same was true for Nurrl and nur77 expression in 3T3-L1 cells, the differentiation 
cocktail was added to post confluent cells and mRNA extracted at  TO, T30, T60, 
T90,  T120,  T240,  and  T480  minutes  and  analysed  for the  expression  of both 
Nurrl and nur77.
Following addition of the differentiation cocktail to the 3T3-L1 cells, a rapid and 
transient induction of both mRNAs was detected.  The expression pattern for both 
these genes was as expected with a peak of expression between T60 and T120 
mins  after which  expression  levels  subsided  (Fig.  2.6 and 2.7).  No detectable 
levels  of  NOR-1  could  be  detected  in  these  cells.  Data  is  presented  as  % 
induction because the numerical values obtained in the different experiments had 
a degree of variation.  This variation could be due to the degree of induction of 
the NGF1B  member, efficiency of reverse transcription step or the efficiency of 
the actual SybrGreen PCR.  Although it may appear that  100% induction is not 
achieved, the results presented are the average of a number of experiments.
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Fig. 2.2  Expression of Nurrl in murine C57BL/6J tissue
Expression  of  Nurrl  in  murine  C57BL/6J  tissue  as  assessed  by  SybrGreen 
analysis.  Data  normalised  to  P-actin  expression  and  expressed  as  ratio  of 
Nurrl/p-actin +/- SEM (n=10). Compared to expression in liver, the kidney, lung, 
brain, heart, and adipose tissues had significantly elevated expression levels (all
p<0.001).
(Epi AT = Epididymal adipose tissue, SC AT = Sub-cutaneous adipose tissue).
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Fig. 2.3 Expression of nur77 in murine C57BL/6J tissue
Expression  of  nur77  in  murine  C57BL/6J  tissue  as  assessed  by  SybrGreen 
analysis.  Data normalised to P-actin expression and expressed as nur77/ P-actin 
+/- SEM (n=10). Compared to the liver, the lung, brain, heart and adipose tissues 
showed elevated expression (all pcO.OOl).
(Epi AT = Epididymal adipose tissue, SC AT = Sub-cutaneous adipose tissue).
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Fig. 2.4 Expression of Nurrl in murine C57BL/6J adipose tissue fractions
Expression of Nurrl  in adipose tissue (a), stromal vascular (b) and adipocyte (c) 
(n=10) as assessed by SybrGreen analysis.  Data normalised to P-actin expression 
and expressed as Nurrl/ P-actin +/- SEM. Expression of Nurrl  in stromovascular 
fraction of both depots higher than seen in isolated adipocytes (all p<0.01).
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Fig. 2.5 Expression of nur77 in murine C57BL/6J adipose tissue fractions
Expression of nur77 in adipose tissue (a), stromal vascular (b) and adipocyte (c) 
(n=10) as assessed by SybrGreen analysis.  Data normalised to P-actin expression 
and  expressed  at  nur77/  P-actin  +/-  SEM.  nur77  expression  only  elevated  in 
stromovascular fraction of sub-cutaneous tissue (p<0.01).
58Nurrl induction in 3T3-L1 cells
100
o
o
80
60
40
20
0
TOO TO T30 T60 T120 T240 T480
N urrl
Time (mins)
Fig. 2.6 Induction of Nurrl during adipogenesis
Graph shows induction of Nurrl  following addition of differentiation cocktail to 
3T3-L1  cells,  as  assessed by  SybrGreen  analysis.  Data  expressed  as  mean  % 
induction compared to mean value of TO, following normalisation to P-actin, +/- 
SEM, n=4. TO v T60-T120 p<0.001; TO v T240-480 p>0.05=NS.
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Fig. 2.7 Induction of nur77 during adipogenesis
Graph  shows  induction  of nur77  following  addition  of differentiation  cocktail 
components to 3T3-L1  cells, as assessed by SyBrgreen analysis.  Data expressed 
as mean  %  induction of mean TO value, following normalisation to P-actin,  +/- 
SEM, n=4. TO v T60-T120 pcO.OOl; TO v T240-480 p>0.05=NS.
60Analysis of cocktail components on Nurrl and nur77 induction
As  described  previously  the  components  of  the  adipogenic  include 
dexamethasone, isobutylmethylxanthine and insulin.  It is widely known that there 
are  number  of  inducers  of  the  NGFIB  family  of  receptors  ranging  from 
neurotransmitters  to  membrane  depolarization  (Milbrandt  1988,  Arender  1989, 
Kovalovsky  2002,  Bartel  1989,  Davis  1994).  The aim of the experiment  is  to 
discover  whether  or  not  it  is  a  combination  of  all  three  elements  which  is 
responsible for the induction of Nurrl  and nur77, or 2 components or just one of 
these inducers.  The  induction experiment was set-up exactly as before but the 
inducers were added individually or as a combination of two.  RNA isolated at the 
same time points TO, T30, T60, T90, T120, T240mins and assessed for induction 
levels of Nurrl and nur77.
The results for each gene  (Fig.  2.8-2.13) are distinct  with Nurrl  exhibiting the 
more  specific  induction.  The  principal  inducer  of  Nurrl  is  IBMX,  which 
correlates  well  with  previous data  which  shows  that elevation of cAMP levels 
induce the expression of this family.  This will be discussed further in the next 
section.  Addition of insulin to the IBMX has little effect on the induction, whilst 
dexamethsone  in combination  with IBMX negatively impacts the expression of 
Nurrl.
nur77  demonstrates  a different  pattern  of induction  compared  to  Nurrl.  Each 
member  of  the  cocktail  seems  to  in  someway  induce  nur77  whether  added 
individually or as a combination.
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Fig. 2.8 Induction of NGFIB family in response to insulin
Nurrl  and nur77 induction levels as assessed by SybrGreen analysis following induction using insulin only.  Data expressed as 
mean % induction, following normalisation to P-actin, +/- SEM, n=4
a)  Nurrl,  significantly elevated  at T60 and T90 compared  to TO prior to returning to TO  levels,  b)  nur77,  stays  significantly 
elevated from T30-T120, compared to TO. All pcO.OOl.
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Fig. 2.9 Induction of NGFIB family in response to dexamethasone
Nurrl  and  nur77  induction  levels  as  assessed  by  SybrGreen  analysis  following  induction  using  dexamethasone  only, 
expressed as mean % induction compared to mean TO values, following normalisation to P-actin, +/- SEM, n=4. 
a) Nurrl, only elevated at T90 b) nur77, elevated at T30-T120. All p<0.00l.
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Fig. 2.10 Induction of NGFIB family in response to IBMX
Nurrl  and nur77 induction levels as assessed by SybrGreen analysis following induction using IBMX only.  Data expressed as
mean % induction compared to mean TO, following normalisation to p-actin, +/- SEM, n=4
a) Nurrl, significantly elevated at T30-T240; b) nur77, significantly elevated at T30-T120, all pcO.OOl.
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Fig. 2.11 Induction of NGFIB family in response to insulin and dexamethasone
Nurrl  and nur77 induction levels as assessed by SybrGreen analysis following induction using insulin and dexamethasone only. 
Data expressed as mean % induction compared to mean TO values, following normalisation to p-actin, +/- SEM, n=4 
a) Nurrl, only significantly elevated at T60, p=0.04; b) nur77, significantly elevated at T30-T120, p=0.03 to p<0.01.
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Fig. 2.12 Induction of NGFIB family in response to dexamethasone and IBMX
Nurrl  and nur77 induction levels as assessed by SybrGreen analysis following induction using dexamethasone and IBMX only. 
Data expressed as mean % induction compared to mean TO value, following normalisation to P-actin, +/- SEM, n=4 
a) Nurrl, b) nur77. All p<0.01
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Fig. 2.13 Induction of NGFIB family in response to insulin and IBMX
Nurrl  and nur77  induction  levels  as assessed by SybrGreen analysis following induction using insulin and IBMX only.  Data 
expressed as mean % induction compared to mean TO, following normalisation to (3-actin, +/- SEM, n=4 
a) Nurrl, b) nur77 All p<0.01
67Induction of Nurrl and nur77 in primary mouse pre-adipocytes and analysis 
of cocktail components.
Primary  pre-adipocytes  were  analysed for their ability  to induce  expression  of 
Nurrl  and nur77 and an investigation into the effects of the individual cocktail 
components  was  also  performed.  Primary  mouse  pre-adipocytes  were  set  up 
exactly as the 3T3-L1  system and post confluency, differentiation was initiated. 
The  pre-adipocytes  require  the  PPARy  agonist  BRL49653  for  differentiation, 
therefore  differentiation  was  induced  with  and  without  the  compound.  The 
cocktail was also analysed as individual components.
To date all  of the expression  analysis has  been  performed  in  the  immortalised 
3T3-L1 cell line and whilst this has been used as an ideal system to elucidate the 
adipogenesis  program,  it  must  be  remembered  that  it  may  not  always  parallel 
events which takes place in vivo accurately.
Nurrl  and nur77 are indeed induced in a similar manner in primary mouse pre­
adipocytes  as  3T3-L1  cells  (Fig  2.14  and  2.15).  Nurrl  exhibits  a  peak  of 
expression  at  approximately  60mins  followed  by  a  return  to basal  in  the cells 
without BRL49653.  However, the cells induced in combination with BRL49653 
appear to show  sustained expression of Nurrl.  nur77  expression  parallels  that 
found in 3T3-L1 cells with a peak of expression between 60-90mins and a return 
to  basal  levels  in  both  differentiation  cocktail  alone  and  in  the  presence  of 
BRL49653.
Analysis of the cocktail shows that IBMX would appear to be the primary inducer 
for  both  Nurrl  and  nur77  (Fig.  2.16-2.17).  Addition  of  either  insulin  or 
dexamethsone has a negligible effect on the induction on either Nurrl or nur77.
68Nurrl  induction in primary mouse pre-adipocytes
100 _
80
60
40
20
D ifferen tia tio n  
C o ck ta il +  B R L 49653
D ifferen tia tio n  
C o ck ta il - B R L 49653
TO T30  T60  T90  T120  T240
Time (mins)
Fig.  2.14  Induction  of  NGFIB  family  members  during  adipogenesis  in 
primary mouse pre-adipocytes
Graph shows induction of Nurrl  following addition of differentiation cocktail to 
primary  mouse  pre-adipocytes,  as  assessed  by  SybrGreen  analysis.  Data 
expressed  as  mean  %  induction  compared  to  mean  TO  value,  following 
normalisation  to  P-actin,  +/-  SEM,  n=3.  All  p<0.001  after  T30  and  remains 
elevated up to T240.
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Fig.  2.15  Induction  of  NGFIB  family  members  during  adipogenesis  in 
primary mouse pre-adipocytes.
Graph show induction of nur77 following addition of differentiation cocktail to 
primary  mouse  pre-adipocytes,  as  assessed  by  SybrGreen  analysis.  Data 
expressed as mean % induction of mean TO level, following normalisation to 0- 
actin, +/- SEM, n=3. All p<0.01 from T30 to T240.
70100
80
60
40
20
a) Insulin
TO T30 T60  T90
Time (mins)
B iittn
T120 T240
O
O
Z3
"O
100
80
60
40
20
0
b) IBMX
TO T30
II
T60  T90
Time (mins)
■
T120 T240
100
80
60
40
20
0
c) Dexamethasone
TO   T30  T60  T90  T120  T240
Time (mins)
Fig. 2.16 Analysis of differentiation cocktail on Nurrl expression in primary 
pre-adipocytes
Nurrl  induction as assessed by SybrGreen analysis following the addition of the 
individual  cocktail  components,  a)  Insulin  all  p>0.05.  b)  IBMX,  all  p<0.01  at 
times  T60-T240,  c)  Dexamethasone,  all  p>0.01.  Data  expressed  as  mean  % 
induction of mean TO value, following normalisation to P-actin, +/- SEM, n=3.
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Fig. 2.17 Analysis of differentiation cocktail on nur77 expression in primary 
pre-adipocytes
nur77 induction as assessed by SybrGreen analysis following the addition of the 
individual cocktail components, a) Insulin p<0.05 at T30-120. b) IBMX, p<0.01 
at times T30-T120, c) Dexamethasone, p<0.01 at T30, T60, T120 and T240. Data 
expressed as  mean  %  induction compared to TO,  following normalisation to  |3- 
actin, +/- SEM, n=3.
72Discussion
Expression of the NGFIB family in mouse tissue
Previous in-house data as presented earlier in this report (Fig.  1.8) illustrates the 
expression of each member of the NGFIB family in human tissues.  Highest levels 
of expression  are  evident,  surprisingly  in  adipose  tissue,  which  has  not  been 
reported before, as well as expression in brain, skeletal muscle with lower levels 
detected  in  a  variety of other tissues.  In  mouse  tissue,  Nurrl  exhibits  highest 
expression in the brain, which correlates well with previous data by others (Law 
1992, Xiao 1996, Watson 1989).  nur77 is expressed at similar levels in the brain 
as Nurrl  but its highest expression appears to be in adipose tissue (Fig 2.2 and 
2.3).  These  studies  have  confirmed  that  both  Nurrl  and  nur77  are  indeed 
expressed  at appreciable levels  in mouse adipose tissue  in both the epididymal 
and the  sub-cutaneous depots.  Nurrl  expression  is  higher in  stromal  vascular 
fraction than adipocytes, whilst nur77 appears to be expressed at similar levels in 
both fractions (Fig 2.4 and 2.5).  This may suggest a role for this family in the 
regulation of adipose tissue function.
Induction  of  Nurrl  in  3T3-L1  cells  following  addition  of  differentiation 
cocktail
The  NGFIB  family  are  transcription  factors  which  are classified  as  immediate 
early  genes  illustrated  by  a  rapid  and  transient  induction  of expression  by  a 
variety of stimuli and intracellular signalling cascades (Milbrandt  1988, Arender 
1989,  Kovalovsky  2002,  Bartel  1989,  Davis  1994).  However,  constitutive 
expression is observed in the adult mouse brain (Xiao 1996, Watson 1989) but as 
described earlier, expression can also be induced.  The induction of immediate 
early genes (EEG) occurs in the absence of de novo proteins synthesis and cannot 
be blocked by protein synthesis inhibitors (Platenik 2000). Extensive research in 
the  area  of the  c-fos  and  c-jun  IEG’s  has  demonstrated  that  the  downstream 
effects  of these  genes  are  critical  for the  proper functioning  of many  cellular
73systems,  although  the  exact  regulatory  mechanisms  still  remain  elusive  (Sng 
2004).
Following  the  addition  of  differentiation  cocktail  to  3T3-L1  cells,  a  rapid 
induction  of Nurrl  and nur77  mRNA levels  was detected,  with  levels peaking 
between 60 minutes and  120 minutes, which parallels that seen in other tissues 
and systems (Davis 1994, Philips 1997, Platenik 2000). Expression then returns to 
basal levels by approximately 4 hours and further expression of these genes is not 
apparent  during  the  differentiation  process  (Fig  2.6  and  2.7).  Tetradis  et  al 
reported  the  induction  of  Nurrl  and  nur77  maximally  at  60mins  following 
addition  of  lOnM  PTH  and  demonstrated  that  pretreating  the  cells  with 
cycloheximide, to prevent protein synthesis, did not inhibit the induction of Nurrl 
(Tetradis 2001,  Philips  1997b).  The transient induction of Nurrl  and nur77  in 
3T3-L1  cells precedes the induction of other genes involved in the adipogenesis 
program.  This suggests that the family could be involved in the very early events 
of adipogenesis.  This role could be one of two:
•  Transient  induction  of the  NGFIB  subfamily  could  be  responsible  for 
maintaining the cells in an undifferentiated state and their induction could bring 
about the switching off of genes such as Wnt’s, Pref-1 or other unidentified genes 
expressed in undifferentiated pre-adipocytes.
•  Transient induction of the NGFIB subfamily could be responsible for the 
induction of genes involved early in the adipogenesis program.
Analysis of cocktail components on Nurrl  and  nur77  induction  in  3T3-L1 
cells
As previously cited, the cocktail  used to initiate differentiation in 3T3-L1  cells 
contains a combination of insulin, isobutylmethylxanthine and glucocorticoids as 
well as the serum provided in the growth medium. Whilst a combination of all 
three induce the expression of both Nurrl and nur77 (Fig. 2.6 & 2.7), the purpose 
of  this  experiment  is  to  analyse  which  component(s)  of  the  cocktail  are  the 
primary inducers of expression.  Surprisingly the results for each gene are entirely
74distinct  (Fig.  2.8-2.13).  In  this  experiment,  it was  observed that the principal 
inducer of Nurrl  is IBMX, which correlates well with previous literature citing 
that the cAMP /PKA pathway regulates the expression of NGFIB family through 
phosphorylation (Maria 2003).  Maria et al demonstrated that stimulation of PKA 
activity augmented nur77 transactivation and DNA binding to the NurRE (Maria 
2003).  In addition, Tetradis et al showed that PTH, which is a potent stimulator 
of cAMP dependent signalling (Abou-Samra 1992), induced expression of Nurrl 
through  the  cAMP  protein  kinase  A  (PKA)  pathway  in  osteoblasts  (Tetradis 
2001).  Recently,  it has  also been  shown  that elevation  of intracellular cAMP 
levels  in  granulosa  cells  induced  Nurrl  and  nur77  expression,  which  were 
subsequently responsible for the down regulation of many FSH responsive genes 
including  aromatase,  which  promotes  transition  from  preovulatory  follicles  to 
corpora lutea (Wu 2005). There are also a number of other genes regulated by the 
NGFI-B family  which are induced by the cAMP/PKA pathway.  These include 
salivary-specific  R15  gene (Lin  1996), steroidogenic P450c21  (21-hydroxylase) 
(Chang  1995), P450cl7 (Zhang  1997) and a variety of thyrocyte-specific genes 
(Pichon 1999).
Addition of insulin to IBMX has a little effect on the induction of Nurrl  and has 
little effect on its own -  a low level of induction is evident at 90mins.  However, 
addition of dexamethasone to IBMX almost abolishes the induction of this gene. 
Dexamethasone  alone  elicits  a  small  induction  which  may  in  part  be  in 
conjunction with the serum.  It is known that dexamethasone and glucocorticoids 
in general antagonize the responsiveness of the NGFIB family of genes (Philips 
1997b).  Also nur77 and Nurrl  regulate POMC which in turn regulates ACTH, 
which is involved with the synthesis of glucocorticoids from the adrenal gland. 
However,  in  this experiment dexamethasone  would appear to  somehow  induce 
nur77  expression,  but  then  most of the cocktail  components  seem  to  induce  a 
hypersensitive induction of this gene, with no one constituent responsible for the 
expression of this gene in 3T3-Ll’s.  Combinations of each component seem to 
result in an augmentative effect.  This hypersensitivity of nur77 to the hormonal
75cocktail  constituents  makes  it  very  difficult  to  decipher  how  exactly  the  gene 
would  be  induced  during  the  adipogenesis  program,  unlike  its  sister  receptor 
Nurrl.
Induction of Nurrl and nur77 in primary mouse pre-adipocytes and analysis 
of cocktail.
Nurrl  and nur77 are indeed induced in primary mouse pre-adipocytes (Fig 2.14 
and 2.15).  Nurrl  shows a sustained pattern of induction with BRL 49653.  Cells 
induced without the BRL compound show a similar first phase of induction and 
then  expression  begins  to  drop  off.  However  a  small  secondary  induction  is 
evident at 8 hours.  This conflicts with the data obtained in the model  system. 
nur77  expression  appears  to  parallel  that  obtained  in  3T3-L1  cells  with  an 
induction within 60mins followed by a rapid decrease in expression.
As  for  the  3T3-L1  cells,  IBMX  would  appear to  be  the  main  inducer in  this 
system for both genes.  Dexamethasone and insulin have little or no effect on the 
induction of Nurrl.  In the primary cells, the induction of nur77 would appear to 
be  more  reliant  on  IBMX,  unlike  3T3-L1  cells  where  nur77  expression  was 
sensitive to multiple induction components.  Insulin and dexamethasone induce a 
small level of expression of nur77 (Fig 2.16 and 2.17).
In  conclusion  Nurrl  and  nur77  are  expressed  in  multiple  mouse  tissues, 
paralleling the results obtained in human tissue.  NOR-1  expression could not be 
detected  in  either  3T3-L1  cells  or  primary  pre-adipocyte  cells.  Nurrl 
demonstrated more  specific expression  in the  stromal  vascular fraction of both 
adipose depots and coupled with the more specific induction of this gene in both 
3T3-L1  cells and primary pre-adipocytes it was decided to focus on this family 
member  to  continue  researching  its  role  for  in  adipose  tissue  function  and 
adipogenesis.  In order to investigate the role of Nurrl  in adipogenesis a method 
of sustained expression is required.  As the pharmacological tools are unavailable 
the alternative method is over-expression using adenovirus.  As stated in Chapter
761,  these  receptors  function  as  constitutive  activators  when  expressed  in  vitro. 
These investigations will be described in Chapter 3.
77Chapter 3: Effect of Nurrl over-expression on 
adipogenesis and adipocyte function
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In vitro adipogenesis
The mechanisms of terminal adipocyte differentiation are well defined and clearly 
understood. A great deal of this work has been made possible through the use of 
the  immortalised  murine  cell  lines  such  as  3T3-L1,  F442A  and  obi771 
preadipocytes  that  subsequently  under-go  differentiation  upon  addition  of  the 
appropriate  hormone  cocktail  (Green  1974,  Green  1975,  Green  1976,  Ailhaud
1992).  These cells are morphologically similar to fibroblastic pre-adipose cells 
found  in  the  stroma  of  adipose  tissue  and  exhibit  virtually  all  the  same 
characteristics associated with adipocytes present within adipose tissue (Novikoff 
1980).  They also can form a fat pad when injected into nude mice (Green 1979).
Initiation of adipocyte differentiation results in a number of morphological  and 
biochemical  changes  within  the  cell.  These  changes  are  brought  about  in  the 
stages summarised below:
1.  Pre-confluent proliferation
2.  Growth arrest
3.  Hormonal induction/Clonal expansion
4.  Permanent growth arrest/terminal differentiation
Activation of this program is typically accomplished in 4-6 days.
One  of the  most common  methods of differentiation  involves  the  treatment of 
post-confluent  cells  with  insulin,  isobutylmethylxanthine  (IBMX)  and 
dexamethasone for two days, followed by an additional two days of insulin only 
(Cornelius  1994, Guller 1988, Hauner 1990, Schmidt  1990, MacDougald  1995). 
Within  72hrs  the  cells  have  adopted a  rounded  shape  and  deposition  of lipids 
within the cytoplasm begins, until greater than 90% of the cytoplasm is filled with 
lipids.
79Numerous  proteins  are  expressed  as  a  result  of  adipocyte  differentiation 
(Cornelius  1994).  Many  of  these  are  expressed  as  a  direct  result  of  the 
differentiation  process,  whilst  others  are  pertinent  to  the  process.  Some  are 
involved with lipid metabolism such as lipoprotein lipase and Glucose transporter 
IV (Vu  1996, Kaestner  1990).  Others such as aP2 are adipocyte specific genes 
but are not necessary for the differentiation process itself.  It is the study of genes 
such as aP2 which has brought about the identification of transcription factors and 
other proteins involved in the regulation of adipocyte differentiation (Cook 1988).
Regulation of adipogenesis
Three classes of transcription factors have been identified that directly influence 
fat cell development.  The key players in this process are the CCAAT/enhancer 
binding proteins (C/EBP's), peroxisome proliferator-activated receptor (PPAR's) 
and the basic helix-loop-helix family (ADDl/SREBPlc).
PPARy is  now widely recognised as  serving an  important role in  adipogenesis 
(Chawla 1994a, 1994b).  Two isoforms of PPARy exist, produced through the use 
of alternate promoters, PPARy 1   and PPARy2, the latter containing an additional 
28 amino acids at the N-terminus.  PPARy2 has been reported to be the form most 
associated with adipocyte differentiation and is highly expressed in adipose tissue. 
Evidence  linking  its role to adipogenesis  includes the demonstration that over­
expression of PPARy2 in NIH3T3 cell line under adipogenic conditions results in 
induction of adipocyte differentiation (Tontonoz  1994).  PPARy heterodimerises 
with retinoid X receptors (RXR) alpha, beta and gamma which are also expressed 
in adipose tissue (Gearing 1993, Keller 1993).
Three members of the CCAAT/enhancer binding protein (a,  P and 8) family of 
transcription  factors  were  the  first  demonstrated  to  play  a  role  in  adipocyte 
differentiation (Cao  1991).  C/EBPp and C/EBP8 were initially proposed to be 
involved in the process based on observations that their expression is induced by
80cAMP,  insulin  and  dexamethasone  and  their  induction  profile  is  rapid  and 
transient.  The  transient  nature  of expression  is  due  to  the  fact  that  their  sole 
purpose appears to be to initiate transcription of the PPARy gene (Cao 1991, Yeh 
1995, MacDougald 1994).
PPARy contains within its promoter sequence a C/EBP binding site and therefore 
its expression is regulated by the C/EBP's.  C/EBPa is also regulated by C/EBPp 
and 5.  Coincident with the rise in expression of PPARy and C/EBPa, the levels of 
C/EBPp and 8 down regulated.  Until recently, the model for the transcriptional 
cascade  leading  to  adipogenesis  was  that  C/EBPp  and  8  induce  low  levels  of 
PPARy  and  C/EBPa,  which  are  then  able  to  induce  each  others  expression 
through  a  positive  feedback  loop.  However,  Spiegelman’s  group  have  now 
shown that C/EBPa induces adipogenesis through PPARy (See Fig. 3.1) (Rosen 
2002).
It  had been  shown  that PPARy can  promote  adipogenesis  in  CEBPa deficient 
cells but to prove the converse had always been difficult as PPARy knock-outs are 
embryonic lethal.  Spiegelman's group created a fibroblastic cell line that lacked 
PPARy and showed that C/EBPa has no ability to promote adipogenesis on  its 
own.  So it would appear that C/EBPa function is to induce expression of PPARy 
(Rosen  2002).  However,  C/EBP  does  confer  insulin  sensitivity  onto  the 
adipocyte, via effects upon the transcription of IR and IRS-1  (Wu  1999).  It also 
activates  a  number of adipocyte  genes  such  as  leptin  and  adipsin  (Hollenberg
1997).
ADDl/SREBPlc,  which plays a role in terminal differentiation, is a membrane 
bound  basic  helix-loop-helix  leucine  zipper  transcription  factor  that  upon 
transactivation is proteolytically cleaved with the soluble form translocating to the 
nucleus where it can bind two classes of response elements (Brown 1997). One of 
these response elements is an E-Box, a helix-loop-helix consensus sequence and 
the  second  is  the  unrelated  sterol  response  element  (Murre  1989,  Yokoyama 
1993).  Upon cleavage, the activated form of ADDl/SREBPlc is responsible for
81inducing  the  expression  of  genes  involved  with  both  lipid  and  cholesterol 
metabolism.  There  are  several  lines  of  evidence  which  suggest  that 
ADDl/SREBPlc is involved in the regulation of adipogenesis.  Expression of a 
dominant negative form inhibits the differentiation of 3T3-L1  cells (Kim  1996). 
Over-expression  of  ADDl/SREBPlc  in  NIH3T3  cells  allows  differentiation 
following  addition  of  a  PPARy  ligand.  Furthermore  the  co-expression  of 
ADDl/SREBPlc  and  PPARy2  result  in  a  synergistic  effect  on  adipocyte 
differentiation  (Kim  1996).  It  has  also  been  postulated  that  ADDl/SREBPlc 
activated  genes  lead  to the  synthesis  of endogenous  ligands  for PPARy  (Fajas
1998).  ADDl/SREBPlc is responsible for stimulating the expression of many of 
the genes necessary for lipogenesis in vivo, including lipoprotein lipase, fatty acid 
synthase,  resistin  and  glycerol  phosphate  acyltransferase  (1996,  Seo  2003, 
Ericsson 1997).
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Adapted from Rosen et al (2002) Genes & Dev. 16(1 ):22-26Inhibitors of adipogenesis
Research  efforts  to date  have  largely been  interested  in  the  field  of adipocyte 
differentiation  and  regulation.  The  subject  of  inhibition  of  adipogenesis  has 
largely been ignored until recently.  There is now a growing volume of literature 
examining many of the genes and signalling pathways proposed to be involved in 
the early events of adipogenesis and a growing number of putative genes involved 
in  inhibition.  Whilst  a  large  number of mRNAs  whose  levels  increase  during 
adipocyte differentiation have been studied and characterised, very few have been 
identified that are down-regulated during adipocyte differentiation.  Early studies 
focussed  on  the  preadipocyte  factor-1   (Pref-1)  and  retinoic  acid  mediated 
inhibition.  However,  more  recently  a  new  area  of  interest  has  opened  up 
examining the Wnt signalling pathway.  Other areas of study include increases of 
calcium concentration  (and Calcineurin)  (Neal  2002),  arylhydrocarbon  receptor 
(AhR)  (Shimba  2001),  PTHrP (Chan  2001),  resistin-like  molecule  a (RELMa) 
(Blagoev 2002).
Pref-1 - Preadipocyte factor-1:
Pref-1  is  a  member of the epidermal  growth  factor -like  (EGF)  family  (Smas
1993).  It is solely found in the stromal vascular fraction and not the adipocyte 
fraction of adipose tissue.  Proteolytic cleavage of Pref-1  results in two soluble 
forms, the larger of which inhibits adipocyte differentiation (Mei 2002).  Pref-1 is 
highly expressed in 3T3-L1  pre-adipocytes at confluency and expression at both 
the  mRNA  and  protein  level  is  diminished  upon  differentiation.  This  down 
regulation  is  primarily  at  the  transcription  level  (Smas  1998).  In  vitro
differentiation  of 3T3-L1  cells  as  described  earlier  involves  the  addition  of a 
cocktail  of dexamethasone,  insulin  and  IBMX.  Studies  have  shown  that  the 
reduction in pref-1 expression in these cells is comparable between the complete 
differentiation cocktail and dexamethasone alone, indicating a negative regulation 
by glucocorticoids (Smas  1999).  It has also been shown that constitutive over­
expression of pref-1  in pre-adipocytes blocks their conversion to adipocytes (Sul
842000).  Although the decrease of pref-1 expression is only an early event and its 
expression  may no  longer be required for the differentiation process,  from the 
data presented to date it is possible that pref-1 may have a role in maintaining the 
cells in an undifferentiated state.  Xing et al suggested that pref-1  may be a non- 
reversible molecular checkpoint early in the differentiation process (Xing 1997).
Retinoic acid inhibition:
Retinoic  acid  (RA)  is  a  known  inducer  of differentiation  in  many  biological 
systems  (Spom  1983).  However,  it  also  acts  an  inhibitor  of  adipocyte 
differentiation  (Kuri-Harcuch  1982,  Sato  1980).  The  actions  of  RA  are 
predominantly mediated by retinoic acid receptors (RARs) (Xue  1996).  In vitro, 
adipocyte differentiation is efficiently inhibited when RA is added shortly after 
the exposure of pre-adipocytes to the differentiation cocktail (Kuri-Harcuch 1982, 
Stone  1990).  There is convincing data to suggest that liganded RAR (alpha and 
gamma) prevents the transcriptional activity of C/EBP protein and that it is this 
mechanism which underlies the inhibitory effect of RA on differentiation.  This 
mechanism would not seem to involve RAR binding to RARE's as a dominant 
negative RAR fails to prevent inhibition of adipogenesis (Schwarz 1997).
Wnt signalling:
Wnts are secreted signalling proteins that regulate many developmental processes 
(Cadigan  1997).  They signal through binding to transmembrane receptors of the 
frizzled  family.  Initial  in  vitro  experiments  to  assess  the  role  of  Wnt  in 
adipogenesis  were  performed  using  Wnt-1.  It  was  shown  that  3T3-L1  cells 
expressing Wnt-1  failed to differentiate.  Subcutaneous injections of 3T3-F442A 
cells expressing Wnt-1 into mice, resulted in mice with pads composed entirely of 
fibroblastic  cells,  indicating  that  Wnt  signalling  can  repress  adipocyte 
differentiation in a more physiological relevant model (Ross 2000).
Further work carried out to assess which of the Wnts were expressed in 3T3-L1 
cells identified Wnt-5a and Wnt-lOb.  Only over-expression of Wnt-lOb stabilised
85P-catenin  (regulator  of Wnt  target  genes)  and  potently  blocked  adipogenesis. 
mRNA analysis of 3T3-L1  cells revealed that Wnt-lOb expression  is highest in 
growing and confluent cells and then decreases upon addition of differentiation 
cocktail  (Ross  2000).  Suppression  of Wnt-lOb  can  be  brought  about  by  the 
addition  of IBMX  alone and this  suppression  is  not cell  specific.  This  would 
suggest  that  elevation  of  intracellular  levels  of  cAMP  is  responsible  for  the 
decrease  in  Wnt-lOb  expression  during  adipogenesis.  Treatment  of confluent 
preadipocytes with a cell permeable analogue of cAMP supported this conclusion 
(Bennett 2002).
Aims and objectives of this chapter
This  chapter  will  investigate  the  effects  of  Nurrl  over-expression,  using 
adenoviral  expression  system  in  differentiating  3T3-L1  cells.  The  effects  of 
Nurrl over expression will be investigated on:
(i)  Growth cellular morphology by microscopy.
(ii)  mRNA  expression  of  adipogenic  transcription  factors  and  adipocyte 
marker  genes.
(iii) Lipolysis and glucose uptake by adipocytes.
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Generation of Nurrl adenovirus construct.
Nurrl  (Human) cDNA was PCR amplified from another plasmid containing the 
gene (GSK) with the addition of Kpnl and Xhol restriction sites and a FLAG Tag. 
Forward primer 5'-3' ggtaccatggattacaaagatgatgatgataagccttgtgttcagg 
Reverse primer 5'-3' tctagattagaaaggtaaagtgtccag
The  amplified product was cloned  into the pCR2.1  Topo Cloning  (Invitrogen) 
vector and then excised from this vector using the Kpnl and Xhol (NEB, Herts. 
UK) restriction sites and ligated into pAdTrackCMV-GFP, which had also been 
digested with the same enzymes.  Clones were checked for integrity by double 
strand sequencing and confirmed to be correct.
Generation of admid DNA: Nurrl pAdTrackCMV-GFP construct was linearised 
with Pmel (NEB), run on a 1% EtBr agarose gel and DNA extracted using Qiagen 
Gel  Extraction  Kit  (as  per  manufacturer's  instruction)  (Qiagen,  Sussex  UK). 
BJ5183-Adl  (Stratagene, Amsterdam Netherlands) cells  were transformed  with 
the Nurrl construct.  40pl of electrocompetent cells were mixed with 2ul of Nurrl 
and transferred to an electroporation cuvette.  Electroporation was performed at 
200Q, 2.5kV, 25 pF. 1ml LB was then added immediately and cells incubated with 
shaking  for  lhr  at  37°C.  lOOul  of  transformed  cells  were  plated  on  LB- 
Kanamycin plates and incubated over-night at 37°C.  12 of smallest colonies were 
picked and grown in 5ml of LB-Kanamycin overnight.  DNA was prepared from 
1.5ml of culture the following morning.  Admid DNA was checked with a PacI 
(Promega) digest which should yield a large 30kb fragment plus a smaller one at 3 
or 4.5kb.
Admid  DNA  which  gave  the  correct  banding  pattern  was  re-transformed  into 
XL 10-Gold  (Stratagene)  cells  for  propagation.  Diagnostic  digests  to  check 
integrity of construct were also performed.
Generation  of  adenovirus:  HEK293  cells  are  routinely  cultured  in  EMEM, 
10%FBS,  1%  Non-Essential  Amino  Acids  and  2mM  L-Glutamine  (all 
Invitrogen). T75 flasks were seeded with 2 x  106 HEK293 cells 24 hrs prior to
87transfection, so that the confluency would be 50-70% at transfection.  Cells were 
transfected  with  PacI  linearised  Nurrl  pAdTrackCMV-GFP  (4pg),  using 
Lipofectamine Plus (as per manufacturers instruction - Invitrogen) and incubated 
for 3hours,  prior to  washing  the  cells  and  replacing  with  fresh  growth  media. 
Cells  were  harvested approx.  5  days  post-transfection.  To harvest,  cells  were 
pelleted by centrifugation, resuspended in PBS and the virus released by 3 cycles 
of freezing-thawing,  followed by pelleting of the cell debris.  Supernatant was 
collected into a fresh tube and virus stored at -20°C.
Virus  was  then  further  amplified  by  2  subsequent  rounds  of amplification  in 
HEK293 cells.  Cells were harvested 5-7 days post-infection and virus collected 
in the same fashion.  Expression in mammalian cells was tracked using the GFP 
marker.
Transduction of 3T3-L1 cells with NurrlpAdTrackCMV-GFP
3T3-L1 cells were cultured as described in Chapter 2.  Prior to transduction, cells 
were seeded at density of 2xl04 cells per well in 24 well plates and left to attach 
of 4-24hrs.
Nurrl pAdTrackCMV-GFP  virus  (MOI  -100-200)  was  incubated  with  Poly-L- 
Lysine (0.5ug/ml) (Sigma) for 30 mins prior to the addition of the transduction 
mix to the cells.  The transduction mixture on the cells was left to incubate over­
night  at  37°C  5%CC>2.  Media  was  then  removed  the  following  morning  and 
replaced with fresh growth media.  Transduction efficiency was assessed by level 
of GFP fluorescence.
Western blot analysis of Nurrl protein
3T3-L1 cells transduced with no virus, GFP virus or Nurrl  virus for 96hrs.  Cells 
harvested in RIPA buffer (Sigma Aldrich) and snap frozen.  Protein lysates runs 
on  4-20%  Tris-Glycine  gel  (Invitrogen)  before  transferred  to  nitrocellulose 
membrane  (Pierce  Rockford,  IL,  USA)  using  Semi-Dry  Blotter  following 
manufacturer’s  conditions  (Bio-Rad  UK).  Membrane  blocked  with  2.5% 
blocking  buffer  for  lhr  before  incubation  with  monoclonal  FLAG  antibody 
(Sigma  Aldrich  F3165)  for  lhr  and  subsequently  mouse  secondary  antibody,
88Alexa  Fluor  680  allophycocyanin  (Invitrogen/Molecular  Probes  A21000). 
Membrane finally washed in PBS-tween before visualisation on Licor Odyssey 
system (Licor BioSystems, Cambridge UK).
Differentiation of 3T3-L1 cells
Following virus removal, cells were allowed to reach confluency.  Post confluent 
cells  were  then  treated  with  the  adipocyte  differentiation  induction  medium  - 
dexamethasone  2.5nM  (Sigma Aldrich),  isobutylmethylxanthine 0.5mM  (IBMX 
Sigma Aldrich) and insulin 5mg/ml  (Sigma Aldrich).  Wild type (WT) 3T3-L1 
cells treated in same manner.  After 48 hours post-induction media was removed 
and replaced with DMEM + 10% FBS and insulin only (5mg/ml) for the duration 
of the experiment and changed every 2-3 days.  RNA samples were isolated at TO, 
T24, T48, T72, T96, T168 and T216 hours post-induction.
Isolation of RNA from differentiating 3T3-L1 cells
Media was removed and cells washed briefly with  1ml of PBS, followed by the 
addition of 500pl Trizol (Sigma Aldrich) per well to lyse the cells.  All samples 
were stored at -80°C and batch processed.  Samples were thawed on ice ready for 
RNA extraction.  To each  sample  lOOjil  of chloroform  was added and  sample 
tubes mixed thoroughly.  Tubes were then placed on ice for  15-20mins to allow 
separation of the phases.  Samples were then centrifuged at room temperature for 
lOmins  at  12000  x  g.  Following centrifugation,  the  upper aqueous phase  was 
carefully removed to a new RNAse/DNAse free tube.  0.7 volume of isopropanol 
was then added to each.  To facilitate a better precipitation of RNA, tubes were 
incubated for 1-2 hours at -20°C.  Samples were then centrifuged at 12000 x g for 
10 mins to pellet the RNA.  Supernatants  were carefully  removed and washed 
with  lOOpl of 70% ethanol.  Following another centrifugation step (5mins 12000 
x g), supernatant was removed and the pellet air-dried.  Finally the RNA pellet 
was resuspended in 25 pi DEPC water.
89cDNA synthesis
Prior to cDNA synthesis, all RNA samples were subjected to DNAse treatment to 
remove any contaminating DNA in the sample.  To each RNA sample, 1   unit of 
DNAse (Promega) 3pi of lOx Buffer and then made up to a final volume of 35pl 
with DEPC water and incubated at room temperature for 30mins.  The reaction 
was stopped by the addition of lpl Stop reagent and incubated at 65°C for 5 mins. 
Tubes were then returned to ice.
The concentration of RNA was measured by optical density at 260nm; an OD of 1  
is  equivalent  to  40pg/ml  RNA  in  an  undiluted  sample.  All  readings  were 
performed on a NanoDrop Spectrophotometer.  lpl of undiluted sample is placed 
on  the  machine’s  aperture  and  an  OD  260/280  performed,  calculating  the 
concentration  per pi  and also the quality of RNA.  Pure RNA would have and 
A260/A280 ratio of approximately 2.  Deviations from  this indicate protein  or 
RNA contaminants.
lpg of RNA was mixed with lpl (0.5ug) of oligo dT (Invitrogen) and made up to 
12pl with DEPC water and annealed at 72°C for 15 mins.  The samples were then 
cooled  slowly  on  ice  for  15mins.  To  this  5  x  First  Strand  Buffer,  2pl  DTT 
(lOOmM),  1   pi dNTP’s (lOmM.) and lpl of Superscript II Reverse Transcriptase 
(Invitrogen)  were  added  giving  a  total  volume  of  20pl.  Samples  were  then 
incubated at 42°C for 45 mins, followed by a heat inactivation step at 70°C for 15 
mins and then cooled at 4°C.  To each reaction 80pl of DEPC water was added, 
giving a final concentration of lOng/pl.
SybrGreen PCR analysis
Semi-quantitative polymerase chain reaction was carried out using Sybrgreen and 
specific primers for P-Actin, Nurrl, PPARy, C/EBPa, Perilipin, HSL and CD36 
(Sigma Genosys).  Master Mix was prepared containing  12.5pl of 2x SyBrgreen 
Master  Mix  (Applied  Biosystems,  Warrington  UK),  lpl  of  forward  primer 
(lOmM),  lpl of reverse primer (lOmM), 5.5pl of dH20 and 5pl of cDNA.  Semi- 
quantitative PCR was performed on the ABI 7700 using standard ABI7700 PCR
90conditions.  Genomic  standards  were  run  in  parallel  to  facilitate  relative 
quantification.
Primer sequences:
Gene Name Forward  Primer Reverse  Primer
Seauence Seauence (5-3)
P-Actin gagctatgagctgcctgacg agtttcatggatgccacagga
Nurrl tcgacatttctgccttctcc ccactctcttgggttccttg
nur77 ggtatccgaaagtgggcaga cggaggatgaagagttccag
PPARy gagcccaagtttgagtttgc ggcggtctccactgagaata
C/EBPa ggaacagctgagccgtgaac gcgacccgaaaccatcct
CD36 ccattggtgatgaaaagca atcaccactccaatcccaag
HSL tggtgcagagagacacttcg ggcttgcgtccacttagttc
Perilipin aaggatcctgcacctcacac gtaacacccttcagggcatc
Fig. 3.2. Primer sequences for SyBrGreen PCR analysis 
Analysis of lipid content in differentiated 3T3-L1 cells
Cells  were  seeded  into  the  appropriate  vessel  for  downstream  analysis.  For 
confocal studies cells were seeded at density of 3xl04 cells on to a confocal slide 
in a 60mm tissue culture dish (Nunc). Cells were allowed to attach and grow to 
confleuncy.  Post  confluent  cells  were  then  treated  with  the  adipocyte 
differentiation  induction  medium  -  DMEM/FBS  containing  -  dexamethasone 
2.5nM (Sigma Aldrich), isobutylmethylxanthine 0.5mM (IBMX Sigma Aldrich) 
and  insulin  5mg/ml  (Sigma  Aldrich).  48hours  post-induction,  the  hormone
91cocktail was removed and replaced with DMEM/FBS + insulin (5mg/ml) for the 
duration of the experiment, changing media every 2-3 days.
Oil Red O Staining:
Media was removed from differentiating cells and cells washed with PBS.  Cells 
were then fixed with 3.7% formaldehyde for lhour.  Fixed cells were then washed 
twice with PBS, before addition of Oil Red O for 1  hour.  Cells were then rinsed 
with PBS and images viewed on an inverted microscope and photographed.
Oil  Red  O  (4.2g)  was  dissolved  in  1200ml  of  absolute  isopropanol  and  left 
without stirring over-night at room temperature.  This solution was then vacuum 
filtered  and  diluted  with  900ml  of distilled  water  and  left  over-night  without 
stirring and then filtered twice.
Confocal analysis - Zeiss LSM 510:
ATm : For measurement of lipid content and ATm , adipocytes were loaded with  1  
pM  Bodipy  493/503,  a  neutral  lipid  dye,  and  25  nM  tetramethyl  rhodamine 
methyl ester (TMRE) (Invitrogen/Molecular Probes D3922), which were allowed 
to  equilibrate  for  30  minutes.  Cells  were  maintained  in  a  HEPES  buffered 
physiological salt solution containing 156 mM NaCl, 3 mM KC1, 2 mM MgS04, 
1.25 mM KH2PO4, 2 mM CaC^, 10 mM glucose and 10 mM Hepes, pH adjusted 
to 7.4 with NaOH. TMRE is a lipophilic cationic dye that equilibrates between 
compartments in response to potential differences. TMRE was used at very low 
concentrations  (30  nM),  when  the  signal  is  proportional  to  dye  concentration, 
which in turn depends on the potential differences between compartments, so that 
comparative  estimates  of AT  may  be  obtained  from  confocal  images  (Mojet 
2001). TMRE fluorescence was excited using the 543  nm HeNe laser line and 
measured  at  >590  nm  using  a  Zeiss  510  CLSM  confocal  microscope  and 
measurements were made from projections of Z-stack data to avoid sampling bias 
from  a  restricted  optical  section.  A  decrease  in  TMRE  signal  indicates 
mitochondrial  membrane  depolarisation  (Loew  1993;  Boitier  1999).  ATm   was 
related to lipid content by coloading with Bodipy 493/ 503 (excitation at 488 nm, 
measured at 505-550 nm). The images were then binarised above a threshold, so
92that  all  pixels  containing  signal  (lipid  droplets)  were  set  to  unity  and  all 
background to zero, again using a projection of a z-stack to include the full cell 
volume. The mean signal per cell was then expressed simply as a fractional value 
-  total lipid engorgement could give a signal of one, no lipid at all a value of zero.
LIpolysis analysis
Primary  adipocytes  (+/-Nurrl  adenovirus)  were  differentiated  as  described 
previously using insulin, dexamethasone, IBMX and BRL 49653 until >90% cells 
contained lipid (as assessed by light microscopy).  Cells then incubated over-night 
in Cell-Gro (VWR).  Following this pre-incubation, cells were then incubated for 
5hrs  in  Cell-Gro containing one  of the  following  P-adrenergic  agonists  -  IpM 
dobutamine (Sigma Aldrich),  lpM clenbutarol (Sigma Aldrich),  lpM CL316243 
(gift  from  Gokhan  Hotamisligil,  Harvard  University,  USA)  or with  no  agonist 
addition. Following the incubation period, supernatants were moved and assayed 
for NEFA release using a NEFA C kit (Wako VA USA), measuring at OD550nm.
Glucose uptake
3T3-L1  cells  were differentiated as described previously using dexamethasone, 
insulin and IBMX.  Once cells were assessed to be >80% differentiated they were 
treated  with  Nurrl  adenovirus or media alone for 24 hrs,  then  incubated  for a 
further 72-96  hrs  with  appropriate  media changes,  and  then  24hrs  prior to  the 
analysis media was replaced with Cell-Gro without Insulin.  Cells were washed 
with Krebs Ringer Phosphate Buffer, pH7.4 (Sigma Aldrich), at 37°C for 60mins. 
Cells were then incubated +/- insulin (lpg/ml) for 30 mins.  After  lOmins,  the 
glucose uptake inhibitor cytochalasin B (5pM) (Sigma Aldrich) was added to the 
appropriate  wells.  After  a  subsequent  lOmins  incubation  lpl  tritiated 
deoxyglucose  (3H-DOG  Perkin  Elmer  37MBq/ml,  Bucks.  UK)  was  added  per 
well  and  incubated  for a  further  lOmins.  Cells  were  then  placed  on  ice  and 
washed twice with cold PBS (Invitrogen), then lysed with 850pl of 0.1% SDS by
93repeat pipetting.  800pl  was  then  added  to  10ml  of scintillation  fluid  and  the 
amount of 3H-DOG uptake measured by liquid scintillation counting.
Statistical analysis
Results are expressed as mean+SD or SEM for normally distributed values or median 
(interquartile range) for skewed data. Comparisons between groups were made by two- 
tailed Student's f-test, Mann-Whitney U test or Wilcoxon rank test, as appropriate. P < 
0.05 was considered to be statistically significant.
94Results
Over-expression of Nurrl in differentiating 3T3-L1 cells
Over-expression  of Nurrl  was  successfully  achieved  in  3T3-L1  cells,  with  an 
average  of 40-50%  transduction  efficiency  achieved  in  all  experiments.  This 
equated  to  approximately  a  60  fold  over-expression  (assessed  by  mRNA 
analysis).  Although there would seem to be a bi-phasic response, this is bourne 
out by the SEM values and expression would appear to be relatively consistent 
with expression levels dropping at the later time point.  Expression  was easily 
tracked by the use of the GFP marker (Fig 3.3 and 3.4).  Transduction efficiency 
with the GFP null virus was similar (Fig 3.5).  Over-expression of Nurrl  is also 
evident from the Nurrl  western blot, using FLAG antibody, which shows a band 
of the correct size (68kD) (Fig 3.6).  There is also non-specific bands evident in 
the other lanes but these are above that of the Nurrl protein.
Analysis of markers of adipogenesis
PPARy and C/EBPa were tracked as markers of adipogenesis.  PPARy expression 
was  induced  within  the  first  24  hours  in  control  WT  cells  (non-infected)  and 
continued  to  increase  until  96 hours,  after which expression  was  more or less 
maintained.  In the Nurrl  over-expressing cells, expression also increased at 24 
hours but did not increase any further after 48 hours and was sustained at levels 
which were about 50% of that of the control WT cells (Fig 3.7).
In contrast to PPARy, little or no difference was seen in C/EBPa expression, with 
levels increasing in the first 24 hours and peaking at 48 hours (Fig 3.8).  At 48 
hours the levels of C/EBPa in Nurrl overexpressing cells was about 2 fold higher 
that  of  control  WT  cells,  but  levels  returned  to  similar  thence  after.  This 
difference in expression between the control WT and Nurrl over-expressing cells 
at 48hrs is insignificant.  A decrease in expression is evident in the Nurrl  over­
expressing cells at the later time points.
The  difference between control WT and Nurrl  over-expressing cells  was  most 
apparent in  the accumulation of lipid within the cells  (see  next result  section), 
which  was  also  supported  when  genes  involved  in  lipid  accumulation  were
95analysed.  Perilipin expression increased in parallel to control WT cells for the 
first 72 hours. However in Nurrl  over-expressing cells, levels fell to practically 
nothing  in  comparison  with  control  WT  cells  (Fig  3.9).  Hormone  Sensitive 
Lipase (HSL) only reached expression levels which were 50% of that found  in 
control WT cells, but the pattern of expression was mirrored (Fig 3.10).  Finally, 
the level of  CD36 expression achieved was only 20% that observed in control 
WT cells (Fig 3.11).
Data is expressed as % expression, as opposed to % induction, as the length of 
time of expression  is longer than that observed  in Chapter 2.  % expression  is 
calculated from gene of interest/(3-actin from a number of experiments.
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Fig. 3.3 Over-expression of Nurrl adenovirus in 3T3-L1 cells
Fold expression, over and above basal  levels of Nurrl  in differentiating 3T3-L1 
cells.  Graph  depicts  Nurrl  over-expression  in  the  3T3-L1  cells  infected  with 
either Nurrl  adenovirus,  GFP adenovirus or no  virus.  Data expressed  as  mean 
fold expression compared to TO of differentiating 3T3-L1  cells +/- SEM, n=5, as 
assessed by SybrGreen analysis.  No statistically significant differences in Nurrl 
expression between GFP (pink) and normally differentiating 3T3-L1  cells (blue) 
at any time-point (all p>0.05), but in the cells with Nurrl  adenovirus significant 
elevation in Nurrl expression is apparent at all time-points (all pcO.OOl).
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Fig. 3.4 Over-expression of Nurrl adenovirus in 3T3-L1 cells
Photograph  image  showing  Nurrl pAdTrackCMV-GFP  adenovirus  in  3T3-L1 
cells.
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Fig. 3.5 Comparison of Nurrl and GFP null adenovirus
Photographs  showing  GFP  expression  in  a)  Nurrl pAdTrackCMV-GFP  vs  b) 
pAdTrackCMV-GFP null adenovirus.
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Fig.  3.6  Western  blot  analysis  of  Nurrl  over-expression  using  anti-FLAG 
antibody.
Membrane  blot  showing  control  non-infected  3T3-L1  cells  (lane  2+3),  GFP 
adenovirus  (lane 4+5),  Nurrl  adenovirus (lane 6+7).  Primary  antibody,  mouse 
anti  FLAG  monoclonal,  secondary  antibody,  goat  anti-mouse  Alexa  Fluor 680 
allophycocyanin
Image viewed using Licor Odyssey system.
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Fig. 3.7 Expression of regulatory genes during adipogenesis in 3T3-L1 cells
Expression  of PPARy  in  control  non-infected  WT  and  Nurrl  over-expressing 
3T3-L1  cells.  Data  expressed  as  mean  %  expression  of  TO  of  WT,  after 
normalisation to P-actin, +/- SEM, n=4, as assessed by SybrGreen analysis. TO 
values are expression of PPARy in pre-adipocytes compared to those that showed 
no differentiation. There was significant elevation in PPARy expression after T48 
in  all  cells  (p<0.01),  however  this  elevation  was  suppressed  in  Nurrl  cells 
compared to WT at T48-T216 (all p<0.001).
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Fig. 3.8 Expression of regulatory genes during adipogenesis in 3T3-L1 cells
Expression  of C/EBPa in control  non-infected WT  and Nurrl  over-expressing 
3T3-L1 cells.  Data expressed as mean % expression, following normalisation to 
P-actin, +/- SEM, n=4, as assessed by SybrGreen analysis.  TO values are mean 
expression  of C/EBPa in pre-adipocytes capable of differentiating compared to 
those that showed no differentiation. There was significant supression in C/EBPa 
expression in only T168 and T216 (both p<0.01) in Nurrl compared to WT cells.
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Fig. 3.9 Expression of adipocyte genes during adipogenesis in 3T3-L1 cells.
Expression  of perilipin  in  control  non-infected  WT  and  Nurrl  over-expressing 
3T3-L1 cells.  Data expressed as mean % expression of TO of WT cells, following 
normalisation  to  (3-actin,  +/-  SEM,  n=4,  as  assessed  by  SybrGreen  analysis. 
Compared to TO,  expression  was  significantly  elevated  in  WT cells  at T72  to 
T216 (all pcO.OOl), however, while in Nurrl  cells expression  increased at T48 
and T72 compared to TO (p<0.01) all  other levels  were not different from that 
seen TO and were significantly lower than those in WT cell (p<0.001).
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Fig. 3.10 Expression of adipocyte genes during adipogenesis in 3T3-L1 cells.
Expression of Hormone Sensitive Lipase in control non-infected WT and Nurrl 
over-expressing  3T3-L1  cells.  Data  expressed  as  mean  %  expression  of TO, 
following  normalisation  to  P-actin,  +/-  SEM,  n=4,  as  assessed  by  SybrGreen 
analysis. Levels significantly elevated following induction of differentiation (T48 
- T216) in WT cells but remained suppressed in Nurrl cells (all p<0.001).
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Fig. 3.11  Expression of adipogenic genes during adipogenesis in 3T3-L1 
cells.
Expression  of CD36 in control  non-infected WT and Nurrl  over-expressing 
3T3-L1  cells.  Data  expressed  as  mean  %  expression  compared  to  TO, 
following normalisation to P-actin, +/- SEM, n=4, as assessed by SybrGreen 
analysis.  Levels  significantly  elevated following  induction  of differentiation 
(T72 - T216) in WT cells but remained suppressed in Nurrl cells (all pcO.OOl).
105Analysis of lipid content in differentiated 3T3-L1 cells
Analysis  of the cells  by  Oil  Red O (ORO)  staining showed  a greatly  reduced 
stained area in the Nurrl over-expressing cells compared to control (non-infected) 
differentiating 3T3-L1  cells.  That which is stained appears as very small  lipid 
droplet  (Fig.  3.12).  This  is  also  paralleled  with  the  Bodipy  staining  on  the 
confocal microscope (Fig. 3.13 and Fig. 3.14).
Lipolysis in differentiated primary mouse adipocytes +/- Nurrl adenovirus
Lipolysis  in  the  absence  and  presence  of  Nurrl  actually  produced  the  same 
results, which is unusual because the Nurrl population of cells had on average at 
least 50% less adipocytes than that of the control WT differentiating 3T3-L1 cells. 
For that reason the results are expressed as the average number of cells containing 
lipid  (Fig.  3.15).  Expressed  in  this  manner,  it  is  apparent  that  although  the 
percentage of lipid containing cells in the Nurrl  population is lower, they have a 
higher rate of lipolysis as witnessed by the NEFA release from these cells.
Glucose uptake in differentiated 3T3-L1 cells +/- Nurrl adenovirus 
It  was  apparent  from  the  lipolysis  results  that  it  would  be  difficult  to  really 
interpret lipolysis and glucose uptake in 3T3-L1 cells as the Nurrl overexpressing 
cells  are  not  fully  differentiated  adipocytes.  The  ideal  way  would  be  to 
differentiate the cells, so that >90% of them are lipid laden and then add Nurrl 
adenovirus to the adipocytes and observe if lipid accumulation could be reversed. 
This provided a number of hurdles to overcome first:
•  adipocytes are very fragile so any interventions could dislodge the cells.
•  because of this fragility and the  nature of the adipocytes they are more 
difficult to transduce with adenovirus.
Over-expression of Nurrl  in differentiated 3T3-L1  cells has no effect on glucose 
uptake (Fig. 3.16).
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Fig. 3.12 Oil Red O images of differentiating 3T3-L1 cells at day 8
(A) GFP Virus (B) Control WT (C) Nurrl  Virus
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Fig. 3.13 Confocal images of differentiating 3T3-L1 cells
(A), (B) Single cell images showing Nurrl adenovirus and control non-infected 
WT 3T3-L1 cells.
(C), (D) Multi cell images showing Nurrl  adenovirus and control non-infected 
WT 3T3-L1 cells.
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Fig. 3.14 Index of Bodipy 493/503 staining of 3T3-L1 cells +/-Nurrl
The index of Bodipy 493/503  staining, representing cellular lipid content, of 
3T3-L1  adipocytes differentiated using dexamethasone, IBMX and insulin in 
the  absence  and  presence  of  Nurrl  adenovirus  (mean  +/-  SEM,  n=40). 
Statistical analysis using 2-tailed student t-test.
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Fig. 3.15 NEFA release from primary adipocytes +/• Nurrl
The release of Nurrl  from primary adipocytes +/- Nurrl  post treatment with a 
pi- (dobutamine), P 2- (clenbutarol), P 3- (CL316243) adrenoceptor agonists 
or no  stimulant.  Data presented  as  mean  and  standard  deviation  of NEFA 
release mg/dL/4xl05  cells.  Cells differentiated using dexamethasone, insulin, 
IBMX  and  BRL49653  (n=3).  NEFA  release  is  significantly  elevated  in 
adipocytes without Nurrl  following induction with clenbutarol  or CL316243 
(p<0.01). However, in adipocytes with Nurrl compared to those without, both 
basal and stimulated NEFA release was significantly elevated (all p<0.001).
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Fig. 3.16 Glucose uptake in 3T3-L1 cells +/- Nurrl
The effect of Nurrl  over-expression on insulin  stimulated glucose uptake in 
3T3-L1  adipocytes,  shown  as  mean  CPM  per  105 adipocytes with  standard 
deviations (n=4).  Cells have been differentiated with insulin, dexamethsone 
and IBMX.  Virus added to the cells upon 90% differentiation and experiment 
performed 72-96 hrs post virus.
IllDiscussion
Over-expression analysis of Nurrl in differentiating 3T3-L1 cells
3T3-L1  cells  are  an  excellent  system  for  studying  the  differentiation  and 
biochemistry/biology of fat cells.  However, these cells are notoriously difficult 
to transfect using naked DNA.  Virally mediated introduction of genes permits 
a vastly enhanced level of gene delivery and adenovirus has become a popular 
and powerful  tool  for the  introduction of DNA  into  many cell  types.  In  a 
number of cell  lines,  adenovirus  vectors  which have  been  made  replication 
deficient can  be  used  to deliver a  gene  of interest  to  100%  of the  cells  in 
culture with little or no adverse effect on the transduced cells.  However, even 
adenovirus is not  100%  efficient for 3T3-L1  cells. To improve transduction 
Orlicky & Schaack have shown that incubating the virus with a poly -lysine 
mix  increased  the  efficiency  dramatically  (Orlicky  2001).  Adenovirus 
transduction  as  a  means  to  deliver  DNA  to  cells  has  been  used  by  many 
researchers  working in the adipogenesis field (B6r6ziat 2005,  Shimba 2004, 
2005,  Seo  2004).  In  the  set  of experiments  in  this  study,  on  average  a 
transduction  efficiency  of  40-50%  was  consistently  achieved,  which  was 
sufficient, to assess the affects of Nurrl  on the 3T3-L1  adipogenesis program 
(Fig.  3.3  and  3.4).  Nurrl  over-expression  was  assessed both at the mRNA 
level and the protein level.
Nurrl and adipogenesis
From experiments in the previous chapter we know that Nurrl  is expressed in 
mouse and human adipose tissue and that it can be induced transiently in 3T3- 
L1  and primary mouse pre-adipocytes.  This would suggest a putative role for 
Nurrl at some stage in the adipogenic program.
To identify and elucidate the role of Nurrl  in adipogenesis, the effect of its 
over-expression in the model 3T3-L1  system was assessed.  Genes which have 
previously been identified as integral to the adipogenic program were assessed
112as  well  as  other  genes  which  have  been  characterised  in  adipogenesis  and 
adipose tissue.
As  discussed  in  the  introduction  of  this  chapter,  PPARy  and  C/EBPa  are 
widely  recognised  as  being  key  players  in  adipogenesis  (Chawla  1994a, 
Chawla  1994b, Cao  1991).  Many groups have shown the induction of these 
genes early in the process and that they are key for the expression of many of 
the later adipogenic proteins.  In the Nurrl over-expression studies, a reduction 
of approximately 50 % is evident for PPARy expression, in Nurrl  transduced 
3T3-L1 cells.  At this stage it cannot be stated whether or not this reduction in 
PPARy expression is responsible for the effects on perilipin, HSL or CD36, or 
if this  effect  is  mediated  by  Nurrl  directly  on  these  genes.  In  contrast to 
PPARy, C/EBPa does not show the same difference in expression -  expression 
levels are comparable across the time course studied (Figs. 3.7-3.11).
However, there is a reduction in lipid accumulation as assessed by Oil Red O 
and  confocal  microscopy,  which  is  consistent  with  the  expression  levels 
detected for the lipid associated genes perilipin, HSL and CD36 (Figs.  3.12-
3.14).
Perilipins are highly phosphorylated proteins in adipocytes that are not secreted 
and are localised at the surface of the lipid droplet (Greenburg  1991).  It has 
been postulated that perilipin coats the lipid droplet and thereby interferes with 
HSL access to the lipid (Blanchette-Mackie 1995, Londos 1996, Souza 1998). 
Phosphorylation  is  brought about  activation  of protein  kinase  A  by  cAMP, 
which results in translocation of perilipin away from the surface of the lipid 
allowing hormone sensitive lipase to hydrolyse the lipid core (Londos  1996). 
This is discussed in more detail below.  It has been shown that by inducing 
lipolysis, in 3T3-L1  cells, with TNFa, a decrease in perilipin expression was 
evident;  however  this  lipolysis  could  be  rescued  by  the  over-expression  of 
perilipin (Souza  1998).  Perilipin knock-out mice are much leaner and more 
muscular than controls, have 62% smaller white adipocytes and have elevated 
basal lipolysis that is resistant to (3-adrenergic agonist stimulation.  These mice
113are also resistant to diet-induced obesity and by cross-breeding with Leprdb/db, 
obesity is reversed by increasing the metabolic rate (Martinez-Botas 2000). 
Hormone sensitive lipase, the rate limiting enzyme of intracellular triglyceride 
hydrolysis, is a major determinant of fatty acid mobilisation in adipose tissue 
and other tissues.  Expression of this gene has been detected in a wide variety 
of tissues  including  white  and  brown  adipose  tissue,  muscle,  steroidogenic 
tissues, mammary gland, macrophages and pancreas (Holm  1988, Khoo 1993, 
Holst  1996, Mulder  1999).  Phosphorylation of HSL is required to stimulate 
lipolysis, brought about by increases in intracellular cAMP concentrations and 
activation of PKA.  HSL -/- mice are resistant to diet induced obesity.  These 
mice show a decrease in weight and triglyceride levels in WAT but an increase 
in both BAT and liver triglycerides (Harada 2003).  Also by crossing the HSL 
null  mice with the Leprob/ob mice, obesity and adipogenesis can be inhibited 
(Sekiya  2004).  It  has  also  been  suggested  that  the  reduced  expression  of 
PPARy in the WAT of the knock-out has an anti-inflammatory effect.  And 
that this might some how allow up regulation of TNFa (Daynes 2002) which 
results in lipolysis.
CD36 is a fatty acid translocase protein which is expressed in tissues involved 
in fatty acid metabolism, such as adipose tissue, skeletal and cardiac muscle 
(Greenwait 1995, Motojima 1998, Goudriaan 2002). CD36 has been shown to 
increase in expression during the process of adipogenesis following induction 
of 3T3-F442A’s and Ob 1771 cells (Abumrad 1993, Greenwalt 1995).  In mice, 
mRNA expression of this gene is induced by PPARa in the liver and PPARy in 
adipose tissue (Motojima 1998).
The  decrease  in  markers  of adipogenesis,  adipocyte  specific  genes  and  the 
reduction in lipid accumulation all advocate a role for Nurrl  in adipose tissue 
function.
114Nurrl effects on lipolysis and glucose uptake
Lipolysis is the hydrolysis of triglycerides into its components - glycerol and 
fatty acids.  The rate limiting step in the process is catalysed by HSL, which 
has been discussed above.  The stimulation of lipolysis is brought about by 
multiple effectors including TNFa,  IL-1,  IFNa,  P and y,  prostaglandins  and 
catecholamines  (Kawakami  1987,  Ogawa  1989,  Feingold  1992). 
Catecholamines act through P-adrenergic receptors resulting in an increase in 
cAMP  concentrations,  activating  the  PKA  pathway  which  in  turn 
phosphorylates the enzymes involved in lipolysis such as HSL.  However, HSL 
is not the only enzyme to mediate lipolysis and other triglyceride lipases may 
work in the absence of HSL, responding to similar stimuli (Okasaki 2002). 
Lipogenesis  is  the  formation  of triglycerides  and  the  major  mechanism  by 
which this occurs is through digestion of triglycerides in the blood stream by 
LPL into fatty acids, thereby allowing them to diffuse into the adipocyte.  The 
fatty acids are then converted to triacylglycerol by fatty acyl-CoA synthase, 
preventing  diffusion  back  out of the  cell,  thereby  facilitating  storage  (Voet 
1990). Lipolysis in adipocytes can be stimulated in vitro by the addition of P- 
adrenergic agonists and then NEFA or glycerol release measured.
Alternatively, triglycerides can be formed from the de novo synthesis of acetyl- 
CoA  and  malonyl  -CoA  precursors,  which  involves  glucose  as  the  base 
substrate.  Unlike fatty acids, glucose cannot passively diffuse through the cell 
membrane, but instead uptake is mediated by a family of transporters known as 
the  glucose  transporters  (GLUTs).  GLUT1  and  4  are  the  predominant 
transporters  in  adipocytes  (Jung  1998).  In  unstimulated  adipocytes,  the 
majority of GLUT4 (95%) and a GLUT1  to lesser degree (30-40%) is located 
in intracellular pools.  Stimulation with insulin redistributes these proteins to 
the plasma membrane, enabling glucose translocation to provide the substrate 
for lipogenesis.  However,  chronic  insulin  exposure  downregulates  GLUT4 
expression  and  upregulates  GLUT1  expression;  resulting  in  an  increase  in
115constitutive glucose uptake and a reduction in insulin-stimulated uptake.  This 
is the basis of the glucose uptake assay.
The  data  generated  from  lipolysis  and  glucose  uptake  experiments  were 
difficult to interpret, even when performed in a “reverse” mode, where Nurrl 
virus was added following differentiation of 3T3-L1 cells into adipocytes.  The 
lipolysis results suggested that the cells had a higher rate of lipolysis compared 
to the control cells, despite the fact there was less lipid in the first place (Fig.
3.15).  Previous results from the Nurrl  over-expression studies suggested that 
HSL mRNA was much reduced in this population of cells possibly due to the 
fact that fewer cells were lipid laden.  However, as mentioned above, HSL is 
not  the  only  lipase  to  be  expressed  in  adipocytes  and  there  is  evidence 
demonstrating that other lipases can regulate lipolysis in the absence of HSL. 
In addition atrial naturetic peptides have been shown to have potent lipolytic 
effects (Lafontan 2005).  Interestingly, a naturetic peptide showed the largest 
fold increase at T72 hrs (94 fold) and significant fold increase at T192hrs (4 
fold) in the microarray data described in Chapter 4 (Table 10).
The glucose uptake experiment indicated that over-expression of Nurrl  had no 
effect on lipogenesis (Fig 3.16).  However as stated earlier the basis of these 
experiments assume that the cells all have differentiated, which is not the case 
in  the  Nurrl  cells  which  still  have  very  much  the  appearance  of  an  pre­
adipocyte cell.
It can be concluded that over-expression  of Nurrl  in differentiating  3T3-L1 
cells decreases the expression of regulatory as well as adipocyte specific genes, 
either by a direct or an indirect mechanism.  This in turn results in a dramatic 
reduction of lipid accumulation in the over-expressing population of cells.  The 
rate of glucose uptake appears to be unaffected by Nurrl, however the basal 
level of lipolysis in differentiating primary adipocytes is elevated compared to 
control WT cells.  In order to explore fully the effect of Nurrl over-expression 
on  differentiating 3T3-L1  cells  a much  higher through-put  technique  would
116need to be employed allowing analysis of many different pathways.  Chapter 4 
discusses  the  effect  of  Nurrl  over-expression  as  assessed  by  microarray 
analysis.
117Chapter 4 -  Effect of Nurrl over-expression on 
adipocyte gene expression by microarrav analysis
118Introduction
To  understand  the  complex  mechanisms  and  networks  involved  in  biological 
pathways and diseases, it is no longer sufficient to focus on isolated pathways or 
single  genetic  events.  Although  quantitative  and  semi-quantitative  PCR  are 
excellent means by  which to analyse changes in  mRNA gene expression,  they 
assume that the scientist knows exactly which pathways and genes are affected. 
The  high  throughput  format  and  semi-quantitative  analysis  of  microarray 
technology  provides  a  very  attractive  platform  for screening  large  numbers  of 
gene expression changes, thereby allowing the scientist to adopt a broad based 
approach to acquiring knowledge of intricate regulatory networks  and complex 
pathways.
Various types of microarrays exist based on their target material - cDNA, mRNA, 
protein,  small  molecules, tissues, or any other material that allows quantitative 
gene analysis.
The  Affymetrix  system  employs  an  oligonucleotide based  system  prepared  by 
light directed DNA synthesis to deposit 22 nucleotides and two types of probes - 
a  Perfect  Match  (PM)  and  a  MisMatch  (MM),  using  a  combination  of  two 
techniques -  photolithography and solid phase DNA synthesis.  The PM probe 
matches the target sequence exactly, whilst the MM probe has a single nucleotide 
change in the middle of the sequence and together these are known as the probe 
pair.  A number of probe pairs constitute a probe set and are used to investigate 
different regions within the same sequence.  The intensity information obtained 
from  the  values  of each  probe  is  combined  and  the  average  expression  value 
obtained  as  the  measured  value.  Following  mRNA  extraction,  RNA  for  the  2 
treatments  under comparison  is  reverse  transcribed  using  an  oligo  dT  primer. 
This is followed by an RNaseH mediated second strand synthesis.  This double 
stranded cDNA then serves as a template for in vitro transcription which is carried 
out in the presence of a biotinlyated nucleotide analog/ribonuclotide mix and T7 
RNA  polymerase  which  generates  biotin  labelled  amplified  cRNA.  The 
biotinlyated cRNA fragments are then purified and fragmented before hybridising
119to the GeneChip expression array.  The GeneChip array is them loaded onto the 
Fluidics  station for washing and staining, with  strepavidin phycoerythrin.  The 
probe  array  is  then  scanned  in  either  the  Agilent  Gene  Array  Scanner  or  the 
Affymetrix Gene Chip Scanner (Figure 4.1  shows a summarised overview of the 
procedure). The data produced is a series of black /white/grey dots, which is then 
analysed by the scanner to yield intensity values.  An example of the type of result 
recorded is illustrated in Fig 4.2.  All catalog GeneChip® expression arrays are 
designed  to have a minimum  sensitivity of  1:100,000.  This concentration  ratio 
corresponds roughly to a few copies of transcript per cell, or an approximate  1.5 
pM concentration.
Large  scale  genomic  approaches  have  become  increasingly  powerful  tools  for 
probing molecular mechanisms.  Microarray analysis has been used as a technique 
to investigate the time-dependent regulation of gene expression during adipocyte 
differentiation (Burton 2002, Guo 2000, Ross 2002).  And the hugely successful 
use of differential gene expression has been used to dissect the biology of nuclear 
receptors and the pathways and genes which they transcriptionally regulate (Ross 
2002, Wang 2005).  Microarray has been used to investigate the role of Nurrl  in 
regulating inflammatory processes in synovial cells (Davies 2005).
In this chapter the effect of Nurrl over-expression on differentiating 3T3-L1 cells 
was  investigated  using microarray  analysis  to identify  changes  in  adipogenesis 
related  genes  and  other  pathways/regulatory  networks  which  were  modulated 
(directly or indirectly) by Nurrl.  Subsequently, expression changes identified in a 
number of cytokines were confirmed using ELISA’s.
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121Fig. 4.2 Image of an Affymetrix GeneChip Array
Data from an experiment showing the expression of thousands of genes on 
single GeneChip® probe array. Image courtesy of Affymetrix.Experimental Procedures
Transduction of 3T3-L1 cells with NurrlpAdTrackCMV-GFP
3T3-L1 cells were cultured as described in Chapter 2.  Prior to transduction, cells 
were seeded at density of 5xl04 cells per well in 6-well plates and left to attach 
over-night.  NurrlpAdTrackCMV-GFP adenovirus was added to the cells and left 
to  incubate  over-night  at  37°C  5%CC>2.  Media  was  removed  the  following 
morning  and  replaced  with  fresh  growth  media.  Transduction  efficiency  was 
assessed  by  the  level  of GFP  fluorescence.  Control  3T3-L1  cells  were  non- 
infected.
Differentiation of 3T3-L1 cells
Following virus removal, cells were allowed to reach confluency.  Confluent cells 
were  then  treated  with  the  adipocyte  differentiation  induction  medium  - 
dexamethasone  2.5nM  (Sigma  Aldrich,  Dorset  UK),  isobutylmethylxanthine 
0.5mM (IBMX  Sigma Aldrich)  and insulin  5mg/ml  (Sigma Aldrich).  Control 
wild type 3T3-L1  cells (non-infected) were treated in same manner. Forty eight 
hours post-induction the media was removed and replaced with DMEM +  10% 
FBS and insulin only (5mg/ml) for the duration of the experiment and replaced 
every 2 days.  RNA samples were isolated at 72 (T72) and 192 (T192) hours post­
differentiation.
Isolation of RNA from differentiating 3T3-L1 cells
The media was removed and cells washed briefly with  1  ml of PBS followed by 
the addition of 1ml Trizol (Sigma Aldrich) per well to lyse the cells.  All samples 
were  stored  at  -80°C  and batch processed.  Samples  were then  thawed on  ice 
ready for RNA extraction.  To each sample 200pl of chloroform was added and 
sample tubes mixed thoroughly.  Tubes were then placed on ice for 15-20mins to 
allow  separation  of the  phases  and  then  centrifuged  at  room  temperature  for 
lOmins  at  12000 x  g.  Following centrifugation,  the  upper aqueous  phase  was 
carefully  removed  to  a  new  RNAse/DNAse  free  tube  and  0.7  volumes  of 
isopropanol added to each.  To facilitate efficient precipitation of RNA tubes were 
incubated for 1-2 hours at -20°C.  Samples were then centrifuged at 12000 x g for
12310 mins to pellet the RNA, then the supernatant solution was carefully removed 
and the pellet washed with lOOpl of 70% ethanol.
Following  another centrifugation  step (5mins  12000  x  g),  the  supernatant  was 
removed  and  the  pellet  air-dried.  Finally  the  pellet  was  resuspended  in  25pl 
DEPC- water.
RNA quantification and QC
The concentration and integrity of the RNA was assessed using the RNA 6000 
Nano  Assay  on  the  Agilent  2100  (Agilent,  West  Lothian  UK).  The  RNA 
quantification assay was set up according to manufacturerer’s protocol. Briefly, a 
gel  dye  mix  was  prepared  using  RNA  gel  matrix  and  an  RNA  dye,  and  then 
loaded onto an RNA chip, using a chip priming station.  The RNA 6000 Nano 
marker is then loaded into all wells, except those with gel-dye mix.  1  pi of RNA 
6000 ladder was added to the comer well and  1  pi of RNA sample added to each 
well, vortexed and run on the Agilent 2000 for an average run time of 45 mins.
See Figs. 4.3 and 4.4 for a view of results.
124Fig. 4.3 In silico gel image of RNA from Agilent 2100
Gel  generated  from  RNA  6000  Nano  Assay  on  Agilent  2100.  In  silico  gel 
generated by the Agilent 2100, showing 18s and 28s bands.T72 WT #1
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Fig. 4.4 RNA chromatograph from Agilent 2100
Chromatograph  shows  18s  and  28s  peaks  and  a  smaller  5s  peak,  with 
calculated  RNA  concentration  and  quality  for  one  of  the  control  3T3-L1 
samples.
126Microarray analysis
RNA samples sent to the Institute of Child Health Labs, at UCL for microarray 
analysis  and  QC.  RNA  processed  according  to  Affymetrix  recommended 
protocol and hybridised to a mouse 430-2 GeneChip® probe array.
Microarray results were analysed using a GSK bioinformatics in-house package - 
which presents data as fold changes.  (A >2-fold change is deemed significant).
All p<0.001.
Confirmation analyses of cytokine microarray data:
3T3-L1  cells and primary pre-adipocytes (as previously cited in the methods in 
Chapter 3  and above)  were transduced with  Nurrl, GFP or no adenovirus and 
following  confluency,  differentiated  as  above.  Supernatants  were  removed  at 
times 0 (TO), 24 (T24), 48 (T48), 72 (T72) and either  120 (T120) or 192 (T192) 
hours after induction of adipocyte differentiation and stored at -80°C until ready 
for assay.  Two-site microplate ELISA assays (R&D Systems, UK) for mouse IL- 
6, MCP-1  and RANTES were performed following manufacturer’s protocol and 
plates read at 450nm.  Results were expressed as pg/ml. The results obtained from 
assays  with  <10%  inter  and  intra-assay  coefficients  of  variation  (CVs)  were 
accepted.
Statistical analysis
Results are expressed as mean±SD or SEM for normally distributed values or median 
(interquartile range) for skewed data. Comparisons between groups were made by two- 
tailed Student's f-test, Mann-Whitney U test or Wilcoxon rank test, as appropriate. P < 
0.05 was considered to be statistically significant.
127Results
Microarray analysis
As adipogenesis induces a vast array of known gene changes these were initially 
analysed in the control cells, between the early (T72) and late (T192) time-points. 
In these cells, as expected, there was an increase in the adipogenic transcription 
factors,  PPARyand  C/EBPa,  as  well  as elevation  in  all  the adipocyte  specific 
genes such as HSL, adipsin etc. Morphologically these cells were adipocyte like 
and  accumulated  lipid.  These  results  confirmed  that  the  control  cells  were 
differentiating as normal. The data were then  analysed to look at the effect of 
Nurrl  specifically on the various adipocyte genes and the pathways that may be 
regulated by Nurrl.
Upon  receiving  the  microarray  data,  an  in-house  GSK bioinformatics  program 
was  employed  to  annotate  and  analyse  the  data  and  express  changes  as  fold 
change  compared  to  control  cells  with  associated  p-values.  Results  were 
expressed as a fold increase or decrease compared to control cells at the same 
time point.  The data represented in Fig. 4.5 shows a Venn diagram of the overall 
changes  across  the  time  points.  A  change  of at  least  2-fold  was  considered 
significant.  All  genes  under  discussion  had  p-values  <0.001.  Tables  1-10 
highlight a number of gene expression changes.
Of note is the fact that, Nurrl  exhibited a 70-fold expression increase, reflecting 
the adenovirus over-expression, over control cells at the earlier 72 hour timepoint 
(T72),  which  then  decreased  with  time  to  about  4-fold  at  the  later  192  hour 
timepoint (T192) (Table 8).
Previous data already showed a number of genes that were differently expressed 
during the differentiation process upon Nurrl  over-expression -  namely PPARy, 
HSL,  CD36  and perilipin.  As expected these changes  are  mirrored in  the data 
obtained  here.  The  microarray  result  showed  many  more  adipogenic  genes 
exhibiting a decrease in expression and also the up-regulation of many genes that 
are  typically  down  regulated  during  adipogenesis.  The  results  obtained  for 
changes  in  mRNA expression at the early time point  (T72)  are  more  likely to
128point to a direct Nurrl effect while the later point (T192) could reflect secondary 
effects or the lower adipogenic rate.  Therefore, a reduction in adipocyte specific 
genes is more likely to be a reflection of less adipocyte number and reduced lipid 
accumulation.
Many of the pro-inflammatory adipose factors were significantly elevated in the 
T72  Nurrl  over-expressing  adipocytes  and  these  results  were  followed  up  by 
determining  changes  in  their protein  levels,  by  ELISA,  namely  those  of IL-6, 
MCP-1 and RANTES.
The results for IL-6 protein secretion confirm those seen in the gene expression 
obtained in the microarray results, in that IL-6 protein release was significantly 
higher in the Nurrl over-expressing cells compared to either control untransfected 
3T3-L1 cells or cells expressing GFP (Fig. 4.6).  GFP was used as a control in this 
experiment  to  ensure  the  adenovirus  itself  was  not  responsible  for  the  up- 
regulation of the cytokines in the study.
In 3T3-L1  adipocytes, an increase in MCP-1  secretion whilst not as dramatic as 
those obtained for IL-6, was also statistically significant in Nurrl  cells (Fig. 4.7). 
The  microarray data  showed a 5-fold increase in MCP-1  mRNA,  which  was a 
much smaller increase than that obtained for IL-6 mRNA. These results were also 
confirmed in primary adipocytes (Fig. 4.9-4.10).
RANTES  release from  3T3-L1  cells in response to Nurrl  over-expression  was 
striking, and this is the first reported evidence of RANTES release in adipocytes. 
Again the results at the protein level are analogous to that seen at the mRNA level 
(Fig. 4.8) and were confirmed in primary murine adipocytes (Fig. 4.10).
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Time Point Up-Regulated
Genes
Down-Regulated
Genes
T72 Unique 1467 718
T192 Unique 224 895
T72 & T192 in Common 925 978
m
Fig.  4.5  Numerical  representation  of mRNA  expression  changes  during 
differentiation between Nurrl over-expressing cells and control cells.
a)  No. of genes up and down regulated at each time point
b)  Venn  diagram  representing  genes  in  common  and  unique  to  each  time 
point
130Adipogenesis transcription factors and related genes:
Gene no. Gene name Function Fold at 72h Fold at 192h
1418982_at C/EBPa Master regulator of adipogenesis 8.25 1 5.94
1420715_a_at PPARy Master regulator of adipogenesis 1.8j 2.84
1425262 C/EBPy May act as inhibitor of other C/EBP isoforms. 
Lacks transactivation domain. Defective form?
3.91 1.94
1460336_at PGCla Adaptive thermogenesis, fatty  acid oxidation, 
gluconeogenesis
2.1 J,
1449945_at PGCip Constitutive  adrenergic  independent 
mitochondrial biogenesis
4.81 141
1450402_at PPARBP Involved in transcriptional activation of NR’s 
including PPARy
3.4T 1.5T
Table 1 Regulators of adipogenesis
131Lipid metabolism related genes:
Gene no. Gene name Function Fold at 72h Fold at 192h
1422820_at Hormone sensitive 
lipase
Rate  limiting  enzyme  of  intracellular 
triglyceride hydrolysis
3.3| 304
1423828_at Fatty acid synthase Key enzyme in de novo lipogenesis 2.64 2.54
1425809_at FABP4 FABP4 binds fatty acids  and transports them 
to  the  nucleus  where  the  FABP4/fatty  acid 
complex activates PPARy
94
142281 l_at Fatty  Acid
Transporter
(SLC27al)
Membrane  protein  that  facilitates  LCFA 
transport across the plasma membrane
34
1423166_at CD36 Fatty  Acid  Translocase  involved  in  FA 
metabolism
1.44 5.84
1435281_at CPT1 Energy  balance;  mitochondrial  oxidation  of 
LCFA
4.71 2.51
Table 2 Lipid metabolism related genes
132Secreted factors/adipokines:
Gene no. Gene name Function Fold at 72h Fold at 192h
1450826_a_at Serum amyloid A3 Inflammatory  biomarker;  Up  regulated  by 
EL-6 and TNFa
4.2T -
1449182_at Resistin Pro-inflammatory cytokine. 
Inhibits adipogenesis.
Putative role in insulin resistance
5.44 494
1450297_at IL-6 Elevated  in  obesity,  is  associated  with 
metabolic  syndrome,  proinflammatory 
cytokine
15f
1420380_at MCP-1 Chemokine, 5.5T -
1418126  at RANTES Chemokine 20| -
1417867  at Adipsin Early adipocyte marker 5.44 174
142265 l_at Adiponectin Endogenous  insulin  sensitiser,  anti­
inflammatory,  elevated  in  healthy,  lean 
subjects
2.84 74
1436900_x_at Leptin Produced by adipocyte “ “
Table 3 Secreted factors/adipokines
133Other adipogenesis associated genes:
Gene No Gene Name Function T72 T192
1426516_at Lipin 1 Modulation causes dramatic shifts in adiposity 2.71 51
1460290_at Lipin 2 Related to Lipin 1 - 2.81
1419015_at WISP2 Inhibits proliferation in VSMC’s 201 2.2|
1448700_at GOS2 Up  regulation  specific  for  adipogenesis; 
associated with growth arrest
4.21 8.11
1450403_at STAT2 Induced by  cytokines,  no  known  function  in 
adipose
9.6| 1.41
1450259_a_at STAT5 Increased  during  adipogenesis,  possible 
regulation  of  preadipocyte  proliferation  and 
differentiation
4i
1449038_at llpHSDl Conversion  of  inactive  cortisone  to  active 
cortisol.  Inhibitors  lower  cholesterol  and 
triglycerides
2.5| 7.51
1450010_at 170HSD 12 Steroid metabolism - 2.11
1417369_at 173HSD4 Steroid metabolism 2.21 21
1448865_at 173HSD7 Steroid metabolism - 2.71
1416968_a_at HSD3|37 Steroid metabolism - 2.31
Table 4 Adipogenesis associated genes
134Nitric oxide pathway related genes:
Gene no. Gene name Function Fold at 72h Fold at 192h
1438879_at DDAH1 Enzyme involved in the metabolism of ADMA 4. It -
1416457_at DDAH2 As above 2.8T -
1416239_at ASS Catalyses  the  condensation  of  citrulline  and 
aspartate to form arginosuccinate, precursor of 
arginine.
9 t 2.4t
1428195_at SAHH Adenosylhomocysteinase - 4.4|
Table 5 Genes associated with the Nitric oxide pathway.
135Matrix Metalloproteinase’s and associated genes:
Gene No Gene Name Function T72 T192
1417234_at MMP11 Involved  in  insulin  resistance.  -/-  higher 
body weight.
13| 1.7T
1418945_at MMP3 Impairs adipose tissue development - lit
1448383  at MMP14 Unknown function in adipose tissue 5.8| -
1417256_at MMP13 Bone Resorption 5.5T 3T
1460287  at TIMP2 Unknown function in adipose tissue 4.4| 3.4T
1460227  at TIMP1 Unknown function in adipose tissue 3.5T 2.5|
1457058_at ADAMTS2 procollagen  N-proteinase;  increased  in 
osteoarthritis
3T -
1416871  at ADAM 8 Osteoclast stimulating factor 2.8T -
1422561  at ADAMTS5 aggrecanase in mouse cartilage 2.4T -
1452595_at ADAMTS4 Degradation  of  aggrecan  in  arthritic 
cartilage.
2.2] -
1421859_at ADAM17 modulate  cell  migration;  unregulated  by 
angll
- 21
1425170_a_at ADAM15 Cartilage remodelling - 2.21
1421171 _at AD  AMI 2 Involved in induction of adipogenesis 21 -
Table 6 Matrix Metalloproteinases and associated genes
136KLF transcription factors:
Gene No Gene Name Function T72 T192
1448890_at KLF2 Negatively regulates adipogenesis 3t 31
1417395_at KLF4 Pro-inflammatory  signal.  Down  regulated  in 
adipogenesis
5.4| 2.1|
1451739_at KLF  5 Down regulated in adipogenesis 3.25f -
1419355_at KLF7 As above 2.75T -
1422264_s_at KLF9 Up regulated in adipogenesis - 2.31
1427786_at KLF14 Unknown function in adipose tissue 3.4| -
1448181_at KLF 15 Up-regulated in adipogenesis 3.71 241
Table 7 KLF transcription factors
137Other nuclear receptors:
Gene No Gene Name Function T72 T192
1450749_a_at Nurrl Putative role in adipogenesis 70| 3.71
1443952_at RevErB alpha Potential  role  in  glucose  homeostasis  and/or 
inflammation. Increased during adipogenesis
51
'
1418157_at Coup-TFl Putative  role  in  inhibiting  differentiation  through 
heterodimerisation with RAR
3T -
1425792_a_at RORy Induced during differentiation of 3T3-L1 cells 5.81 7.81
1450444_a_at LXRa Regulate cholesterol and fatty acid metabolism in 
liver tissue and in macrophages.
Putative  role  in  the  execution  of  adipocyte 
differentiation  by  regulation  of  lipogenesis  and 
adipocyte-specific gene expression
4.71 16.51
1426464_at TRa Metabolically active. 4.31 3.21
1420583_at RORa Induced during differentiation of 3T3-L1 cells 2.81 2.31
1421747_at ERRy Not known to be expressed in 3T3-L1 cells 4.11 -
1418175_at VDR Evidence  to  show  inhibition  of differentiation  of 
preadipocytes
3.21 -
1416505_at nurr77 Induces lipolysis in skeletal muscle 2.41 -
Table 8 Nuclear receptor expression changes
138GPCRs:
Gene No Gene Name Function T72 T192
1419721_at HM74a Anti-lipolytic 8.6| 10.84
1425216_at GPR43 Free fatty acid receptor 7.2| 11.74
1457745_at GPR4 Lysophospholipid receptor 8.3| -
1418603_at Arg Vaso R Role in hypertension and regulation of HPA 7.6T -
142357 l_at EDG1 sphingosine-1  -phosphate/ chemotactic 
Role in atherogenesis 
Endothelial cell functions
6.4|
146066l_at EDG3 As above 5T -
1415832_at Angiotensinll Production of inflammatory cytokines 3.3f -
1423396_at Angiotensinogen Hypertension - 2.54
1421667_at GPR66 Neuromedin U Receptor (NMU) Type 1   for the 
anorexigenic hormone NMU
3.2| 0
1421073_a_at EP4 Prostaglandin E4 receptor, signals via elevation 
in intracellular cAMP levels. Pro-inflammatory
2.8| 0
1417625_s_at RDC1 Chemokine  orphan  receptor  1   Similar  to 
CXCR2.  Involved  in  angiogenesis  and 
endothelial cell migration
19T 2.8|
1450260_at GRPbombesin R Involved in Satiety 8.8t 2.8T
1421471_at NPY1 Role in regulating energy homeostasis 6.1T 2.71
Table 9 G-protein coupled receptor expression changes
139Other genes of interest:
Gene No Gene Name Function T72 T192
1450791_at Natriuretic 
peptide  precursor 
B
Proposed to have lipolytic effects 951 4t
1449015_at Resistin Like a Putative role in insulin resistance 7| -
1423954_at Complement 
component 3
Precursor  to  acylation-stimulating  protein. 
Increases efficiency of triacylglycerol synthesis. 
KO - reduced fat, obesity resistant & improved 
insulin sensitivity
4i 4j
1450652_at Cat K Role in bone degradation 17f 2.6|
1450383_at LDLR Lipoprotein  transport.  Some  evidence  over­
expression can stimulate adipogenesis
2.8| 10.24
142263 l_at AHR Down  regulated  during  adipogenesis.  Can 
inhibit adipogenesis if over-expressed
13T -
1450110_at ADH3 Alcohol Dehydrogenase putative NBRE?? 4.4j -
1418848_at Aquaporin 7 Adipose glycerol transporter - 154
1448201_at SFRP2 Modulator of wnt signalling -wnt inhibitor 10| 2.8|
Table 10 Genes associated with adipose tissue
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Fig. 4.6 Mouse IL-6 release in differentiating 3T3-L1 cells.
The  release  of IL-6  into  supernatant  of  3T3-L1  cells  during  differentiation  in 
untransduced,  GFP transduced  or Nurrl  transduced  cells.  Results  presented  as 
mean with standard deviations (n=5)
**p = 0.004; *** p <0.001
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Fig. 4.7 MCP-1 release from differentiating 3T3-L1 cells.
The release of MCP-1  into supernatant of 3T3-L1  cells during differentiation in 
untransduced,  GFP transduced or Nurrl  transduced  cells.  Results  presented  as 
mean with standard deviations (n=5)
** p =0.002 * p =0.02
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Fig. 4.8 RANTES release from differentiating 3T3-L1 cells.
The release of RANTES into supernatant of 3T3-L1  cells during differentiation in 
untransduced,  GFP transduced  or Nurrl  transduced cells.  Results  presented  as 
mean with standard deviations (n=5)
*** p <0.001
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Fig. 4.9 MCP-1 release from differentiating mouse primary adipocytes
The  release  of  MCP1  into  supernatant  of  murine  primary  adipocytes  during 
differentiation in untransduced, GFP transduced or Nurrl transduced cells.  Results 
presented as mean with standard deviations (n=5)
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Fig. 4.10 RANTES release from differentiating mouse primary adipocytes
The  release  of RANTES  into  supernatant of murine  primary  adipocytes  during 
differentiation in untransduced, GFP transduced or Nurrl transduced cells.  Results 
presented as mean with standard deviations (n=5)
* * *  p<0.001  * *  p=0.005
145Discussion
Microarray analysis is an incredibly powerful means of investigating changes  in 
gene expression, as witnessed by the tremendous number of changes observed in 
this  particular experiment.  As  a tool,  most  scientists  use  it as  an  investigative 
means  at  the  beginning  of  experiments  to  validate  targets  and  to  examine 
compound  effects  on  a  cell-line  or  animal  tissue.  In  this  study,  a  lot  of  the 
investigative work was performed before the microarray analysis and it was used 
to substantiate the  SybrGreen  analysis and of course  also  to probe further gene 
expression  changes  occurring  due  to  the  over-expression  of  Nurrl  in  3T3-L1 
adipocytes.  The wealth of data obtained from such an experiment is overwhelming 
and deep scrutiny of the results is required to try and elucidate the reasons behind 
these gene expression changes.  What is paramount to remember is that this, along 
with  SybrGreen analysis, is all at the mRNA level  and although the differences 
between  the  control  or  GFP  adenovirus  and  Nurrl  adenovirus  cells  is 
phenotypically  evident,  further  experiments  are  required  to  corroborate  these 
findings at the protein level.
Potent  effects  were  evident  on  several  of  the  adipogenic  transcription  factors 
belonging  to  the  PPAR  and  C/EBP familys  (Table  1).  Previously  PPARy  was 
identified (Chapter 3) as being expressed at much lower levels in the Nurrl over­
expressing cells compared to wild type, a result which has been confirmed here. 
However,  whilst  the  fold  reduction  of PPARy  was  not as  marked  as  witnessed 
before, the trend was similar and as stated the results are all semi-quantitative so 
expression  levels  are  only  indicative.  Surprisingly  C/EBPa  showed  a dramatic 
reduction in expression which was not evident in the previous SybrGreen studies. 
This anomaly could be due to design of primers employed in the SybrGreen studies 
and further primer sets would be required to confirm this finding.  As PPARy and 
C/EBPa have been  discussed at length in Chapter 3  they will  not be discussed 
further  here.  Nurrl  also  significantly  reduced  C/EBPymRNA  levels,  which 
encodes  a  small  protein  belonging  to the  C/EBP family  lacking  transactivation 
domains. Therefore dimerisation of this molecule with the other C/EBP isoforms 
may produce  inactive heterodimers and is thought to be a defective form or an 
inhibitor of the other forms of C/EBPs.
146Two co-factors,  PGCla,  P as well as the PPAR binding protein, PBP (Table  1) 
were identified as being down regulated and up regulated respectively.  The PGC1 
co-factors  interact  with  and  co-activate  PPARy  as  well  as  a  number  of  other 
nuclear receptors (Kamei 2003).  PGCla is expressed in several tissues and is cold 
inducible in brown fat and skeletal muscle (Larrouy 1999).  PGCip is expressed in 
brown fat and heart (Lin J 2002).  Ectopic expression  of PGC1  in  white fat or 
skeletal  muscle  cells  induces  a  broad  program  of  thermogenesis,  including 
increased respiration, mitochondrial biogenesis and increased expression of UCPs 
(Spiegelman  2000).  Although decreased levels of PGC-1  expression have been 
reported in morbidly obese individuals, the lower levels of PGC1 evident from the 
microarray data may be a consequence of lower levels of PPARy (Semple 2004) or 
it could be indicative of insulin resistance (Hammarstedt 2003).
PPAR  binding  protein  (PBP)  was  originally  cloned  as  a co-activator for PPAR 
(Zhu  1997) as well as other nuclear receptors (Torra 2004, Savkur 2004).  PBP is 
an  integral  component  of  a  multiprotein  thyroid  hormone  receptor-associated 
protein  (TRAP)/vitamin  D(3)  receptor-interacting  protein  (DRIP)/activator- 
recruited cofactor (ARC) complex required for transcriptional activity.  Its elevated 
level in this study could be due to the fact that this protein co-activates a number of 
other nuclear receptors, one of which is also up-regulated in this study, VDR.
HSL and CD36, 2 genes identified with altered expression patterns in Chapter 3; 
showed  the  same  reduced  expression  levels  in  the  microarray  study  (Table  2). 
HSL is greatly reduced by T192 with CD36 showing lower, but still significant, 
levels of decrease.  It is possible that this is a consequence of reduced adipogenesis 
which decreases the expression of these genes and hence resulting in lower lipid 
accumulation.  All  the other fatty  acid  metabolism  genes  identified have  lower 
levels of expression, except for CPT1  - carnitine palmitoyltransferase (Table 2). 
CPT1  is  located  in  the outer mitochondrial  membrane.  Although  not normally 
expressed  in  adipose  tissue  it  may  be  suggestive  of  its  activity  and  kinetic 
properties with changing physiological state.
Some the most intriguing and exciting data to emerge from the microarray study 
was that obtained for the adipokines (Table 3).  Gene expression studies in adipose 
tissue  have  revealed an  increased expression of inflammatory markers  in obese 
animals (Soukas 2000, Moraes 2003, Weisberg 2003) and conversely a decrease in 
their expression  following weight loss (Clement 2004).  As  well  as  adipocytes,
147adipose  tissue  contains  a  number of other cells  types,  contained  in  the  stromal 
vascular fraction.  A study comparing the adipocyte and stromal vascular fraction 
(SVF)  revealed  that  the  majority  of adipose  cytokines  are  in  the  non  fat  cells 
(Bouloumie 2005).  It is also suggested that an integral part of the inflammatory 
response might evolve from progressive macrophage infiltration into the adipose 
tissue during weight gain (Xu 2003, Weisberg 2003).
Resistin:  Resistin  belongs  to  a family of cysteine rich  proteins  termed RELMs 
(resistin  like molecules), each having unique tissue expression (Steppan 2001a). 
The  principal  source  of resistin  is  the  adipocyte  in  the  mouse;  its  release  was 
increased in obese mice and accompanied by insulin resistance. Adipocyte derived 
resistin was thought to be the link between obesity and diabetes (Steppan 2001b). 
However, human studies show an entirely different picture.  Unlike the situation in 
mice, human fat cells do not produce resistin, although there is some evidence of 
resistin  derived  from non-fat cells  (Nagaev 2001,  Fain  2003).  There  are  some 
findings  which  suggest  both  resistin  and  resistin-like  molecules  can  inhibit 
preadipocyte differentiation (Kim 2001, Blagoev 2002).  However, in the results 
obtained in the microarray study of Nurrl  over-expressing cells, it is possible that 
the observed down-regulation of resistin expression may be more of a character of 
the reduced lipid accumulation in the 3T3-L1 cells (Table 3).
IL6: IL-6, a cytokine, is secreted by many tissues and cell types including adipose 
tissue  (Papanicolaou  2000,  Mohamed-Ali  1997,  Fried  1998).  It  decreases 
expression of lipoprotein lipase and its activity, in the 3T3-L1 cell line, (Greenberg
1992)  as well as increasing lipolysis (Feingold 1992, Hardardottir 1994), possibly 
through  a  down  regulation  of  triglyceride  deposition  and  an  increase  in  fuel 
mobilisation  (Greenberg  1992).  This cytokine can be  induced by  a number of 
molecules  including  TNFa,  IL-ip  and  also  by  P-adrenergic  agonists  (Stephans 
1992,  Flower  2003,  Mohamed-Ali  2000).  IL-6  deficient  mice  have  reduced 
glucose tolerance and females have increased circulating triglycerides and leptin 
insensitivity.  These mice develop mature onset obesity with an increase in sub­
cutaneous adipose tissue that can be partly reversed by IL-6 injections (Wallenius 
2002).  Interestingly IL-6 also has stimulatory effects on the HPA axis, increasing 
hypothalamic  secretion of CRH  and release  of ACTH  and cortisol  (Mastorakos
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in  Chapter one.  The  microarray data shows  a  15-fold  increase  in  IL-6  mRNA 
(Table 3) and the ELISA results also demonstrate an increase in this cytokine in 
response to Nurrl  overexpression (Fig. 4.6).  We know that IL-6 is expressed at 
higher levels in the pre-adipocyte than the adipocyte;  however the results show 
approximately 3-fold increase in IL-6 release compared to the wild type control 
differentiating cells.  We also know that glucocorticoids suppress the induction of 
IL-6, and in general antagonize the responsiveness of the NGFTB family of genes 
(Philips 1997).  And as alluded to above, nur77 and Nurrl  regulate POMC which 
in turn produces ACTH, which is involved with the synthesis of glucocorticoids 
from the adrenal gland.
Is  it possible  that Nurrl  induces  IL-6 and then  there  is  some kind of feedback 
system that can re-induce Nurrl or keep it constitutively active?  Prostaglandin E2 
and  PGI2  both  elevate  intracellular  cAMP  and  are  constitutively  produced  by 
adipocytes and this may mediate an increase in Nurrl which then induces IL-6.
MCP1:  Monocyte  chemoattractant-1  is  a  pro-inflammatory  chemokine,  mainly 
produced by macrophages and endothelial cells, and suggested to be involved in 
atherosclerosis in vitro (Inoue 2002, Tabata 2003).  Circulating MCP-1  has been 
found to be elevated in obese animal models and reduced after weight loss (Sartipy 
2003, Takahashi  2003).  As with the other cytokines, expression is higher in  the 
pre-adipocyte  stromal  vascular  fraction  as  compared  to  the  adipocyte  fraction 
(Christiansen  2005).  There  is contrasting  evidence  which  suggest  that IL-6  can 
induce  MCP-1,  which  may  be  due  to  the  model  systems  used  (Murao  1999, 
Fasshauer 2004).  Like with IL-6, lipid accumulation is inhibited in the presence of 
MCP-1, down-regulating LPL expression and a number of other adipogenic genes 
expressed in mature adipocytes (Gerhardt 2001, Greenberg 1992).  Again MCP-1 
was another cytokine with elevated expression levels in the Nurrl  population of 
cells (Table 3).  There would appear to be a significant increase in MCP-1 release 
in  3T3-L1  cells paralleling that found at the  mRNA  level,  but the  results  were 
variable  for  the  primary  cells,  with  GFP  giving  wildly  erratic  release,  making 
confirmation of this result difficult to verify (Figs. 4.7 and 4.9).  GFP adenovirus 
has  had  no  influence  on either IL-6 or RANTES  release or mRNA expression, 
although there is some previous reports to suggest that adenoviral vectors can have
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At this stage it is hard to deduce whether the MCP-1 effect is real and further work 
will be required.
RANTES: RANTES, an abbreviation for “regulated upon activation normal T cell 
expressed  and  secreted”  (Appay  2001),  is  induced  in  leukocyte  migration  by 
RANTES binding to a GPCR - CCR1, 3, 4 or 5 and mediates the trafficking and 
homing of classical lymphoid cells such as T cells and monocytes, but also acts on 
basophils, eosinophils, natural killer cells, dendritic and mast cells (Schall  1991). 
To date there is no evidence of expression or release of RANTES from adipose 
tissue.  Here is the first evidence that basal levels of RANTES expression can be 
detected in both 3T3-L1  cells and primary differentiated adipocytes (Table 3).  In 
3T3-L1  cells, expression in the Nurrl  population is approximately 5  fold higher 
than that of either control or GFP infected cells, peaking 2 days post-induction and 
returning to basal levels by day 5.  In the primary cells, although approximately 10 
fold  less  release  of RANTES  is  observed,  there  is  still  an  increase  in  release 
observed in the Nurrl cells, up to day 3 and levels have returned to baseline by day 
7 (Figs. 4.8 and 4.10).  Any concern that this is an adenoviral effect is borne out by 
the absence of induction in the GFP cells.
Adiponectin:  Adiponectin  is  secreted  exclusively  from  the  adipocyte  (Scherer 
1995).  In  contrast to leptin, adiponectin  is reduced in obesity and increased  in 
response  to  weight  loss.  It  has  also  been  shown  to  decrease  in  diabetes  but 
improves with insulin sensitising agents (Chandran 2003).  It has been described as 
an  endogenous  insulin  sensitiser  and  an  anti-inflammatory  factor.  Adiponectin 
knock-out mice develop insulin resistance, glucose intolerance, dyslipidemia and 
susceptibility  to  vascular injury  and atherosclerosis.  Restoration  of adiponectin 
reverses these effects (Maeda 2002, Kubota 2002).  The microarray data shows a 
3-7 fold decrease in adiponectin levels, which maybe solely due to the reduction in 
number of adipocytes, compared to the control cells - this would correlate with the 
data which suggests  that this adipokine is expressed and secreted by adipocytes 
(Table 3).
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2004)  and  is  the  enzyme  responsible,  along  with  C3  and  factor  B,  for  the 
generation of another adipose tissue protein - acylation-stimulating protein (ASP). 
An early observation was made that expression was reduced in both genetic and 
acquired  models  of  obesity;  however  it  is  no  longer  regarded  as  a  signalling 
molecule  in energy balance  but  more  of an  early  adipocyte marker  gene  (Flier 
1987).  Again reduction of adipsin mRNA expression (5-17 fold) in the microarray 
data maybe more indicative of a decreased number of adipocytes (Table 3).  The 
decrease in expression of complement component 3  could  also be due to fewer 
mature  adipocytes.  Mice  lacking  this  factor have  a  greater caloric  intake  with 
normal fat absorption but are significantly leaner (Faraj 2004).
SAA3:  Expression  of  Serum  Amyloid  A  (SAA),  as  with  other  acute  phase 
reactants, is predominantly in the liver.  However, expression in tissues other than 
the liver has been reported (Norkina 2004).  Adipocytes are highly responsive to 
inflammatory stimuli and treatment with TNFa and IL-6 induces serum amyloid 
A3 protein in 3T3-L1  cells (Lin 2001).  It could be speculated that the increase in 
SAA3 expression (4-fold) apparent from the microarray data is probably due to the 
up-regulation and release of IL-6 (Table 3).
Matrix  Metalloproteinases:  Adipocyte  differentiation  is  associated  with  an 
extensive reorganisation and remodelling of the extra cellular matrix (ECM).  Two 
major families of proteases have been involved in the process - serine proteinases 
and  matrix  metalloproteinases  (MMPs)  (Carmeliet  1998).  MMPs  are  highly 
regulated enzymes with expression, secretion and activity levels under very precise 
control.  They  are synthesised in a precursor format and must be proteolytically 
cleaved to  generate the mature enzyme.  Their activity  is  further modulated  by 
Tissue  Inhibitors  of  MMPs  (TIMPs)  (Gomez  1997).  Several  MMPs  have 
intriguing and opposing effects in the adipogenic process suggesting that they have 
distinct roles and substrates during fate decisions and/or terminal differentiation. 
Discussions will centre on those MMPs and related genes that were highlighted by 
the microarray data.  The microarray data indicates an increase in expression of 
MMP3,  11,13 and  14 (Table 6).  MMP3 and  11  knock out mice both exhibit an 
increase in body weight, compared to WT (Maquoi 2003, Lijnen 2002), suggesting
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other MMPs,  may  have  implications for angiogenesis  (Stetler-Stevenson  1999), 
which  is central  to the differentiation of adipose tissue  (Crandall  1997).  So an 
increase in expression of these particular MMPs  would  have a negative role  in 
adipogenesis.
TIMP  1   and 2 also showed an increase in expression (Table 6).  It would appear 
expression of both these TIMPS is highest in the pre-adipocyte with expression 
decreasing  during  differentiation  (Maquoi  2002).  The  other  metalloproteinase 
associated  family  of proteins  - the  ADAM  and  ADAMTS  (A  Disintegrin  And 
Metalloproteinase  and ADAM  proteins  with a thrombospondin  (TS)),  have  also 
had  minor  implications  in  adipogenesis,  with  most  information  available  on 
ADAM  12  and  ADAMTS 1.  Data  on  ADAM  12  suggests  an  involvement  in 
adipogenesis as over-expression of this gene in mice leads to an increase in body 
fat  compared  to  WT,  through  an  unknown  mechanism  (Kawaguchi  2002). 
ADAMTS 1   KO  shows  a  leaner  phenotype  (Shindo  2000),  although  in  this 
microarray  study no apparent changes were found in this gene.  There does not 
appear to be any evidence relating to the other members of the ADAMs family 
highlighted in this study, but changes in their gene expression could be related to 
changes in cellular differentiation, due to the over-expression of Nurrl (Table 6).
Krtippel-Like Factors (KLF):  These are members of a family of transcription 
factors, which are important regulators of development, cellular differentiation and 
growth,  as  well  as  pathogenesis  of  atherosclerosis  and  tumor  development 
(Kaczynski  2003).  Members  of this  family  are  characterised  by  multiple  zinc 
fingers containing regions with conserved sequences (Bieker 2001).  A role for this 
family has been demonstrated in adipocyte biology.  One study has shown KLF2 
(LKLF) can decrease expression of PPARy as the promoter contains a consensus 
KLF binding site but also possibly through inhibtion of C/EBPa (Baneijee 2003). 
Others  have  shown  a  down-regulation  of  its  expression  during  differentiation 
(Soukas  2001, Burton 2002).  More recently, it has been established that KLF2 
does not actually affect the differentiation process per se, but actually maintains 
the cells in a preadipocyte form (Wu 2005).  Another member, for which a putative 
role  has  been  postulated,  is  KLF15.  KLF15  is  induced  late  in  3T3-L1  cell 
differentiation and positively regulates GLUT4 (Gray 2002).  It is also suggested
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characteristics of mature adipocytes through direct induction of PPARy expression 
(Mori 2005). The majority of the other family members have also been shown to 
up or down-regulated during differentiation of 3T3-L1  cells (Inuzuka 1999, Mori
2005).  A number of the KLF family members were conversely regulated in the 
microarray study.  KLF2, the negative regulator of adipogenesis, was up-regulated 
at the early time point and the surprisingly down-regulated at the later time point, 
for reasons unknown.  KLF4, 5 and 7 have previously been shown to be down- 
regulated  in  adipogenesis  and  are  upregulated  in  this  study  at the  earlier time- 
point, in the Nurrl over-expressing cells, with KLF4 still exhibiting an increase at 
the later time point.  KLF4 has been implicated in pro-inflammatory signalling and 
can be induced by IFNy, LPS and TNFa (Feinberg 2005).  KLF9, which has been 
shown in the Mori paper to up regulated during differentiation, is down-regulated 
at the later time point.  These results, along with what is already known about these 
factors would suggest multiple roles for this family in adipogenesis (Table 7).
Nuclear  receptors:  Quite  a  few  nuclear  receptors  with  implications  in 
adipogenesis appear to be differentially expressed in this experiment (Table 8). It 
cannot be categorically stated that these changes are due to Nurrl direct action on 
their expression, but perhaps it could be due to the non-differentiation of the cells 
and  lack of lipid accumulation.  Further work would be required to characterise 
whether the changes are directly mediated by Nurrl.
Rev-Erb alpha, encoded on the opposite strand of the thyroid receptor alpha gene, 
has been  shown to be dramatically induced during the differentiation of 3T3-L1 
cells (Chawla  1993).  It is possible that it acts as an enhancer of adipogenesis by 
acting downstream of PPARy (Fontaine 2003).  In contrast to this, its expression is 
down-regulated in C2C12 mouse myoblastoma cell line during differentiation into 
multinucleated myotubes (Downes  1995).  Its down regulation in this study could 
be due to the down regulation of PPARy.  Because it is encoded on the opposite 
strand to TRa, this could explain the down -regulation of this gene as well.  TRa is 
involved in the modulation of fatty acid synthesis via regulation of expression of 
lipogenic  enzymes.  SPOT 14,  a  thyroid  responsive  gene,  is  also  hugely  down- 
regulated in this study.
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during  differentiation  of  3T3-L1  cells  are  the  ROR’s  -   retinoid-like  orphan 
receptor.  ROR alpha and gamma were upregulated in 3T3-L1  cells while ROR 
beta could not be detected (Austin  1998).  ROR alpha and Rev-ErbA alpha have 
been  reported  to  have  opposing  effects  on  inflammatory  responses  in  VSMC, 
whether there  is  evidence  in  adipose  tissue  remains  unknown  (Laitinen  2005). 
However,  in  this  study both  ROR  alpha and ROR  gamma  are  down-regulated, 
again possibly due to the down regulation of PPARy and subsequent reduction in 
lipids.
Liver  X  receptors  have  a  well  established  role  in  regulating  cholesterol 
homeostasis (Tontonoz 2003).  They are also potent stimulators of fatty acid and 
triglyceride  synthesis  through  the  regulation  of  SREBPlc  and  its  downstream 
targets  (Yoshikawa 2001).  It has also been reported that LXR knock-outs have 
defective  hepatic  lipid  metabolism  and  are  resistant  to  diet  induced  obesity 
(Kalaany 2005).  There is also some evidence that LXR’s can regulate the activity 
of PPARy during adipogenesis and knock-down of LXR expression using siRNA 
inhibited differentiation (Seo 2004).  LXR expression is markedly reduced in this 
study and this reduction of LXR could be responsible for the reduced lipogenesis 
and subsequent adipocyte gene expression and lipid accumulation.
Another  nuclear  receptor  which  recently  has  been  shown  to  be  implicated  in 
differentiation  is COUP-TF1,  which was  induced  upon  the  addition of an  RAR 
agonist (TTNBP), known to inhibit adipogenesis (Brandebourg 2005).  It has also 
been shown that mutations of the fly homolog, Svp, impair body fat (Hoshizaki 
DK 1994).  Interestingly we observe an increase in COUP-TF1  expression at the 
earlier time  point.  As  a role for this  receptor has  not been  fully  elucidated  in 
adipogenesis, any conclusions as to why there is an increase would be difficult to 
reach until further study.
VDR  another receptor  in  which  an  increase  in  expression  from  the  microarray 
experiment  is  evident also has  some association  with  adipogenesis  and obesity. 
Recently,  it  has  been  demonstrated  that  VDR expression  is  one  of the  earliest 
nuclear  receptors,  excluding  the  NGFIB’s,  to  be  expressed  during  the 
differentiation of 3T3-Ll’s, with levels peaking at 4hrs and then returning to basal 
levels by 24hours (Fu 2005).  Polymorphisms in VDR have been associated with 
obesity  in  type  2  diabetes  with  early  age  of  onset  (Ye  2001).  Also,  serum
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(Arunabh  2003).  And  finally,  there  are  studies  to  suggest  that  in  vitro  VDR 
activation might inhibit adipogenesis (Sato 1988).
To date, ERRy has not been  shown to be expressed in  3T3-L1  cells.  Even the 
recent  paper  examining  the  expression  of  all  nuclear  receptors  in  3T3-L1 
differentiation  was unable to detect expression  (Fu  2005).  Therefore,  as of yet 
there is an unknown role for this receptor in adipose.
A  number  of  GPCR’s  were  shown  to  be  differentially  regulated  upon  over­
expression  of Nurrl,  with  a  number of these  known  to  be  involved  in  energy 
homeostasis,  satiety  and  hypertension.  The  activity  of these  GPCR’s  may  be 
regulated  by  nuclear receptors  and  their  ligands,  so  their differential  regulation 
may be a consequence of up/down regulation of these.  However, it is worthy to 
note, that the anti-lipolytic receptor HM74a and the free fatty acid receptor GPR43 
are greatly down-regulated at both time points (Table 9).
Steroids  and  adipose  tissue:  Sex  steroid  hormones  are  involved  in  the 
metabolism, accumulation and distribution of adipose tissue.  The distribution of 
fat is greatly different for men and women, with men having a more central fat 
deposition, whilst women a more gluteal/femoral accumulation (Bjomtorp  1996). 
LPL and leptin, two key adipose proteins, appear to be regulated by sex  steroid 
hormones in a classic genomic mechanism.  Normal amounts of steroids such as 
estrogen  and androgens favour homeostasis of adipose tissue,  with decreases  in 
either leading to some form of obesity, normally central (Mayes 2004).  It is also 
known that glucocorticoids, as mentioned earlier in Chapter 2, and the HPA axis 
have much influence on adipose tissue and so may be involved in the pathogenesis 
of  obesity.  The  enzyme  lip-HSD  (1  and  2)  inter-converts  the  active 
glucocorticoid,  cortisol,  and  inactive  cortisone.  lip-HSDl  is  the  only  isoform 
present  in  adipose  tissue,  where  it  acts  predominantly  as  an  oxoreductase  to 
generate  cortisol  (Ricketts  1998).  Given  the  direct  regulation  of  the  steroid 
synthesis pathway by members of the NGFIB family (Fig. 4.11) and the intricate 
involvement of steroids in adipose tissue, the results obtained by the microarray are 
very encouraging in the supposition of this family in adipogenesis (Table 4).  A 
number of steroid metabolising enzymes are all down-regulated, especially  110- 
HSD1,  inhibitors of which have been cited as potential obesity pharmacological
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metabolic syndrome some success has been met as a diabetes therapy (Barf 2002).
Nitric Oxide pathway: Specific amino acids, particularly L-arginine, can modify 
insulin action, perhaps through both NO-dependent and NO-independent pathways 
(Tong  2004).  L-arginine  either  acts  as  a  precursor  in  the  formation  of  NO, 
catalysed by a family of NO synthases (NOS), or is metabolised to L-omithine, 
urea  and  polyamines.  Intracellular  arginine  is  maintained  by  three  important 
processes:  transport  from  extracellular  sources  via  the  cationic  amino  acid 
transporters, intra-cellular protein degradation and biosynthesis in the  ‘citrulline- 
NO cycle’, where it is regenerated from citrulline via successive actions of ASS 
and ASL (Fig. 4.12) (Husson 2003).
Another enzyme that may participate in the cellular regeneration of L-arginine by 
providing cytosolic  citrulline is  DDAH  (Fig.  4.12).  This  enzyme  catalyses  the 
catabolism  of  asymmetric  dimethyl  arginine  (ADMA)  to  form  citrulline  and 
dimethlyamine. ADMA is released during the hydrolysis of proteins that contain 
arginine  residues  which  are  methylated  by  protein  arginine  methyltransferases 
(PRMTs).  It  competitively  inhibits  all  forms  of  NOS  and  therefore  causes 
endothelial dysfunction (Vallance 2002).  Thus, inhibition of DDAH activity could 
potentially  depress cytosolic citrulline, the  substrate for ASS,  as well  as elevate 
levels of an endogenous NOS inhibitor, and vice versa.
Both extracellular transport and intracellular regeneration contribute significantly 
to the levels of cellular arginine.  However their relative contributions may vary 
depending  on  the  prevailing  hormonal  and  metabolic  conditions.  It  has  been 
discovered that a number of the enzymes shown in Figure 4.12 are expressed in 
adipocytes, however, ASS, the rate-limiting step in the citrulline-NO pathway, and 
both isoforms of DDAH are particularly abundant.  The tissue generates significant 
amounts of ADMA, and DDAH activity is modifiable by changes in weight and 
insulin sensitizers (Mohamed-Ali 2005).  A number of the enzymes that regulate 
cellular NO are identified here, DDAH 1/2 and ASS, as being expressed in 3T3-L1 
cells and interestingly would appear to be increased upon the over-expression of 
Nurrl,  which  would  lead  to  a decrease  in  circulating  ADMA  levels  (Table  5). 
Putative PPAR response elements have been identified in the DDAH2 gene (Achan 
2002) which could possibly also function as NBRE’s.  Increases in ADMA levels
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modulate its expression would be advantageous.  Thus, ASS and DDAH may be 
good targets to regulate the production of NO.
As can be seen there are large number of gene changes brought about by the over­
expression  of Nurrl  in  differentiating  3T3-L1  cells.  It  is  more  than  likely  the 
changes at the earlier time point are due to Nurrl, whilst the later changes may 
reflect  the  pre-adipocyte  like  nature  of the  cell.  In  this  thesis,  only  a  smaller 
number  of  genes  have  been  discussed  and  the  comprehensive  involvement  of 
Nurrl  in regulating these pathways still needs to be further elucidated.  However, 
what is evident is the number of different cellular adipose functions which have 
been affected, some of which have not been recognised before eg NO pathway.
To date, most of the work in the thesis has concentrated on the over-expression of 
Nurrl  in differentiating 3T3-L1  cells.  Initial data in Chapter 2 demonstrated that 
the adipogenic cocktail induced a rapid transient induction of expression whereas 
the  subsequent  chapters  concentrated  on  the  overexpression  of  Nurrl  in 
differentiating cells.  What is unknown at this stage is whether or not the transient 
induction of Nurrl  is required for adipogenesis, by either switching off the genes 
which  maintain  the  cells  in  the  preadipocyte  state,  or  for  inducing  very  early 
adipogenesis  events.  The  next  chapter  demonstrates  preliminary  data  into  the 
knock-down  of  Nurrl  and  nur77  in  differentiating  3T3-L1  cells,  to  begin  to 
decipher which phenomenon the NGFIB’s are responsible for in adipogenesis.
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159Chapter 5 -  Effect of Nurrl gene knockdown on 
adipogenesis and adipocyte secretory functions
160Introduction
A  number  of  techniques  have  been  used  in  an  attempt  to  down-regulate  gene 
expression e.g. antisense oligonucleotides and ribozymes (Loke  1989, Funato  1992). 
However, they were relatively unsuccessful  in producing effective  silencing of the 
gene in question in complex mammalian systems.  Recent developments in the RNA 
interference methodologies have seen siRNAs become the method of choice for the 
down regulation of target genes.
RNAi was first used in gene knock down studies in C.elegans, drosophila and plants 
(Hamilton  1999,  Tuschl  1999,  Sijen  2001).  It  was  discovered  that  long  double­
stranded  RNA  can  specifically  silence  genes  through  an  evolutionary  conserved 
mechanism to protect against viral infections.  Introduction of long dsRNA inhibits 
gene expression  by  sequence specific degradation of mRNA.  The  long dsRNA  is 
digested into smaller 21-23mer active intermediates by a member of the RNase III 
family  of  dsRNA-specific  endonucleases,  Dicer  (Bernstein  2001).  These  small 
interfering RNAs (siRNAs) act as functional intermediates and induce target mRNA 
cleavage by being incorporated and unwound by the RNA inducing silencing complex 
(RISC) (Hammond 2000).  RISC then utilises the unwound antisense siRNA to bind 
to a complementary sequence on the mRNA and cleaves between nucleotide  10 and 
11  of  the  siRNA,  initiating  degradation  and  inhibiting  further  gene  expression 
(Elbashir 2001).
However, as a method, its use in mammalian systems is limited due to long dsRNA’s 
eliciting an  interferon response, resulting in general  inhibition of protein  synthesis, 
often leading to cell death (Baglioni  1979).  It was discovered that in contrast to the 
long  dsRNA.  siRNAs  (21-23nucleotides)  generally  do  not  elicit  this  interferon 
response (Elbashir 2001, Caplen 2001)  Over the past few years a number of methods 
have been developed to create these siRNAs including chemical  synthesis (Elbashir
2001), in vitro transcription (Donze 2002) or a vector based system (Miyagishi 2004). 
The efficiency of the siRNA is more dependent on the design of these siRNA, rather 
than the method of transfection itself.  Advances in the understanding of the actual 
biochemical mechanisms of action of siRNA (Schwarz 2003), statistical analysis of 
experimentally  verified  siRNA  (Mittal  2004)  and  sequence  characteristics  of 
functional siRNA (Reynolds 2004, Jagla 2005) have revolutionised target validation, 
drug discovery and therapeutic development.
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target  validation,  but the ability  to be able to down-regulate  the gene  and analyse 
functional and phenotypic changes is incredible.  The use of both approaches, over­
expression and siRNA, to complement each other, should allow elucidation of the role 
of Nurrl in adipogenesis.
As a target, the NGF1B family have been subjected to siRNA studies but mainly in the 
fields  already  described  in  Chapter  1.  Nurrl  has  been  knocked  down  in  vivo  to 
investigate the expression of genes related to the dopaminergic system of the ventral 
mesencephalon  (Backman  2003).  Both  Nurrl  and  nur77  down  regulation  in  the 
human granulosa-like cell  line,  KGN,  significantly decreased aromatase expression 
(Wu 2005).  And finally knock down of Nurrl  and nur77 in HeLa cells, reduced the 
anchorage  dependent  growth  and  promoted  intrinsic  apoptosis,  similar  to  that 
observed in other experimental cancer cell lines.  This work showed that both Nurrl 
and  nur77  exhibit  oncogenic  functionalities  with  regards  to  cell  proliferation  and 
apoptosis,  suggesting evaluation of these targets as potential therapeutic targets for 
cancer (Ke 2004).
To  date  all  the  experimental  work  in  this  thesis  has  concentrated  on  the  over­
expression  of  Nurrl  in  3T3-L1  adipocyte  cells.  This  chapter  focuses  on  very 
preliminary work on knock-down of Nurrl and nur77 in 3T3-L1 cells using siRNA.
162Experimental Procedures 
Nurrl and nur77 siRNAs
Mouse  Nurrl  SMARTpool  siRNA,  nur77  SMARTpool  siRNA  and  transfection 
control  siGlo  were  obtained  from  Dharmacon  (Perbio,  Northumberland  UK). 
SMARTpool  combines  four  SMARTselection-designed  siRNAs  with  a  high 
probability of knock down. Sequences for these were not available.  Reagents were 
resuspended as recommended by the manufacturer.
Transfection efficiency
3T3-L1  cells  were  seeded  in  6-well  plates  at  a  density  of 4xl05  cells  per  well. 
Transfections were performed when cells were 60-70% confluency.  siGlo (25nM and 
50nM) reagent was used to assess transfection efficiency into 3T3-L1  cells and also 
the  best  delivery  agent  -  Fugene  (Roche  Diagnostics,  East  Sussex  UK)  or 
Lipofectamine 2000 (Invitrogen, Paisley UK).
Fugene  method:  2pl  of  Fugene  was  diluted  in  300pl  of  Optimem  (Invitrogen). 
25nM/50nM  of  siGlo  was  diluted  in  300pl  Optimem,  mixed  and  the  complex 
incubated for 15 mins.  A further 400pi of Optimem was added to the complex, before 
adding to the cells. Cells were returned to incubator and incubated at 37°C 5% CO2 
for 6 hrs.  Transfection mix was removed after 6hrs and replaced with fresh growth 
media (as described in Chapter 2).
Lipofectamine  2000  Method:  lpl  of Lipofectamine  2000  was  diluted  in  300pl  of 
Optimem.  Then followed as per Fugene method above.
24  hrs  post-transfection  the  cells  were  assessed  for  transfection  efficiency  by 
fluorescence light microscopy (Abs Max 550nm, Emission Max 570nm).
Nurrl and nur77 siRNA Transfections
Following the Lipofectamine 2000 protocol, 3T3-L1  cells were transfected as before 
with  InM,  lOnM  or  50nM  of  Nurrl/nur77  or  25nM  of  siGlo  control  or  mock 
transfected.  Post  confluent  cells  were  treated  with  the  differentiation  cocktail  as 
described  in  Chapter  1   (dexamethasone,  IBMX and  insulin).  2  hrs post-induction 
cells  were  lysed  for  RNA  extraction,  cDNA  synthesis  and  SybrGreen  analysis  as 
described before.
163Functional analysis of Nurrl and nur77 siRNA in 3T3-L1 cells
As outlined  in the transfection protocol above,  3T3-L1  cells  were transfected  with 
lOnM of Nurrl,  nur77 or siGlo Control. Cells were then grown to confluency and 
differentiated with IBMX alone.  14 days post-differentiation cells were analysed for 
differentiation efficiency by Oil Red O staining.
Statistical analysis
Results  are  expressed  as  mean±SD  or  SEM  for  normally  distributed  values  or  median 
(interquartile  range)  for skewed data.  Comparisons between  groups  were  made by  two- 
tailed Student's r-test, Mann-Whitney U test or Wilcoxon rank test, as appropriate. P < 0.05 
was considered to be statistically significant.
164Results
3T3-L1 cells transfection efficiency with siGLO
3T3-L1  cells  were  assessed  for  their  transfection  efficiency  using  siGlo  siRNA 
control with either Fugene or Lipofectamine 2000.  siGlo siRNAs are labelled with 
the fluorophore Cy3, which produces a strong, punctate, perinuclear staining pattern 
that is sustained in cultured cells for at least 7 days.  These are a non-targeting, non­
functional siRNA, which can be used to assess transfection efficiency or as a negative 
control.  The  fluorescence  observed  24-48hrs  post-transfections  is  most  likely 
associated with the intact molecule.
The 3T3-L1  cells proved to be very susceptible to toxicity issues, resulting in cell 
death.  Initial experiments performed using lOOnM siGlo proved toxic to the cells, so 
25nM and 50nM were chosen for subsequent transfections.  Upon examination under 
a fluorescent microscope, Fugene transfected cells displayed no fluorescent signal at 
either concentration.  Lipofectamine transfected cells displayed transfection efficiency 
in the region of 75% at the lower concentration of siGlo which also demonstrated the 
least  toxicity  issues.  There  was  some  evidence  of toxicity  visible  at  the  higher 
concentration used.  The appearance of the cells was less fibroblast-like.
Nurrl and nur77 siRNA in 3T3-L1 cells
Using the optimised siGlo protocol, 3T3-L1  cells were transfected with a range of 
concentrations of either Nurrl or nur77 (InM, lOnM, 50nM), siGlo (25nM) and mock 
transfected cells  (Lipofectamine 2000 only).  Following transfection the cells were 
grown  to  confluency  before  the  addition  of  the  differentiation  cocktail 
(dexamethasone, insulin, IBMX) and then 2hrs post-induction the cells were lysed for 
RNA  extraction  and  analysis  by  SybrGreen  for both  Nurrl  expression  and  nur77 
expression (Fig 5.1  -  5.4).  Between 70-80% knockdown at the mRNA level was 
evident for both Nurrl and nur77.  No effect was evident on nur77 expression in the 
Nurrl  siRNA experiment, whilst some evidence of compensation was evident in the 
nur77 siRNA experiment.
14 Days post IBMX differentiation the cells were analysed for lipid accumulation by 
Oil Red O staining.  It was difficult to draw any conclusions from this experiment.
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Fig. 5.1 Nurrl expression in 3T3-L1 cells expressing Nurrl siRNA
Nurrl  expression  as  assessed  by  SybrGreen  Analysis  and  expressed  as  %age 
induction  compared  to  the  control  mock-transfected  cells,  with  SEM,  n=3.  Data 
normalised to P-actin.
* p=0.04,  **p=0.003
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Fig. 5.2 nur77 expression in 3T3-L1 cells expressing Nurrl siRNA
nur77  expression  as  assessed  by  SybrGreen  Analysis  and  expressed  as 
induction  compared  to  the  control  mock-transfected  cells,  with  SEM. 
normalised to J3-actin.
* p— 0.05 -  ns.
Ctrl
%age
Data
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Fig. 5.3 nur77 expression in 3T3-L1 cells expressing nur77 siRNA
nur77 expression  as assessed by SybrGreen Analysis and expressed as mean %age 
induction  compared  to  the  control  mock-transfected  cells,  with  SEM,  n=3.  Data 
normalised to P-actin.
** p-< 0.0l
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Fig. 5.4 Nurrl expression in 3T3-L1 cells expressing nur77 siRNA
Nurrl expression as assessed by SybrGreen Analysis and expressed as mean %age 
induction compared to the control mock-transfected cells, with SEM, n=3.  Data 
normalised to P-actin.
**p<0.01
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Fig. 5.5 Oil red O staining of differentiated 3T3-L1 cells following transfection 
of siRNA
3T3-L1  cells were transfected with siRNA for a) siGlo control, b) Nurrl, c) nur77 
and then differentiated with IBMX alone.  Cells assessed for lipid accumulation by 
Oil Red O staining 14 days post differentiation.
170Discussion
Dharmacon’s SMARTpool technology is based on 4 non-identical siRNAs directed at 
different regions of the target sequence ensuring efficient knock-down of the gene. 
The scientist can then perform further experiments to identify which siRNA produces 
the  best  down  regulation  of  the  target.  Unfortunately  at  the  early  stage  of 
optimisation  the  sequence for each duplex  is  unknown to the  scientist.  Based on 
statistically significant analysis and specific algorithms, Dharmacon guarantee at least 
75% knock-down, when “transfected under optimal cell culture conditions”.
3T3-L1  cells  are,  as  discussed  in  chapter  3,  notoriously  difficult  to  transfect. 
However, advances have been made with the cationic lipids available for use today. 
Surprisingly  Lipofectamine 2000 exhibited the most efficient transfection  (75%) of 
the siGlo reagent and Fugene which is marketed as being able to transfect even the 
most difficult cell  lines failed.  Another means which would be a potential way to 
introduce  the  siRNA  to  the  cells  is  Amaxa  Nucleofector  technology.  This  is  a 
technology which is especially designed for primary cells and hard-to-transfect cell 
lines.  It is a non-viral method based on electroporation and cell specific solutions. 
The  DNA  is  delivered  directly  to  the  cell  nucleus,  thereby  allowing  detection  of 
expression a few hours later.
Both Nurrl  and nur77 siRNAs were used in the experiment as it is known that these 
family  members  can  play  redundant  roles  for each  other  (Crawford  1995,  Cheng 
1997).  Both siRNAs appear to work well in 3T3-L1  cells in that, on average a 75% 
knock-down  of both  genes  is  evident.  In  the  Nurrl  down-regulated  cells,  nur77 
expression  appears  to be  unaffected.  However,  in the  nur77  down-regulated cells 
Nurrl  expression is at least 2 fold higher than the control cells.  This result correlates 
well with literature reports on the nur77 knock-out mouse -  which demonstrates an 
increase in expression of Nurrl  in the absence of nur77 (Crawford  1995) (Fig. 5.1- 
5.4).
A limited number of functional studies have been performed on the siRNA studies. 
An  initial  study  to  assess the  ability of 3T3-L1  cells to undergo adipogenesis  and 
differentiate into adipocytes was carried out using an IBMX only protocol.  IBMX 
alone has the ability to differentiate about 60% of the population of cells.  The reason 
IBMX was chosen as the sole differentiation inducer in this particular experiment is 
because  it  is  known  from  Chapter 2  (Fig.  2.10) that IBMX  is  the  sole  inducer of 
Nurrl, in the differentiation cocktail.  nur77 can also be induced but to a lesser extent
171that Nurrl.  The preliminary results are at this stage quite inconclusive as there is no 
SybrGreen mRNA data on each of the adipogenesis markers that have been analysed 
before (Chapter 3).  It could be postulated that perhaps nur77 knock down cells have 
differentiated to a slightly greater degree than either the control or Nurrl knock-down 
cells (Fig. 5.5).  However, at this stage it is unknown how stable the silencing of each 
siRNA  species is.  Following the three day incubation in IBMX the cells are then 
replenished  with  medium containing insulin,  which  is known  to  induce  nur77  and 
induce  Nurrl  to  a  very  small  degree  (Fig.  2.8).  This  may  have  an  effect  on  the 
experiment.
The unprovoked release of IL-6 from 3T3-L1  cells post-differentiation has also been 
examined.  However, the data from this experiment was unreproducible due to a high 
degree of variability and the level of sensitivity to measure IL-6 is at the lower end of 
detection of the ELISA kit.  This would need to be repeated in primary adipocytes 
which have a higher basal concentration of IL-6.
The results obtained in this chapter are all very preliminary and further work would be 
required  to  optimise  the transfection  of the  siRNA  and  to  analyse  the  effect  that 
knock-down of Nurrl and nur77 will have on 3T3-L1 cells.  It is likely that the down- 
regulation  of  both  NGFIB  species  will  be  required  to  assess  their  function  in 
adipocytes and adipogenesis.  It will also be very important to assess the knock-down 
of the  mRNA  also  results  in  knock-down  at  the  protein  level.  As  the  available 
antibodies appear not to be very specific for family members further work will be 
required to assess/design a more specific antibody (see supplementary data).
172Chapter 6: Conclusions and Future Plans
173Interest in the NGFIB family has escalated dramatically in the last 2-3 years with a 
wealth  of data published on  their implications  in  a  number of disease areas  from 
Parkinson’s  disease  (Le  2003)  to  inflammation  (Crofford  1993,  McEvoy  2001, 
McEvoy 2003, Pei 2005).  Pharmaceutical interest has waned slightly as data would 
suggest that this  family  may be intractable as drug targets  in  the  more  traditional 
approach.  However, as a family of nuclear receptors they remain some of the most 
fascinating and interesting molecules.  The data presented herein is some of the first 
data on their involvement and implications in the secretory and metabolic adipocyte 
functions, as well as in adipocyte differentiation.
Initial  findings  showed  that  this  family  were  highly  expressed  in  human  adipose 
tissue, with evidence that Nurrl  could be induced during differentiation (Chapter 1). 
The results presented in Chapter 2 formed the basis of the project as they follow up 
and substantiate this initial data.  In these studies, it was found that NOR-1  was not 
basally  expressed  in  adipocytes  and  recent  evidence  seems  to  suggest  that  its 
expression  may  need to be induced by  P-adrenergic  agonists  (Muscat 2005).  This 
family  member  appears  to be  predominantly  associated  with extraskeletal  myxoid 
chondrosarcoma (EMC), through fusions and translocations (Ohkura 2002) and at this 
stage it because of its lack of involvement in adipogenesis it was decided to not study 
this  further  in  this  project.  Murine  adipocyte Nurrl  and  nur77  exhibited  similar 
expression patterns during adipogenesis to those obtained from the human cells, in 
that  they  are  both  rapidly  and  transiently  elevated  very  early  in  the  adipogenic 
process.  This  was then further confirmed by the expression data in  adipose tissue 
fractions and found that the Nurrl  and nur77 receptors diverge in their expression 
profiles.  Following collagenase digestion of adipose tissue nur77, the more abundant 
of the two receptors, appears to be equally abundant in both the adipocyte and stromal 
vascular fractions, whilst Nurrl  is expressed  10-fold higher in the stromal vascular 
fraction.  Both  are significantly induced during differentiation,  but are induced by 
different stimuli.  Nurrl  is preferentially and potently induced by the cAMP inducer, 
IBMX.  cAMP is an important regulator of both adipogenesis and lipolysis.  It has 
also  been  shown  that  Nurrl  has  a  cAMP response  element  present  its  promoter, 
whereas the nur77 promoter does not appear to contain one (Ohkubo 2000, McEvoy
2002).  This combination of data suggested that Nurrl is the family member which is 
most likely to be implicated in the adipogenic program.
174The  transient  nature  of  induction  of  Nurrl  makes  studying  the  function  of  its 
expression  a  little  more  challenging;  however  there  are  many  over-expression 
methods available for use, although not all are amenable to all cell lines eg 3T3-L1 
cells.  In Chapter 3,  adenovirus over-expression  of Nurrl  is described in order to 
investigate  the  function  in  the  mouse  3T3-L1  cell  line.  Despite  the  transient 
induction of Nurrl  expression it must be remembered that it is possible that in vivo 
constitutive  expression  of this  receptor  may  exist,  as  adipose  tissue  reveals  high 
expression  of  Nurrl.  Astonishingly,  dramatic  results  were  achieved,  with  a 
significant reduction in PPARy expression and substantial decrease in expression in 
several adipocyte specific genes.  In addition, at the phenotypic level, a significant 
decrease  in  lipid  accumulation  was  also  evident.  Glucose  uptake  and  lipolysis 
experiments were challenging to conduct and interpret.  Both experiments work on 
the  premise  of lipid laden cells and as discovered Nurrl  dramatically reduced the 
lipid  accumulation.  Numerous  attempts  were  made  to  perform  the  experiments 
including addition of the virus following differentiation.  But as already described this 
produces  another  set  of  challenges.  The  methods  employed  to  analyse  gene 
expression  initially  are  at  best  not  very  high  through-put  and  so  limiting  in  the 
quantity of data that can be extracted.  Therefore, microarray experiments were used 
as a follow-up experiment, as described in Chapter 4.
The  data  obtained  by  the  powerful  microarray  technique  opens  many  different 
avenues and provides data on changes in expression of numerous genes involved in 
adipogenesis.  The changes that were expected e.g.  PPARy,  CD36 etc did  indeed 
behave as in the SybrMan experiments in Chapter 3.  The exact expression levels may 
be  some  what  different as  neither technique  is  wholly quantitative.  Interestingly, 
Nurrl over-expression did appear to have an affect on C/EBPa, not seen by SybrMan. 
However, this could be dependent on primer design and position.  This needs to be 
followed up for future work.  At this early stage it cannot be categorically stated 
whether Nurrl  over-expression directly or indirectly results in the gene expression 
changes  evident  from  the  microarray  data.  A  number  of the  genes  with  altered 
expression  do indeed have NGFIB  response elements in their promoters.  It could 
also  be  postulated  that  Nurrl  changes  in  PPARy  expression  mediate  downstream 
effects.  It is possible that the early reduction in PPARy expression is responsible for 
the decrease in expression of many of the adipogenic genes.  The gene changes of 
most interest are those at the earlier time point, 72hrs, as the changes at this point are
175the  ones  that  shape  the  adipogenic  pattern.  The  microarray  results  also  present 
interesting data on a number of cytokines (adipokines) which were then followed up 
using ELISA’s.  The results obtained at the mRNA level accurately predicted those 
obtained when monitoring protein release using the ELISA technique.
So  this  data taken  in  conjunction  with  the  data presented  in  the  previous  chapter 
strengthens  the  role  for  Nurrl  in  adipogenesis  both  at  the  gene  expression  and 
secretory function level.
To date all the data concentrate on the over-expression of Nurrl in 3T3-L1 cells and 
even though this provides a wealth of functional data, it would also be useful to know 
what would happen if the transient induction of Nurrl  were not to occur.  What is 
unknown at this stage is whether or not the transient induction of Nurrl  is required 
for adipogenesis, by either switching off the genes which maintain the cells in the 
preadipocyte  state,  or  for  inducing  very  early  adipogenesis  events.  The  Nurrl 
homozygote knock-out is embryonic lethal and in the timescale of the PhD it has not 
been possible to obtain the heterozygote mice and is definitely worth considering for 
future  work.  The alternative option was to employ the current exciting and novel 
siRNA  technology.  Although  timescales,  did  not  allow  full  exploitation  of  this 
technique, it did show that both Nurrl and nur77 mRNA expression can successfully 
be diminished to near insignificant levels (Chapter 5).  It is known that Nurrl  can 
compensate for nur77 expression as is evident in the nur77 knock-out mice, although 
the opposite was not reported for Nurrl, perhaps due to the nature of the lethality - no 
known role for nur77 in dopamine synthesis.  So it was investigated whether or not 
knock-down of both genes would be required to perform the subsequent experiments. 
It would appear that the results obtained in these very preliminary experiments mirror 
that obtained in animal models.  Further work is planned to evaluate the knock-down 
of these genes in differentiating 3T3-L1 cells.
In conclusion, through the use of many molecular biology and cellular techniques a 
role for Nurrl has emerged in adipose tissue and adipogenesis.  Here in the very early 
novel results are presented suggesting that this nuclear receptor may play an opposing 
role to PPARy, and hence have a putative role in adipogenesis, lipid accumulation 
and  adipocyte  secretory  function,  with  implications  for  insulin  resistance  at  the 
adipocyte  level.  Adipogenesis  and the  program  of events  which  bring  about  the 
differentiation of pre-adipocytes to adipocytes have been extensively studied over the 
last number of years.  More recently interest in the events which inhibit or alter the
176adipogenic programme has grown.  However the genes studied to date have produced 
varied results depending on the cell types and conditions used.  This could be due to 
the fact the programme of events are controlled at the transcriptional level and only 
changes in transcriptional events will bring about true changes.
The data presented in this thesis provides an excellent outlay for future work.  The 
data obtained by the microarray study also provides a vast amount of information that 
can be utilised and scrutinised further to fully elucidate the mechanism of action of 
Nurrl in other adipose tissue functions.
Of  course,  further  work  is  required  to  tease  out  the  exact  role  of  Nurrl  in 
adipogenesis and this will rely on  using over-expression and siRNA techniques as 
laid out below, perhaps with some adaptations.
One approach which could be employed is to reduce the variability produced by the 
adenovirus over-expression.  As a method it is an excellent means to introduce your 
gene of interest into cultured cells, however there is intrinsic  variability associated 
with it.  A relatively new method using, more established techniques would be the use 
of the Amaxa  nucleofector - a method based on electroporation  (and cell  specific 
solutions) to introduce DNA to cells.  DNA is delivered directly to the cell nucleus 
and expression can be detected very shortly after nucleofection.  It is also possible to 
generate  stable  integrants  of the  gene  of interest,  thereby  eliminating  the  need  to 
continually transfect cells, reducing experiment to experiment variation.
The siRNA work would also need further validation and follow-up on the effect of 
knock-down on adipogenesis.  From the perspective of siRNA expression, the above 
technique  could  also be  employed to  increase  the  transfection  efficiency.  Similar 
experiments to those employed in the over-expression studies could then be used to 
fully elucidate the effect of Nurrl on adipogenesis.
Some very preliminary work has been performed (not reported here) on the induction 
of Nurrl  by other stimuli and it is possible to induce its expression through IL-ip, 
forskolin and PGE2.  However, sustained expression has never been achieved.  There 
are reports in the literature of activators of Nurrl, so it would be interesting to confirm 
the activity of these “activators” and examine their effects during differentiation in 
3T3-L1  cells,  primary  mouse  cells  or  even  human  primary  cells.  Also,  from  a 
pharmacological stand-point, investigations into Nurrl/RXR specific agonists would 
be hugely exciting and perhaps the best way forward to modulate Nurrl  regulated 
pathways.
177Another  avenue  which  would  be  tremendously  advantageous  in  the  dissection  of 
Nurrl  in adipose tissue function would be through the use of animal models.  There 
are a number of approaches which could be used.
i)  Obtain heterozygote Nurrl  mice (Thomas Perlmann,  Karolinska Institute, 
Stockholm) and extract adipose tissue for analysis.  Tissue could be fractionated into 
adipocytes and stromal vascular fractions which could be subsequently cultured for 
differentiation experiments.
ii)  Tissue transplant studies:  Over-expression  of Nurrl  using adenovirus  in 
3T3-L1 cells and then transplant these cells into mice and analyse the effects.
iii)  Generation  of  adipose  tissue  specific  knock-outs  (possibly  conditional 
knock-outs) and again analyse the effects.  These types of experiments would depend 
on the outcome from the siRNA work.
The  pathways  referred  to in Chapter 4, NO pathway,  steroidogenesis and cytokine 
production are hugely exciting and perhaps some of the more interesting and novel 
data  to  come  from  the  microarray  experiment.  Investigations  into  the  pathways, 
several  of which are over-lapping,  in obesity associated pathologies would provide 
today’s society with greater insight into both the development of metabolic disease 
and provide targeted drug therapies.
178Supplementary Data
1791   2  3  4  5  6
Supplementary Figure showing Western Blot using Nurrl  specific antibody.  Lane 
1&2 Nurrl  Gal4 LBD, Lane 3&4 NOR-1  Gal4 LBD, Lane 5&6 nur77 Gal4 LBD. 
Lysates  from  transient  transfections.  Expected  band  at  approximately  30kD  is 
faintly evident in lanes 1  and 2 but some evidence in 5 and 6.  Many other products 
also detected.
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